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First articulated half a century ago, allostery has remained a universal 
phenomenon and is essential in understanding processes beyond the molecular level, 
such as cellular signaling and disease. Allostery, also referred to as allosteric regulation, 
is a process by which biological macromolecules transmit the effect of binding at one site 
to an often distal, functional site, allowing for regulation. To facilitate the modulation of 
function between sites, allosteric signal is propagated through conserved amino acid 
residues, often comprising various structural elements of a protein. In general, allosteric 
communication is of fundamental interest and potentially of high relevance for drug design 
and protein engineering. Furthermore, the dysfunction of allosteric networks has been 
implicated in the etiology of human diseases. However, defining these networks of 
residues that mediate crosstalk between distal sites remains experimentally challenging 
and thus, poorly characterized. Since allosteric signal propagation relies on subtle 
conformational rearrangements, nuclear magnetic resonance (NMR) has emerged as an 
instrumental tool in investigating allosteric communication. This thesis aims to map 
allosteric networks at atomic resolution to understand how mutations in protein kinase A 
(PKA) influence allosteric communication to elicit the progression of various disease 
states. In this work we demonstrate how disease mutations associated with Cushing’s 
Syndrome and Fibrolamellar Hepatocellular Carcinoma attenuate the allosteric network of 
PKA, thereby disrupting the finely tuned regulation, specificity, and activation of PKA to 
generate dysfunctional signaling. The findings of this thesis provide critical insights into 
the importance of intramolecular allostery in facilitating functional signaling, directly 
showing how changes in allosteric networks of proteins lead to dysfunction.  
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Allostery, also referred to as allosteric regulation, is a process by which biological 
macromolecules transmit the effect of binding at one site to an often distal, functional site, 
allowing for regulation. First articulated half a century ago, allostery has remained a 
universal phenomenon and is essential in understanding processes beyond the molecular 
level, such as cellular signaling and disease[1-3]. Despite its importance, allosteric 
mechanisms have remained an enigma, eluding a general, quantifiable and predictive 
atomic description.  
Allostery has evolved over time as experimental techniques have improved. The 
first allosteric protein studied, hemoglobin, was highly amenable to high-resolution x-ray 
crystallography. Thus, classical models of allostery, including the Monod-Wyman-
Changeux (MWC)[4] and the Koshland-Nemethy-Filmer (KNF) models[5], evolved from 
static structural images and led to the paradigm that allostery involves conformational 
change. Indeed, further studies involving hemoglobin by Parsegian and colleagues[6], and 
later Nussinov[7, 8], deduced that allosteric transitions involved multiple pre-existing 
dynamic and conformational states, whose relative populations were tunable over a range 
of physiological conditions. As experimental structural, dynamic, and thermodynamic 
approaches have been developed, modern descriptions of allostery have become more 
complex, with the static-centric view of allostery being replaced by more quantitative, 
dynamic views. Regardless of the view, allostery offers a highly specific way to modulate 
protein function and control nearly all biological processes. 
To facilitate the modulation of function between sites, allosteric signal is 
propagated through conserved amino acid residues, comprising various structural 
elements, defined as an allosteric network or pathway. In general, allosteric 
communication is of fundamental interest and potentially of high relevance for drug design 
and protein engineering. Furthermore, the dysfunction of allosteric networks has been 
significantly associated with the etiology of human diseases[9-12]. However, defining 
these networks of residues that mediate crosstalk between distal sites remains 
experimentally challenging and thus, poorly characterized. Computational approaches 
have provided insights into some of the underpinnings of allostery, but have their 
shortcomings[13-15]. Since allosteric signal propagation relies on subtle, but critical 
conformation and side-chain packing rearrangements, nuclear magnetic resonance 
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(NMR) has emerged as an instrumental tool in investigating allosteric communication[16-
18].  
Regulating nearly all cellular processes, protein kinases comprise one of the 
largest and most diverse families of enzymes. Protein kinases act as molecular switches 
by phosphorylating Ser/Thr/Tyr groups to modulate the activity of protein substrates. It has 
been estimated that nearly one-third of all cellular proteins are phosphorylated at some 
stage. Given their role in dictating cellular signaling outcomes, the catalytic activity of 
kinases is stringently regulated. Indeed, abnormal phosphorylation patterns are observed 
in various pathological conditions including endocrine disorders[19, 20], cancers[21], 
immunodeficiencies[22], and cardiovascular disease[23]. 
For the past few decades, mutations in kinase genes have been found to underlie 
many human diseases, and the knowledge of these diseases is of great clinical 
interest[24, 25]. Mutations can either be activating or inactivating, although activating 
mutations are much more commonly associated with disease as they often cause 
constitutive activation leading to pronounced phenotypes. A mechanistic understanding of 
the molecular mechanisms underlying mutations involvement in various disease states is 
likely to revolutionize treatment.  
Cyclic AMP-dependent protein kinase A (PKA) has served as the prototype for the 
eukaryotic kinase superfamily, modulating most of the physiological response to cAMP in 
the cell. Recently, genetic alterations in PKA have been associated with a variety of 
metabolic and tumorigenic disease states, most recently, Cushing’s syndrome (CS)[26-
30] and Fibrolamellar Hepatocellular Carcinoma (FL-HCC)[31, 32]. While an enormous 
amount of information about the structure and function of PKA is available, the 
mechanisms underlying these disease states are largely unknown. The overall goal of this 
work is to map allosteric networks based on the covariance analysis of chemical shifts to 
elucidate, at atomic resolution, how mutations in PKA-C influence allostery and elicit the 
progression of various disease states.  
Specifically, this thesis aims to address the following questions: How do mutations 
in PKA-C influence allostery and cooperativity to elicit the progression of various metabolic 
and tumorigenic disease states? What role do alterations in intramolecular allostery and 
cooperativity play in PKA-C regulation, activity, and substrate specificity? Is there a 
relationship between binding cooperativity and intramolecular allostery? These questions 
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were addressed using a combination of NMR spectroscopy, isothermal titration 
calorimetry (ITC), activity assays, and molecular dynamic (MD) simulations.  
Chapter 1 reviews background on PKA structure, regulation, and catalysis, and 
introduces the involvement of PKA in various human diseases. Chapter 2 discusses some 
of the major advances in solution-state NMR methods that have facilitated the 
characterization of allostery as applied to cAMP-dependent protein kinase A. The following 
chapters consist of re-prints with permission from peer reviewed articles. A cumulative list 
of publications published or in preparation are located at the end of this thesis, including 
works that address topics outside the scope of this thesis. 
Protein-protein interactions (PPIs) regulate nearly all cellular processes, though 
the study of them by NMR spectroscopy is usually complicated by the necessity to prepare 
multiple samples to ‘visualize’ all components. Chapter 3 reviews a method that is 
applicable for the study of PPIs using a combination of asymmetric labeling and a selective 
pulse sequence. 
Chapter 3: “Probing Protein-Protein Interactions Using Asymmetric Labeling and 
Carbonyl-Carbon Selective Heteronuclear NMR Spectroscopy.” Larsen, E.K.; Olivieri, C.; 
Walker, C.; V.S., M.; Gao, J.; Bernlohr, D.A.; Tonelli, M.; Markley, J.L.; Veglia, G. (2018) 
Molecules. 23, 1937. PMCID: PMC6205158. 
Recent literature has identified mutations in PKA-C that are linked to the 
development of cortisol-secreting adrenocortical adenomas resulting in Cushing’s 
syndrome, but the aberrant mechanism of these mutations is unknown. Motivated by this, 
Chapter 4 details how the most common Cushing’s syndrome mutation disrupts the 
intramolecular allosteric network eliciting changes in cooperativity, substrate specificity, 
and regulation.  
Chapter 4: “Cushing’s Syndrome Driver Mutation Disrupts Protein Kinase A Allosteric 
Network Altering Both Regulation and Substrate Specificity.” Walker, C.; Wang, Y.; 
Olivieri, C.; Karamafrooz, A.; Casby, J.; Bathon, K.; Calebiro, D.; Gao, J.; Bernlohr, D.A.; 
Taylor, S.S.; Veglia, G. (2019) Science Advances. 5, eaaw9298. PMCID: PMC6713507. 
An aberrant fusion of the DNAJB1 and PRKACA genes generates a chimeric 
protein kinase that is the oncogene responsible for the pathogenesis of Fibrolamellar 
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Hepatocellular Carcinoma (FL-HCC). Chapter 5 probes the contribution of dysfunctional 
allosteric cooperativity of this chimeric protein kinase in eliciting FL-HCC. 
Chapter 5: “Defective Internal Allosteric Network Imparts Dysfunctional ATP/Substrate 
Binding Cooperativity in Oncogenic Chimera of Protein Kinase A.” Olivieri, C.*; Walker, 
C.*; Karamafrooz, A.*; Wang, Y.; V.S., M.; Porcelli, F.; Blumenthal, D.K.; Thomas, D.D.; 
Bernlohr, D.A.; Sandford, S.M.; Taylor, S.S.; Veglia, G. (2021) Communications Biology. 
4(321). PMCID: PMC7946884.   *authors contributed equally 
Multiple mutations are associated with Cushing’s syndrome, all lying on the R-
subunit interface with the exception of one. Chapter 6 investigates an allosteric Cushing’s 
syndrome mutation, showing that losses in binding cooperativity are proportional to 
attenuations in intramolecular allostery and further suggesting a common mechanism 
underlies all Cushing’s syndrome mutations. 
Chapter 6: “Is Disrupted Nucleotide-Substrate Cooperativity a Common Trait for 
Cushing’s Syndrome Driving Mutations of Protein Kinase A?” Walker, C.; Wang, Y.; 
Olivieri, C.; V.S., Manu; Gao, J.; Bernlohr, D.A.; Calebiro, D.; Taylor, S.S.; Veglia, G. 
(2021) Submitted. 
The findings of these works provide critical insights into the importance of 
intramolecular allostery in facilitating functional signaling, while at the same time directly 
show how changes in allosteric networks of a protein lead to disease. Furthermore, the 
work presented here shows the intricacy of allosteric information transfer and 
demonstrates how small perturbations to protein or ligand architectures can disrupt 
catalytic function through alterations of these networks and conformational ensembles. 
These studies provide a foundation for future studies on the allosteric mechanisms of 
proteins and their disease-associated variations with a particular emphasis on how 
mutations and ligands exert control over allosteric networks to manifest (dys)function. 
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 Overview of cAMP-dependent Protein 
Kinase A 
1.1 Protein Phosphorylation and Protein Kinases 
Protein phosphorylation is one of the most common and most important post-
translational modifications, responsible for regulating every basic cellular process 
including metabolism, cell growth, cell division, muscle contraction, immunity, and 
memory. Protein kinases are responsible for catalyzing the transfer of the γ-phosphate 
from adenosine triphosphate (ATP) to specific amino acids in proteins – in eukaryotes, 
these are usually Ser, Thr, and Tyr residues. Indeed protein kinases themselves are in 
turn regulated by phosphorylation, along with inhibitory and activation protein partners, 
cellular localization, protein degradation and gene transcription. Considering the broad 
importance of phosphorylation in signal transduction, it is not surprising that over 500 
kinases have been discovered and that they comprise ~2% of the human genome[33]. 
Furthermore, it is estimated that 30% of all cellular proteins are phosphorylated on at least 
one residue.  
Despite their diversity in sequence and regulation, all kinases share a highly 
conserved catalytic domain fold that was first observed following the crystallization of 
cAMP-dependent protein kinase A (PKA) in 1991[34-36]. This crystal structure not only 
provided the canonical domain organization of a kinase but also revealed how kinases 
recognize peptide/protein substrates[37]. Classical protein kinases have catalytic domains 
of 250-300 amino acids in length. The catalytic domains adopt a bilobal fold, consisting of 
two structurally and functionally distinct lobes that contribute to catalysis and regulation. 
Details regarding specific structural features of kinases within each catalytic domain will 
be discussed further in section 1.2 in the context of PKA. Briefly, the smaller N-lobe is 
composed of 5 β-sheets and 1 helical subdomain called the αC-helix, while the larger C-
lobe is composed of α-helices plus a β-sheet. Between the N- and C-lobe is the binding 
cleft (commonly known as the active site) responsible for binding adenosine triphosphate 
(ATP), with the adenosine moiety buried in a hydrophobic pocket and the phosphate 
backbone oriented outward towards solution, and one or two divalent cations: magnesium 
or manganese. These cations provide coordination within the active site. The C-lobe on 
the other hand serves as a tethering surface for substrates, positioning them appropriately 
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for phosphoryl transfer. In addition to a conserved domain layout, all catalytic domains 
contain a conserved set of non-consecutive hydrophobic residues referred to as “spines” 
that anchor all elements important for catalysis to the αF-helix, located within the C-lobe. 
The regulatory spine (R-spine) is the hallmark of an active kinase and is assembled as 
part of regulation. In contrast, the catalytic spine (C-spine) is completed upon the binding 
of the adenine ring of ATP[38, 39]. 
While their core domain fold is conserved, most kinases are flanked by other 
domains or are a part of a multi-subunit complex that is in part responsible for the 
regulation of the catalytic domain. The toggle between active and inactive states is often 
complex and highly regulated. In the case of PKA, N- and C-terminal extensions flank the 
catalytic (C) subunit to assist in maintaining PKA-C in an active conformation, while relying 
on regulatory subunits to regulate activity. Whereas for cyclin dependent kinase 2 (Cdk2), 
activation is dependent on the association with a cyclin subunit. Along with 
phosphorylation on the activation loop, these domains or subunits are ultimately 
responsible for properly positioning subdomains (αC-helix, activation loop, DFG motif) or 
motifs within the catalytic domain. 
1.2 Architecture of PKA-C 
The sequence homology of kinases was first described in a monumental paper by 
Hanks and Hunter in which they described, from 65 known sequence available at the time, 
conserved residues and twelve ‘subdomains’ that are conserved throughout the 
kinome[40, 41]. From these comparisons, twelve residues: Gly50 and Gly52 in subdomain 
I, Lys72 in subdomain II, Gly91 in subdomain III, Asp166 and Asn171 in subdomain VIB, 
Asp184 and Gly186 in subdomain VII, Glu208 in subdomain VIII, Asp220 and Gly225 in 
subdomain IX, and Arg280 in subdomain XI, were recognized at being invariant or nearly 
invariant, thus implicating them as playing essential roles in enzyme function. The results 
of these comparisons also indicated that kinases all fold into a topologically similar 3-
dimensional structure and perform phosphoryl transfer with a common mechanism. 
Despite all kinases sharing a similar 3-dimensional structure, Hanks and Hunter devised 
a classification scheme based on each kinases structural and functional properties and 
grouped corresponding kinase’s together in families (Figure 1.1) [40, 41]. This 
classification is still in use today, although updated.  
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Figure 1.1. Architecture of PKA-C. 
The subdomains of PKA-C colored as defined by Hanks and Hunter [41]. PKA-C is composed of a 
N-lobe that binds and orients ATP for catalysis and a C-lobe that serves as a docking site for 
substrate or regulatory subunit. PDB: 1ATP 
 
Since its crystallization in 1991, PKA-C has served as the prototypical kinase and 
has been used as a model kinase where basic questions widely applicable for the EPK 
superfamily can be addressed. PKA-C adopts the characteristic bilobal kinase fold with a 
smaller N-lobe composed of β-sheets and a larger C-lobe filled with α-helices (Figure 
1.1). Both lobes are flanked by a helical motif in the N-terminus (αA) and a loosely 
structured tail in the C-terminus (C-tail). Consistent with all kinases, the N-lobe is 
responsible for binding and orienting the phosphates of ATP for efficient phosphoryl 
transfer, while the C-lobe provides a scaffold for substrate binding and regulatory sites. 
Within the small lobe and between β1 and β2 is the glycine-rich loop which contains a 
conserved GxGxxG motif and is responsible for folding over the nucleotide and positioning 
the γ-phosphate of adenosine triphosphate (ATP) (Figure 1.2 panel A)[42]. Indeed, 
mutation of either Gly50 or Gly52 in this motif within PKA-C results in a decrease in affinity 
for ATP accompanied by a decrease in KM and Kd for Kemptide. Linking the β-strands to 
the αC-helix is a conserved salt bridge occurring between Lys72 in β3 and Glu91 in the 
αC-helix. This interaction directly depends on the conformation of the mobile αC-helix. 
The importance of Lys72 is highlighted in pseudo-kinases where loss of this residue 
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results in a loss in catalytic activity. The αC-helix is another highly conserved, key element 
within the N-lobe responsible for bringing together different elements of the kinase and 
whose orientation determines kinase activation (Figure 1.2 panel B). For PKA, the αC-
helix is highly ordered, adopting an αC-in conformation permitting activity. Whereas, in the 
inactive conformation the αC-helix is either disordered or adopts an αC-out conformation 
that results in Glu91 facing outward toward solvent[43, 44]. In addition to controlling 
activation, the αC-helix’s electrostatic interactions with the activation loop (pThr197), 
cation-π interactions with the αA-helix (Trp30), and ion pair interactions with the C-tail 
(Phe350) serve to stabilize the orientation of the αC-helix in a catalytically competent 
state[42].  
The C-lobe of PKA-C contains various loops each with conserved residues 
positioned in the active site cleft that play pivotal roles in catalysis. Amongst these loops 
in the catalytic loop (residues 166-171) which contains Asp166 that functions as a catalytic 
based, Lys168 which interacts with the γ-phosphate of ATP, and Asn171 that interacts 
with the secondary Mg2+ ion that bridges the β- and γ-phosphates of ATP. Following the 
catalytic loop is the conserved DFG motif (residues 184-187) which contributes to ATP 
binding in addition to regulating catalysis. The activation loop begins following the DFG 
motif and extending up to the APE motif, including the P+1 loop. This 20-30 residue 
segment is responsible for binding substrates, although it lies outside the active-site cleft 
(Figure 1.2 panel C). The activation loop contains the phosphorylation site Thr197 that 
upon phosphorylation, becomes ordered and adopts an active conformation. Within this 
loop is the P+1 loop or peptide positioning loop (residues 198-208) that tethers the P+1 
residue of substrates into a hydrophobic pocket composed of Leu198, Pro202 and 
Leu205. Overall, the activation loop is the most variable part of the kinase core – both in 
length and sequence – and its highly dynamic regulation is one of two elements that 
distinguish eukaryotic protein kinases (EPKs) from eukaryotic-like kinases in 
prokaryotes[45, 46]. The conserved APE motif (Ala206-Pro207-Glu208) ends the 
activation loop segment of the kinase providing integration between various structures 
within the C-lobe. Glu208 forms a salt bridge with Arg280 of the αH-αI loop, stabilizing the 
position of the activation segment relative to the GHI-domain (αG-, αH-, αI-helices). Within 
the interior of the C-lobe is a series of stable, hydrophobic α-helices (αE, αF, and αH), 
9 
with the large αF-helix serving as a scaffold for the assembly of two hydrophobic spines 
(discussed later)[39]. 
 
Figure 1.2. Important conserved motifs in eukaryotic protein kinases. 
(A) Interactions occurring between ATP and residues in the active site cleft. (B) Interactions 
between the αC-helix, activation loop, αA-helix, and ATP-binding groove. All interactions are critical 
to elicit activity. (C) Interactions between the peptide position loop and the pseudosubstrate, PKI5-
24. PDB ID: 1ATP 
 
On either side of the two lobes in PKA-C are two critical segments that have been 
shown to optimize the catalytic efficiency and increase stability of the kinase. Preceding 
the N-lobe is the N-terminal segment consisting of a myristoylation motif (GNAAAAK) 
followed by an amphipathic helix (αA-helix). Upon myristoylation of the N-terminal Gly, the 
myristoyl group interconverts between a “myr-in” and “myr-out” conformation, where the 
myr-out conformation is able to bind to the membrane. Additional post-translational 
modifications occur in this portion of PKA-C including deamidation of Asn2 and 
phosphorylation at Ser10. Indeed, phosphorylation at Ser10 stabilizes a helix-turn-helix 
conformation of the N-terminal αA-helix, which in turn increases the correlated motions 
between the N-terminus and glycine-rich loop[47]. The αA-helix tethers the αC-helix in the 
αC-in position through cation-π interactions between Trp30 and the sidechains of Arg93 
(αC-helix) and Arg190 (β9)[47, 48]. Wrapping around both lobes with ends firmly anchored 
to each lobe is the C-terminal tail. The C-terminal tail consists of three major segments: 
N-lobe tether, active site tether, and C-lobe tether[49]. The N-lobe tether, the most terminal 
portion of the C-terminal tail, contains a FxxF motif (recognition site of PDK1) that docks 
into the PDK1 interacting fragment (PIF) pocket in the N-lobe, contributing to the stability 
of the αC-helix[50]. The active site tether has two main functions. This portion of the C-
terminal tail controls the entry and exit of ATP (residues 320-327), while residues 328-
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334, which contains a cluster of acidic residues, helps attract basic substrates to the active 
site[51]. An additional phosphorylation site is present in the C-terminal tail at Ser338 and 
has been shown to be critical for a fully functional kinase[52]. 
Despite the extensive work done to understand conserved features of kinases 
through a structure-function perspective, many conserved residues were unexplained by 
primary sequence alone. Using Local Spatial Patterns (LSP) alignment, Kornev and 
coworkers identified a series of hydrophobic residues within the core of the kinase that 
had previously not been recognized in playing an important role in regulation[39]. These 
hydrophobic motifs, termed ‘spines,’ traversed the kinase core, integrating catalytic and 
regulatory elements of the kinase and finally anchoring to the αF-helix[38]. The first 
hydrophobic motif, termed regulatory or R-spine, is composed of Leu95 from the αC-helix, 
Leu106 from β4, Tyr164 from the HRD motif of the catalytic loop and Phe185 from the 
DFG loop. In the active state, kinases contain an assembled R-spine and in the inactive 
state the R-spine is disassembled. Most often, disassembly of the R-spine results from 
the flipping of the phenylalanine in the DFG motif (commonly termed ‘DFG-out’) or 
displacement of the αC-helix. The second hydrophobic motif, termed catalytic or C-spine, 
is composed of Val57 and Ala70 which contact the adenine ring of ATP, Met128 from the 
αD-helix, Leu172, L173 and Ile174 from β7, and Leu227 and Met231 from the αF-helix. 
This spine is fully assembled by the adenine ring upon ATP binding thereby linking the 
two lobes together and committing the kinase to catalysis. Both R- and C-spines are 
docked into the αF-helix. More recently, hydrophobic residues surrounding the spine, 
termed ‘shell’ residues, were shown to contribute to the activity of the kinase via 
stabilization of the R-spine residues. In PKA-C, these residues include Val104, Met118, 
and Met120[43]. 
1.3 Regulation of PKA 
 The Regulatory Subunits and A-kinase Anchoring Proteins 
In its inactive state, PKA exists as a hetero-tetramer composed of two catalytic (C) 
subunits that bind to a dimer of regulatory (R) subunits[53]. Upon increases in intracellular 
cyclic-adenosine monophosphate (cAMP), two cAMP molecules bind each R-subunit 
resulting in a conformational change and thereby releasing PKA-C. Multiple genes code 
for R and C subunits. A total of three genes code for the C-subunit, referred to as Cα, Cβ, 
and Cγ each with a host of other splice variants. Four regulatory subunit genes have been 
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identified and are subdivided into two classes: RI isoforms (α and β) and RII isoforms (α 
and β). All four subunits are functionally non-redundant. While RIα and RIIα are 
ubiquitously expressed, RIβ and RIIβ are tissue specific. All R-subunits differ in their amino 
acid sequences (75% identity), molecular weight, isoelectric point, and cAMP binding 
affinity. RII subunits contain an auto-phosphorylation site within their inhibitory sequence 
(IS) affecting RII:C interactions and signal amplification. Moreover, RI subunits require 
ATP and two magnesium ions, while RII subunits have no dependence on nucleotide or 
magnesium to form high-affinity complexes. 
R-subunits all have a conserved domain structure composed of an N-terminal 
dimerization and docking domain (D/D), which is responsible for the assembly of the R-
subunit dimer and interactions between R-subunits and A-kinase anchoring proteins 
(AKAPs) (Figure 1.3 panel A) [54]. Structurally, the D/D domain is ~50 residue segment 
that forms an anti-parallel X-type helical bundle, creating a hydrophobic surface for AKAP 
docking. Connecting the D/D to cyclic-nucleotide binding domain (CNB) A is a flexible 
linker region that includes the IS. The IS contains PKA’s substrate recognition sequence, 
acting as a substrate (in the case of RII subunits) or a pseudo-substrate (in the case of RI 
subunits) by binding the active site of PKA-C. The two CNB domains (CNB-A, CNB-B) are 
located c-terminally from the linker region. Each CNB domain consists of an eight β-strand 
sandwich with a Phosphate Binding Cassette (PBC) at the core of the sandwich. Both 
CNB-A and CNB-B undergo large conformational changes upon binding cAMP, with CNB-
A forming the most extensive contact with PKA-C in the absence of cAMP (Figure 1.3 
panel B). 
Tethering the kinase to distinct subcellular compartments, AKAPs mediate second 
messenger responsiveness acting as scaffold[54, 55]. Originally it was proposed that 
AKAPs were specific towards RII subunits, while RI subunits were primarily cytosolic. 
However, more recently RI-specific AKAP’s have been discovered, challenging this 
assumption. To date, more than 50 AKAPs have been discovered all sharing a 
characteristic motif for R-subunit binding but differ largely in their remaining sequence. All 
contain a targeting domain that is responsible for localizing AKAPs to specific subcellular 
locations (i.e. cytoskeleton, golgi, ER, nucleus, mitochondria). In addition, AKAPs contain 
modular interaction motifs for interactions with other signaling molecules including kinase 
substrates, phosphodiesterase (PDE), phosphatases, additional kinases, and channels. 
12 
By functioning as scaffolds that assemble and tether distinct signaling molecules to 
subcellular compartments, AKAPs ensure precise PKA-centered regulation and signal 
transduction[55].  
 
Figure 1.3. Architecture of PKA R-subunits. 
(A) Domain architecture of RI and RII subunits. D/D refers to the dimerization/docking domain, IS 
refers to the inhibitory sequence, and CNB refers to cyclic-nucleotide binding domains. (B) 
Structural transition from cAMP-bound RIα (compact) to PKA-C-bound RIα (extended) highlighting 
the secondary structural elements of RI subunits. PDB ID: 1RL3 (+cAMP structure); 6NO7 (-cAMP, 
+PKA-C structure) 
 
 PKA Activation and Inactivation  
Cellular signal transmission requires spatiotemporally controlled molecular 
interactions that begin at the cell surface[56]. At the cell surface information is received by 
receptor complexes often in the form of hormones or neurotransmitters, as is the case for 
PKA signaling. Signaling via hormones or neurotransmitters often involves second 
messenger molecules which relay the effects of receptor input to cytoplasmic and nuclear 
targets. The largest family of receptors are G protein-coupled receptors (GPCRs), with 
cAMP being the best-studied second messenger downstream of GPCRs. 
Following activation of GPCRs, stimulatory or inhibitory G alpha proteins control 
adenylyl cyclase (AC), thereby regulating the conversion of ATP to cAMP. Once 
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synthesized, cAMP diffusion is restricted through molecular machinery responsible for 
coordinating localized cAMP signaling events. The coordinated effort of ACs and PDEs 
compartmentalize cAMP near AKAPs. This compartmentalization ensures information 
flow between supramolecular signaling complexes. Upon cAMP-mediated activation of 
PKA-C, substrates co-localized, either via AKAPs or via other scaffolds, are 
phosphorylated. Independent of cAMP, PKA is hypothesized to be activated by 
mechanisms involving the nuclear factor κB (NF-κB), the Ubiquitin Proteasome System 
(UPS), and the transforming growth factor-beta (TGF-β). All mechanisms involve either 
other proteins interacting with PKA-C to block activity and target distinct cellular targets, 
or binding to the R:C holoenzyme thereby activating PKA-C.  
 
Figure 1.4. General cAMP signaling pathway. 
Upon binding an extracellular ligand, a GPCR converts GTP to GDP triggering the intracellular 
increase in [cAMP] by adenylate cyclase. At high [cAMP], cAMP can bind to the regulatory subunits 
of PKA resulting in a conformational change and thereby releasing PKA-C to phosphorylate 
substrates. PKA-C is also able to translocate to the nucleus via a nucleoporin to phosphorylate 
transcription factors, such as CREB, to upregulate lipid metabolism and cell proliferation. 
 
PKA inhibition and the restriction of cAMP fluxes occurs via several control points 
within the cAMP signaling pathway outlined above and through direct inhibition of PKA-C 
activity. Upstream of PKA, regulation occurs in the form of GPCR localization and 
desensitization, GTP hydrolysis, and cAMP hydrolysis by PDE, many mechanisms 
themselves involving feedback thanks to the concerted response of kinases, 
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phosphatases, and the UPS system within seconds to minutes. The resulting lower cAMP 
levels lead to a reformation of the PKA holoenzyme. On the other hand, direct inhibition 
of PKA-C activity can be achieved through interaction with the PKA inhibitor peptide 
(PKI)[57]. PKI is a heat stable endogenous peptide that is responsible both for inhibiting 
activity of PKA-C and exporting PKA-C from the nucleus. Two functional domains allow 
for these processes to occur including a pseudo-substrate recognition sequence and a 
nuclear export signal (NES)[58]. Importantly, this NES domain is masked prior to binding 
PKA-C and only upon interaction with PKA-C becomes visible[59]. Following binding to 
PKA-C, PKI undergoes an increase in helicity of the NES motif that is preparatory for 
nuclear export by the CRM1/RanGTP complex[60]. Another interacting partner 
responsible for restricting PKA-C activity is A-kinase interacting protein (AKIP1)[61]. 
Conserved amongst mammals, little is known about AKIP1 outside of its ability to retain 
and inhibit PKA-C in the nucleus via a nuclear localization sequence (NLS).  
1.4 Conformational States and Dynamics of PKA 
It is well established that proteins kinases are very flexible, undergoing significant 
conformational changes upon activation and throughout the catalytic cycle. Indeed, the 
flexibility of any protein has been shown to be critical for their functionality. X-ray 
crystallography has been used extensively to study a variety of kinases, while NMR has 
been used to study only a few including: PKA-C [47, 60, 62-71], extracellular receptor 
kinase 2 (ERK2)[72], cyclin-dependent protein kinase 2 (Cdk2)[73], p38 kinase[74-76], 
and Abl-kinase[77]. Perhaps the most studied of these though is PKA-C. 
Extensive x-ray crystallographic studies of PKA-C have identified three major 
conformational states: open (apo-form), intermediate (binary, or nucleotide-bound form), 
and closed (ternary, or substrate/pseudo-substrate-bound form) (Figure 1.5 panel A) [34-
36, 63, 78, 79]. These studies indicate that PKA-C, like other kinases, undergoes a closing 
motion upon binding nucleotide and pseudosubstrate/substrate and an opening motion 
following phosphorylation and release of substrate and nucleotide. While x-ray studies 
have identified discrete conformational states of PKA-C, NMR studies have allowed the 
conformational dynamics of PKA-C to be mapped. The µs-ms conformational dynamics of 
PKA-C were first mapped using the TROSY Hahn-Echo experiment[80]. These studies 
revealed that the kinase in the absence of nucleotide or pseudosubstrate/substrate is 
dynamic, but uncommitted to catalysis (Figure 1.5 panel B). Upon nucleotide binding the 
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kinase becomes more dynamic, undergoing significant conformational exchange in the µs 
to ms timescale in catalytically critical regions such as the glycine-rich, activation, DFG, 
and peptide positioning loop. Since nucleotide-bound enzyme is the preamble to substrate 
binding, the dynamic nature of this state is critical to substrate recognition. While the 
subsequent binding of substrate shifts the conformational equilibrium towards a closed 
state with persistent dynamics that correlate with the rate of catalytic turnover, the binding 
of pseudosubstrate, PKI5-24, dramatically attenuates the dynamics of the enzyme, shifting 
the kinase to a dynamically quenched state. These results were later corroborated by 
thermocalorimetric data revealing that the binding of substrate is entropically-driven, while 
the binding of pseudosubstrate is enthalpically-driven.  
 
Figure 1.5. Structural transitions and energy landscape of PKA-C. 
(A) The structural transitions of PKA-C upon binding nucleotide and (pseudo)substrate as depicted 
by their crystal structures. PDB ID: 1J3H (apo), 1BKX (binary), and 1ATP (ternary). (B) The 
conformational energy landscape of PKA-C upon effector binding. The apo enzyme is dynamically 
uncommitted sampling a large range of conformations in solution, while upon binding ATP the 
dynamics become synchronous (“dynamically committed”). Following the binding of substrate such 
as PLN, dynamics persist but are redistributed. Binding of inhibitor or pseudosubstrate such as 
PKI5-24, the dynamics are quenched. Adapted from [80]. 
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The importance of synchronous dynamics in catalysis was further underscored in 
the case of PKA-C mutant Y204A[70, 81, 82]. Y204A, distal to the active site, has been 
shown to be structurally indistinguishable from the wild-type kinase but exhibits substantial 
reductions in kcat/KM and kcat. Indeed, µs to ms spin relaxation measurements indicate that 
Y204A obliterates synchronous motions present in the wild-type enzyme, motions 
essential for catalytic efficiency. Furthermore, in a follow-up study the dependence of 
synchronous dynamics was evaluated in the context of substrate binding[68]. Upon 
binding a cardiac substrate of PKA-C, phospholamban (PLN), catalytically critical 
elements of PKA-C remain dynamic, while the dynamics of other elements of PKA-C are 
attenuated. In contrast, when binding a mutant of PLN, R14del, PKA-C displays enhanced 
conformational dynamics in regions important for catalysis. More recent studies of PKA-C 
have focused on the role of conformational dynamics in the context of the catalytic 
cycle[83]. Using relaxation dispersion measurements, Wang and coworkers discovered 
that synchronous breathing motions of the kinase in the µs-ms timescale accompany 
positive binding cooperativity between ATP and substrate, meanwhile asynchronous 
dynamics drive the negative cooperativity between ADP and phosphorylated substrate. 
These studies and others have demonstrated that the conformational landscape of the 
kinase is modulated by changes in the dynamics of PKA-C which themselves are induced 
by ligand binding.  
1.5 Chemical Mechanism of PKA-C 
By far the best understood protein kinase from a mechanistic standpoint is PKA-
C[84]. Reactions catalyzed by protein kinases require both ATP and substrate and are 
thus viewed as a bi-substrate kinetic mechanism. The first mechanistic study of PKA-C 
was performed by Cook et al. in 1982 in which a series of initial velocity measurements 
were performed using ATP and the standard substrate Kemptide with ADP and pKemptide 
acting as competitive inhibitors[85]. This study concluded that reactants bound in a 
random bi-bi mechanism, meaning the binding of either ATP or Kemptide does not occlude 
the binding of the other. Despite this, PKA-C still preferentially binds ATP first prior to 
substrate[86]. This has been substantiated by Whitehouse and Walsh[87] and more 
recently, NMR spectroscopic and thermodynamic methods which showed ATP has an 
order of magnitude higher affinity for apo PKA-C compared to Kemptide[82]. While the 
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majority of kinases undergo random kinetic mechanisms, there are numerous examples 
of kinases where ordered processes are observed. 
As is a requirement for all protein kinases to perform catalysis, PKA-C contains 
two Mg2+ binding sites. In PKA-C the first Mg2+ is chelated between the β- and γ- 
phosphates and Asp184 in the activation loop. This is the primary Mg2+ binding site and 
binds under low concentration conditions. The second Mg2+ ion is located between the α- 
and γ-phosphates and Asp184 and Asp171, but binds only under high [Mg2+] conditions. 
The involvement of Mg2+ during the catalytic cycle were recently elucidated using the high-
affinity substrate derived from PKI5-24, PKS5-24. Recent crystal structures of PKA-C’s 
Michaelis complex, partial phosphorylation complex and product complex have provided 
insights into the chemical steps of turnover by PKA-C[88]. While Mg2+ is present in both 
binding sites in the Michaelis complex and partial phosphorylation complex, Mg2+ was 
absent in the first site in the product complex. This suggests that the removal of Mg2+ is 
required prior to the release of ADP[89]. Overall, metal ions play a critical role in 
phosphoryl transfer and turnover, but the exact mechanism of involvement of metal ions 
is not conserved amongst protein kinases.  
Further work on PKA-C dissected the rates associated with each step within the 
catalytic cycle. Using pre-steady-state quenched flow techniques at high [Mg2+] revealed 
the that chemical step of PKA-C has a rate of kchem = 500 ± 60 s-1, while kcat = 21 ± 1 s-
1[90]. These studies revealed that for low affinity substrates, as most are assumed to be, 
the phosphoryl transfer step is very rapid, while ADP release is the rate-limiting step. For 
high affinity substrates, such as PKS5-24, ADP release was only partially the rate-limiting 
step[91]. At physiological [Mg2+] and upon initiation of catalysis with ATP, studies have 
shown the chemical step is slightly attenuated in part due to a conformational change upon 
ATP binding that precedes phosphoryl transfer[92]. These same studies have shown a 
similar behavior during ADP release as a result of low [Mg2+], highlighting the subtle role 
Mg2+ plays in catalysis. It is likely that the conformational changes observed under low 
[Mg2+] are present under high [Mg2+], but happen too fast to be observed. Moreover, NMR 
studies under high and low [Mg2+] have shown changes in the conformational dynamics 
of PKA-C[80]. 
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1.6 Relevance of PKA in Human Diseases 
 Cushing’s Syndrome (CS) 
A number of genetic defects have been associated with adrenal diseases including 
McCune-Albright syndrome[93], Carney complex[94-96], and more recently, Cushing’s 
syndrome (CS)[26-29]. CS results from overproduction of cortisol either via endogenous 
(i.e. adrenocortical adenomas, bilateral adrenocortical hyperplasia, and cancer) or 
exogenous (i.e. steroids) means[97, 98]. The clinical picture of patients with CS is 
characterized by severe comorbidities including central obesity, hypertension, and 
metabolic abnormalities. Moreover, for CS patients prolonged hypercortisolism ultimately 
leads to increased morbidity and mortality due to cardiovascular, infectious, and other 
complications. While the molecular pathogenesis of other adrenal diseases has been 
thoroughly investigated, the underpinnings of CS was not well established until recently.  
Indeed, in endocrine tissues, activation of the cAMP signaling pathway leads to 
increased function and replication of endocrine cells[99]. In normal physiology, 
adrenocortical cells are under tight regulation of cortisol secretion via the hypothalamic-
pituitary-adrenal axis. Secretion of corticotropin-releasing hormone (CRH) stimulates the 
release of adrenocorticotropic hormone (ACTH) from the pituitary gland, in turn binding to 
the melanocortin-2 receptor (MCR2) and leading to the activation of adenylate cyclase. 
Following increases in intracellular cAMP, PKA activation stimulates glucocorticoid 
production thereby leading to increases in cortisol production via transcriptional induction 
of steroidogenic enzyme genes. 
With the aim of identifying genetic alterations in patients with sporadic cortisol-
secreting adrenocortical adenomas that produce Cushing’s syndrome, whole exome 
sequencing was conducted by several groups. Beuschlein et al. discovered two mutations 
in the gene encoding the C-subunit of PKA (PRKACA) in nearly 30% of adrenocortical 
adenomas associated with overt Cushing’s syndrome[28]. The most common mutation 
identified resulted in the substitution of a leucine residue at position 205 with arginine 
(L205R). The second mutation identified resulted in the insertion of a tryptophan residues 
between Leu198 and Cys199 (L198_C199insW). In vitro studies showed impaired 
inhibition of both mutants by R-subunits, causing constitutive activation independent of 
cAMP. Importantly, these mutations fall on residues that are highly conserved across 
species suggesting their key role in protein function.  
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The findings from this initial study were confirmed by various other independent 
studies[26, 27, 29]. Following these studies, additional papers in the proceeding years 
identified additional mutations including: C199_G200insV, S212R+insIILR, W196R, 
E31V, and d243-247+E248Q. Although less mutated than the common L205R mutation, 
all mutations involve amino acids that are located on the surface of PKA-C and at the 
interface with R-subunits. From analysis of the x-ray structure of the PKA-C:RIIβ 
holoenzyme, it was inferred that it was likely these mutations would interfere with the 
association with the R-subunits rendering PKA-C constitutively active.  
Altogether these results demonstrate that PRKACA mutations are a main 
contributor to adrenocortical tumorigenesis, but PRKACA is not the only gene mutated in 
cortisol-producing adenomas. Activating mutations have been identified in the genes 
encoding G protein subunit α[26, 27, 29], phosphodiesterase 8B[100], and the regulatory 
subunit of PKA 1α[96], and catenin beta 1[101, 102], though at a lower frequency than 
PKA-C. In totality, the cAMP signaling pathway is highly mutated in CS, along with other 
metabolic disorders. 
 Fibrolamellar Hepatocellular Carcinoma (FL-HCC) 
Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare and aggressive liver 
cancer that predominantly occurs in teenagers without a history of chronic liver 
disease[103, 104]. FL-HCC accounts for 1-9% of hepatocellular carcinoma (HCC) cases 
and is histologically characterized by large eosinophilic cells, prominent nucleloli, and 
intratumoral fibrosis. Symptoms of FL-HCC are often vague with patients presenting with 
no symptoms during the early-stage. As FL-HCC progresses, patients often have 
abdominal pain, malaise, nausea, weight loss, and present with a palpable mass in the 
abdomen. Formal diagnosis of FL-HCC requires histological confirmation along with 
immunohistochemical detection of anterior gradient-2, a highly specific protein for FL-
HCC. Treatment for FL-HCC includes surgical resection, followed by transplantation. 
Common treatments for other cancers such as chemotherapy or radiation, are not 
successful. For patients who undergo resection the 5-year survival ranges from 50-70%, 
but when disease presents at a stage too advanced for resection, the 5-year survival rate 
is 0%.  
PKA overexpression is associated with colon cancer, invasive breast carcinoma, 
and rectal adenocarcinoma, but more recently was linked to FL-HCC. In 2014, Honeyman 
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et al. identified a chimeric transcript expressed in FL-HCC and not in normal liver tissue 
that arises because of a ~400 kB deletion on chromosome 19[31]. The chimeric RNA 
codes for a protein that contains the amino-terminal domain of DNAJB1, which encodes 
a member of the heat shock 40 protein family, fused in frame to exons 2-10 of PRKACA. 
The chimeric fusion, DNAJB1-PRKACA, was detected in 15/15 FL-HCC samples, and had 
not previously been reported in the literature although was confirmed in Graham et al[32]. 
Indeed, these studies confirmed the RNA transcript was translated into a chimeric protein, 
from hereon referred to as PKA-CDNAJB1, and retains full kinase activity when compared to 
wild-type PKA-C (PKA-CWT). In patients with FL-HCC, the DNAJB1-PRKACA transcript is 
up-regulated. Further studies involving mice models have gone on to show that DNAJB1-
PRKACA alone drives tumorigenesis in FL-HCC, and is not a result from enhanced 
PRKACA expression alone[105]. In addition to confirming DNAJB1-PRKACA is an 
oncogene, the authors show that the catalytic activity of the kinase domain is necessary 
and required for tumorigenesis. 
Structurally, the kinase domain of PKA-CDNAJB1 adopts a near identical structure to 
the wild-type kinase upon binding nucleotide and PKI5-24[106]. Superposition of PKA-
CDNAJB1 and PKA-CWT reveals that the N-terminal helix of the kinase is extended in PKA-
CDNAJB1 with the DNAJB1 appendix adopting its canonical fold beneath the large lobe of 
the kinase core. Despite the additional appendix on the kinase, PKA-CDNAJB1 retains its 
ability to bind to both RI and RII regulatory subunits. Subsequent studies of PKA-CDNAJB1 
have shown that the DNAJB1 appendix is quite dynamic adopting a variety of 
conformations in solution[64, 107]. Indeed, some studies have suggested that this domain 
alone is responsible for the recruitment of β-catenin[105] and Hsp70[108] and that this 
scaffolding function is involved in the oncogenic action of PKA-CDNAJB1. Regardless, the 
exact molecular mechanisms of FL-HCC and the involvement of PKA-CDNAJB1 are still 
under debate and investigation. 
 Cardiac Myxomas (CM) 
Tumors of the heart are rare with an incidence between 0.0017 and 0.19 percent 
although three quarters are benign[109]. Although rare, nearly half of the benign heart 
tumors are classified as cardiac myxomas (CM). CM occur in all age groups, but are most 
frequent between the third and sixth decades of life. Most CM occur sporadically, but are 
sometimes classified as ‘complex’ in the case that they are familial and in combination 
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with two or more of the following conditions: skin myxomas, myxoid fibroadenomas of the 
breast, pituitary adenomas, primary adrenocortical micronodular dysplasia with Cushing’s 
syndrome, Carney complex, and testicular tumors. Derived from multipotent 
mesenchymal cells, CM usually develop in the atria, with a majority originating in the left 
atrium and to a lesser extent, the right atrium. Patients with CM exhibit symptoms including 
shortness of breath, dizziness, fainting, palpitations, and chest pain or tightness. 
Treatment of CM involves surgical removal and sometimes repair of patients’ mitral valve. 
Although myxoma are not at risk for metastasis, complications are common. If left 
untreated CM can lead to embolisms, arrhythmias, and heart failure.  
Multiple studies have investigated the pathogenesis of CM. Indeed, two-thirds of 
Carney complex-associated CM exhibit mutations in PRKAR1A, the gene encoding the 
protein kinase A type 1α regulatory subunit[110]. With the exception of a recent study, 
these mutations are only associated with familial CM, therefore leaving the pathogenesis 
of sporadic CM unknown. Recently one study by Tseng et al. identified mutations, 
specifically insertions, in PKA-C associated with sporadic CM[111]. From Sanger 
sequencing of 41 CM specimens, mutations were identified in four (9.7%). In contrast to 
CS mutations, all CM associated mutations were in-frame microinsertions of 18-33 bp from 
exons 7 and 8. These in-frame microinsertions resulted in the following mutations: 
S212insTEYLAPEIILS, S212SLAPEIILS, S212insTVIILS, and L224insGYNKAVDWWAL. 
All mutations were located near the peptide positioning loop and adjacent to where 
substrate would bind. Biochemical characterization confirmed that all mutations enhanced 
the phosphorylation of substrates such as cAMP-response element binding protein 
(CREB) indicating each mutation elicited higher activity in comparison to the wild-type 
kinase. The authors of this study suggested that this was because the mutations interfered 
with the binding of PKA-C to the regulatory subunits. Since the initial publication identifying 
the in-frame microinsertions associated with CM, no studies have confirmed the existence 
or addressed the biochemical consequences of these mutations leaving many questions 
unanswered. Future studies will need to focus on the contribution of the cAMP signaling 
pathway in the pathogenesis of CM. 
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 An NMR Perspective on Intramolecular 
Allosteric Communication in PKA. 
2.1 Introduction 
Allostery is a fundamental biological regulatory mechanism characterized by the 
long-range coupling of remote sites within a molecular system, whereby allosteric effectors 
such as small molecules (i.e. inhibitors, activator) or binding partners (i.e. proteins, DNA, 
RNA) and post-translational modifications work to modulate protein function (Reviews on 
allostery: [1, 2, 112-115]). Despite the importance of allosteric regulation in most biological 
processes the molecular mechanisms underpinning allostery continue to be revised and 
remain largely uncharacterized. Classical biochemistry postulates that proteins exist in 
two states, commonly referred to as an active (R) state and inactive (T) state, and that 
interconversion between these states is modulated by allosteric effectors. Many models 
have been developed to explain allosteric effects including induced fit or conformational 
selection (population shift), sequential or concerted mechanism and evidence supports 
all[116-121]. Regardless, in their simplest view all models postulate that effectors 
modulate substrate binding affinity and/or enzymatic activity by inducing or stabilizing 
specific conformational states. 
While early studies of allostery relied on crystallographic work providing a purely 
mechanical view based on structural changes induced upon binding allosteric effectors 
have been invaluable, more recent studies have highlighted the role of protein motions in 
mediating these long-range, structural changes. Indeed, the intimate link between these 
internal motions over a wide range of timescales and structure underlies a protein’s 
function. In particular, NMR spectroscopy has been instrumental in exploring the different 
ways protein motions contribute to allosteric interactions (Figure 2.1) [17, 18]. In addition 
to providing structural information of biological systems in solution, NMR is highly sensitive 
to subtle changes in protein structure and dynamics providing unique information on the 
amplitude of motions taking place on a wide range of timescales and residue specific 
information. 
In the following sections, I will discuss some of the major advances in solution-
state NMR methods that have facilitated the characterization of allostery as applied to 
cAMP-dependent protein kinase A (PKA), as well as the role of several complementary 
techniques in elucidating allosteric networks. Furthermore, this review of NMR methods 
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to characterize allostery will showcase powerful experimental techniques used to elucidate 
the allosteric mechanisms of PKA-C. 
 
 
Figure 2.1. Timescales of protein motions and their corresponding NMR techniques. 
Schematic of the timescale for various protein motions (above) and the corresponding NMR 
experiments (below) to characterize them. Adapted from [18]. 
 
2.2 PKA as a Model Allosteric Enzyme 
Regulation of protein function is critical in the careful control of virtually all cellular 
processes. Regulation can be exerted at various stages of a biomolecule’s lifetime, 
including: regulation of gene transcription and translation, control of protein activation and 
degradation. Allosteric regulation is one of the many controls exerted to control the activity 
level of biomolecules, including enzymes.  
PKA is one of the most well studied members of the AGC kinase family and has 
been a standard for years of research on kinase catalysis and allostery. In its resting state, 
PKA consists of two catalytic subunits (PKA-C) and two regulatory subunits. Upon binding 
cAMP, the regulatory subunits undergo a conformational change thereby releasing 
catalytically competent PKA-C. To date, groups have studied both the regulatory subunits 
and catalytic subunits in isolation. The catalytic subunit of PKA contains a small lobe 
composed of β-sheets and a large lobe composed of α-helices. The binding of nucleotide 
occurs within the small lobe, docking near the glycine-rich loop in the crevice between the 
small and large lobe, while the large lobe is responsible for binding substrate and 
regulatory subunits. Pioneering structural studies by Taylor and coworkers provided 
snapshots of major conformational states associated with PKA-C allostery using 
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nucleotide analogues, pseudosubstrates and inhibitors. On the basis of this data, Taylor 
and coworkers revealed a hinge-like conformational change associated with the binding 
of substrate and nucleotide and proposed an extensive allosteric network involved in 
substrate recognition and conversion. Indeed, the driving force of allostery in PKA-C relies 
on its intrinsic flexibility, as significant conformational changes within the kinase are 
observed locally and globally upon effector binding. Indeed, the interplay between 
structure and dynamics underlies the functions of proteins. 
Along with conformational changes, extensive studies have shown how fast and 
slow conformational dynamics, conformational entropy, and intramolecular interactions 
contribute to allostery in the catalytic subunit of protein kinase A. Together these studies 
have shown PKA-C to be an elegant example of how classical (structure based) and 
modern (dynamic based) views of allosteric signaling merge. The following sections 
describe the studies undertaken to map the conformational dynamics and allosteric 
signaling of PKA-C using NMR in an effort to understand their role in enzymatic turnover 
and function. 
2.3 H/D Exchange 
The transitions of the kinase between different states involves both conformational 
and dynamic changes that propagate from the ligand binding sites to remote parts of the 
molecule. Indeed, a complete understanding of allosteric signaling required for this 
propagation necessitates the analysis of intra- and intermolecular interactions that hold a 
protein together such as hydrophobic packing, ionic interactions, hydrogen bonds, and 
Van der Waals forces. Among those interactions, hydrogen bonds have recently been 
shown to be critical in catalysis and inhibition. Traditionally, hydrogen/deuterium exchange 
mass spectrometry (DXMS) has been used extensively to analyze hydrogen bond 
networks of proteins to identify domains that might be involved in allosteric transitions, 
however, it lacks site-specific information[122]. Unlike DXMS, solution NMR spectroscopy 
monitors hydrogen/deuterium (H/D) exchange in a site-specific manner allowing for 
hydrogen bonds throughout the protein to be tracked at the atomic level. 
To obtain residue-specific information about the hydrogen bond strengths and 
therefore insights into protein conformational dynamics and allow for the identification of 
long-range allosteric changes upon effector binding or mutations, Li and coworkers 
measured the H/D fractionation factors of PKA-C using solution NMR spectroscopy[69]. 
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While H/D exchange traditionally requires the lyophilization of the protein under 
examination, equilibrium fractionation factors (φ) report directly on hydrogen bond strength 
and can be measured by incubating proteins in H2O/D2O solutions without 
lyophilization[123, 124]. Briefly, backbone amide fractionation factors of PKA-C were 
measured by incubating the kinase in aqueous solutions with D2O concentrations ranging 
from 5% to 60% in three different forms: apo, ADP-, and ADP/PKI-bound. H/D equilibrium 
fractionation factors are defined as the equilibrium constant of following reaction: 
𝑁𝑁𝑁𝑁:𝐵𝐵 +  
1
2




where NH represents a weak acid and B a weak base. Following acquisition of a series of 
1H-15N TROSY-HSQC’s[125] on the three different forms of the kinase for all D2O 








where I is the peak intensity, x is the mole fraction of water, and C is the normalization 
parameter, which is the inverse peak intensity at 100% H2O. Once measured and fit with 
the equation above, φ values report on the preference of each amide site in exchanging 
deuterium over protium. For amide sites that are involved in strong hydrogen bonds φ 
values are <1, whereas amide sites that are involved in weak hydrogen bonds φ values 
are >1[126]. 
Globally, upon binding nucleotide and pseudosubstrate and undergoing the 
transition from the open to closed conformation, the average φ values decrease (Figure 
2.2). This decrease suggests a strengthening of the intramolecular hydrogen bonds and 
are consistent with X-ray crystallography[42], NMR spectroscopy[82], fluorescence[127, 
128], thermodynamic and DXMS analyses[122] which have previously shown the structure 
of PKA-C becoming more compact and closed upon nucleotide and pseudosubstrate 
binding. Furthermore, the changes in hydrogen bond strength upon the binding of effectors 
are not localized to the binding site, rather they are pervasive throughout the entire protein. 
Upon binding ADP, hydrogen bonds are strengthened both in the N-lobe and C-lobe, while 
subsequent binding of pseudosubstrate strengthens hydrogen bonds located primarily in 
the large lobe. Moreover, these studies revealed that the hydrophobic core is more 
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resistant to deuterium exchange upon effector binding, consistent with the rigidification of 
the core.  
 
Figure 2.2. Distribution of amide fractionation factors for apo, ADP-bound and ADP/PKI-
bound PKA-C. 
The distribution of amide fractionation factors for apo, ADP-bound, and ADP/PKI-bound PKA-C. 
Histogram displays the number of occurrences vs fractionation factor values for each state, while 
fractionation factors are mapped onto the structure of PKA-C. Blue spheres correspond to strong 
hydrogen bonds and high φ values, while red spheres correspond to weak hydrogen bonds and 
low φ values. Figure reprinted with permission from [69] and can be found at the following link: 
https://pubs.acs.org/doi/10.1021/acs.biochem.5b00387. Copyright 2015 Biochemistry.  
 
Overall these studies on PKA-C revealed that changes in the allosteric network of 
the kinase are manifested through variations in hydrogen bond strengths. While these 
changes are not uni-directional, they provide a residue specific view of allosteric 
communication within proteins and enzymes. H/D fractionation factors emerge as an 
important complement to other NMR parameters to characterize protein conformational 
dynamics and to identify long range allosteric changes upon ligand binding or mutations. 
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2.4 Chemical Shift Perturbation 
Of the NMR methods for monitoring changes in an allosteric system, perturbation 
of chemical shifts is the most straight-forward. NMR-active nuclei are highly sensitive to 
alterations in local chemical and structural environment and thus provide invaluable 
information regarding conformational changes and interactions with effectors. Chemical 
shifts are especially useful for measuring populations of states in the fast chemical 
exchange timescale. The simplest case involves an enzyme that interconverts between 
two states referred to as T- and R-states (nomenclature used from hereon). The 
expression representing this interconversion is given by the following equation:  
𝛿𝛿𝑜𝑜𝑜𝑜𝑜𝑜 =  𝑝𝑝𝑅𝑅𝛿𝛿𝑅𝑅 + 𝑝𝑝𝑇𝑇𝛿𝛿𝑇𝑇 
Where the observed chemical shift (δobs) is a population weighted average of the T- and 
R-states, pR/T are the equilibrium populations of each state, and δR/T are the chemical shifts 
of each state. Importantly, this expression is only valid for fast exchange between the two 
states. Thus, changes in chemical shift in any allosteric system can be representative of 
the equilibrium shift between conformations. Powerful methods to decode the allosteric 
information embedded in chemical shift changes have been introduced by Melacini and 
coworkers[129-132], McDermott and coworkers[133], and more recently, Dokholyan and 
coworkers[134].  
Studies on the allostery of PKA-C began with atomic-resolution mapping of the 
backbone of PKA-C by Masterson and coworkers[82]. This study represented the first 
picture of the changes occurring during the transition from apo to intermediate and from 
intermediate to closed conformations. From chemical shift perturbation (CSP) 
measurements, it was apparent that PKA-C is dynamic, interconverting between multiple 
dynamic or conformational states as evidenced by exchange broadening of highly 
conserved residues. Moreover, the characterization of PKA-C by NMR revealed that the 
kinase exhibits positive cooperativity for ligand binding, such that the binding of nucleotide 
increases the affinity of subsequent (pseudo)substrate binding. To test the existence of 
an allosteric network that facilitates the positive cooperativity of ligand binding, Masterson 
and coworkers mutated Tyr204 to Ala (Y204A). Indeed, this single point mutation caused 
disruptions of the allosteric network as evidenced by CSP and the reduction in binding 
cooperativity (Figure 2.3). Specifically, Y204A caused an overall rearrangement of the 
allosteric communication between the two lobes of the kinase upon nucleotide binding and 
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an interruption of this communication upon substrate binding as deduced from CSP 
measurements. Additional MD studies and dynamics studies on PKA-CY204A have further 
highlighted the altered allosteric communication and will be discussed further in the 
following sections 2.5 and 2.6. 
 
Figure 2.3. Chemical shift perturbations upon ligand binding for PKA-CWT and PKA-CY204A. 
Upon binding both nucleotide and substrate, Kemptide, PKA-CY204A experiences attenuated local 
and allosteric perturbations. Reprinted with permission from [135]. Copyright 2012 Elsevier. 
 
Following the initial characterization of chemical shift perturbations upon 
nucleotide and (pseudo)substrate binding[82], recent studies of PKA-C have focused on 
mapping the allosteric network of PKA-C[83] and its associated mutations[65, 107]. In a 
powerful method introduced by Melacini and coworkers, CHEmical Shift Covariance 
Analysis (CHESCA) uses statistical comparative analyses of NMR chemical shifts elicited 
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by selected effectors to identify patterns of chemical shift perturbations[129]. This method 
is governed by two assumptions: first, subtle but functionally relevant structural changes 
that underlie allosteric modulations of dynamics are effectively probed by measuring NMR 
chemical shift variations; and second, when a system is subjected to a set of perturbations, 
residues that belong to the same allosteric network exhibit concerted responses in 
response to the effector set. Perturbations to the collective response of residues or the 
allosteric network may arise from mutations, modifications of the effector, and binding 
partner. Briefly, after assigning the spectra for each state from the perturbation library, a 
combined chemical shift (CCS) is computed for each residue which represents the 
weighted contributions from the ppm values of the amide proton and nitrogen. Next, a 
correlation matrix is generated containing residue numbers and a Pearson’s correlation 
coefficient between every two residues contained in the matrix. Generally, Pearson’s 
correlation coefficients greater than 0.98 will be used to map onto a 2D matrix of residue 
number vs residue number for visual evaluation of allosteric networks. In addition to 
generating a correlation matrix, CHESCA allows for agglomerative clustering in order to 
define functional clusters of coupled residues using dendrograms. Nonetheless, this 
method has been successfully applied to various systems including exchange protein 
activated by cAMP (EPAC)[129, 136], α-subunit of tryptophan synthase[137, 138], cystic 
fibrosis transmembrane conductance regulator[139], and PKA-C[65, 83]. 
To map the site-specific allosteric changes during the catalytic cycle of PKA-C, 
Wang and coworkers used CHESCA on the methyl groups of the kinase[83]. Indeed, 
mapping the allosteric network of PKA-C over the reaction coordinate suggested that both 
nucleotide and substrate binding bring together important catalytic motifs and organize the 
active site for catalysis in a cooperative manner. These studies further emphasized the 
concerted structural changes necessary for ligand binding and release as first captured 
by x-ray crystallography. 
Since perturbations to the allosteric network of a protein often arise from mutations, 
additional studies of PKA-C focused on the impact of point and in-frame fusion mutations 
in PKA-C[65, 107]. In a first-of-its-kind study, our group used solution NMR to map the 
allosteric network of a point mutation associated with Cushing’s syndrome in order to gain 
mechanistic insights into the mutation’s multifarious effects[65]. Previous studies of this 
particular point mutation, L205R, suggested that regulation was disrupted on the basis of 
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an inability of PKA-CL205R to bind to regulatory subunits. Additionally, phosphoproteomic 
studies revealed dramatic changes in the phosphorylation profile of the kinase. Using 
CHESCA, we found that L205R disrupts the internal allosteric communication of the 
kinase, preventing the kinase from reaching a fully closed state, reducing the enzymes 
affinity for both nucleotide and (pseudo)substrates and thus hindering endogenous 
regulation (see Chapter 4). Notably, these studies showed that while this was true for 
canonical substrates, non-canonical substrates identified by phosphoproteomic analyses 
exhibited the opposite. Indeed, for non-canonical substrates, PKA-CL205R exhibited a 
higher catalytic efficiency and a rearrangement of the internal allosteric network. Together, 
these results indicated that a rewiring of the internal allosteric network and global changes 
in dynamics contribute to the complex dysfunction of the signaling network of PKA-CL205R 
(Figure 2.4).  
 
Figure 2.4. Cushing’s syndrome somatic mutation disrupts the allosteric network of PKA-C 
to elicit dysfunction. 
CHESCA correlation matrices for PKA-CWT + PKI, PKA-CL205R + PKI, and PKA-CL205R + VPS36, 
respectively, plotted on the structure of PKA-C with colors to match previous community map 
analyses [140]. Adapted from [65]. Copyright 2019 American Association for the Advancement of 
Science. 
 
Further studies on how mutations disrupt the allosteric network of PKA-C have 
followed this initial study as pertaining to fibrolamellar hepatocellular carcinoma (FL-
HCC)[107]. It is well established that FL-HCC is driven by the gene fusion between heat 
shock protein 40 (DNAJB1) and PRKACA. Structurally this fusion protein (hereon referred 
to as PKA-CDNAJB1) results in an extended αA-helix with the J-domain of DNAJB1 tucked 
under the large lobe of the kinase, while the kinase core is virtually identical to the wild-
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type enzyme[106]. Despite the little differences in structure, it has remained unclear how 
this kinase contributes to the progression of FL-HCC. Using CHESCA analyses coupled 
with thermodynamic experiments, Olivieri and coworkers found that similar to PKA-CL205R, 
the dynamic J-domain of PKA-CDNAJB1 re-wires the intramolecular allostery of the 
kinase[107]. Concomitant with the disruption in allosteric network, PKA-CDNAJB1 attenuates 
the canonical positive cooperativity between nucleotide and (pseudo)substrate. Indeed, 
reductions in both intramolecular allostery and binding cooperativity have been exhibited 
for other Cushing’s syndrome, further solidifying the link between allostery and 
cooperativity[141]. 
2.5 Slow Timescale Motions (µs-ms) 
Any type of long-distance signaling, otherwise termed allostery requires signal 
transmission; however, mechanisms can vary widely. In general, transmission of signal 
can occur in two different manners: 1) a sequential set of events propagated from the 
allosteric site to the active site or by 2) modification of the dynamics of the protein. 
Originally, both models assumed large conformational changes, but that has since been 
challenged by Cooper and Dryden[142] and confirmed in studies of calmodulin[143], PDZ 
domains[144], and the catabolite activator protein[145]. Several of the most critical 
functions of biomolecules occur in the µs-ms timescale, including but not limited to 
allostery, catalysis, folding, and ligand binding. The experiments used to probe protein 
dynamics over this timescale are often referred to as relaxation dispersion NMR and 
include: TROSY Hahn-echo, Carr-Purcell-Meiboom-Gill (CPMG), Chemical exchange 
saturation transfer (CEST). Indeed, when used in conjunction with one another, these 
experiments provide a near complete picture of the processes governing enzyme function 
having been successfully applied to systems to examine ligand binding, protein motions, 
enzymatic catalysis, and protein folding.  
Veglia and coworkers have used NMR extensively to characterize the role of µs-
ms conformational motions in substrate recognition and the binding of inhibitors or 
pseudosubstrates. Indeed, the methods of characterization mentioned in the preceding 
paragraph have been successfully applied to various systems[146-150]. First 
characterizing the role of slow timescale motions in substrate recognition, Masterson and 
coworkers measured the transverse relaxation (Rex) rate of the backbone of PKA-C using 
the TROSY Hahn-Echo experiment[67]. The authors observed very little conformational 
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exchange in the absence of nucleotide and substrate, while synchronous motions 
specifically in the residues surrounding the active site are promoted upon nucleotide 
binding (Figure 2.5). Subsequently, upon binding of a substrate of PKA-C, 
phospholamban (PLN), the dynamics of PKA-C are redistributed, but persist around the 
active site of the kinase. Importantly, these dynamics occur on the same timescale as the 
rate-determining step of enzyme turnover. Together these µs-ms conformational 
dynamics proceed through continuous paths throughout the active site, while 
simultaneously occurring in remote regions of the enzyme, underscoring the complexity 
of the allosteric network of PKA-C. Furthermore, these initial studies highlighted the 
importance of well-tuned dynamic interplay between enzyme and substrate to maintain 
optimal catalysis. In a follow-up study, Masterson and coworkers looked at these slow 
timescale motions upon binding inhibitors[80] and compared them to what was observed 
for the binding of substrate. Using the TROSY Hahn-Echo experiment, the authors 
observed that pseudosubstrate PKI5-24 and excess Mg2+, which acts as a noncompetitive 
inhibitor to PKA-C[151], restrict the slow timescale conformational dynamics of the kinase. 
These studies led to the finding that inhibitor binding modifies the energy landscape of the 
kinase in a manner different from substrate by restricting the motions of the enzyme 
backbone. Uniquely, these studies together highlight the role of dynamics in modulating 
active vs inactive sites, as oppose to the structural motifs alone. 
 
Figure 2.5. Slow timescale backbone dynamics of PKA-C in different ternary complexes. 
Adapted from [80]. Copyright 2011 National Academy of Sciences, U.S.A. 
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In a follow up study, Kim and coworkers sought to determine how substrates alter 
the conformational dynamics of the kinase[68]. For these studies, authors compared 
canonical substrate, PLN, to a lethal variant R14del (PLNR14del) linked to familial dilated 
cardiomyopathy. Measuring the Rex values from the TROSY Hahn-Echo experiment, 
authors found striking differences in the conformational dynamics between wild-type PLN 
and PLNR14del. Upon binding PLN, PKA-C experiences attenuated dynamics when 
compared to the binding of nucleotide; whereas, for the binding of PLNR14del PKA-C 
experiences enhanced conformational dynamics particularly in regions essential for 
catalysis (Figure 2.6). Importantly, these enhanced conformational dynamics contribute 
to a reduction in binding affinity, cooperativity, and turnover towards PLNR14del. Ultimately 
the deletion of R14 disrupts the intermolecular interactions between the enzyme and 
substrate, augmenting the conformational dynamics involved in the opening and closing 
of the active site and enzyme turnover. These monumental studies introduced the concept 
that dysfunctional conformational dynamics of biomolecules may result in pathological 
phenotypes via alterations in dynamic allostery.  
 
Figure 2.6. Allosteric changes in conformational dynamics of PKA-CWT upon binding PLN 
(top) or PLNR14del (bottom). 
Slow conformational dynamics plotted on the X-ray crystal structure of PKA-C. Upon binding 
PLNR14del, PKA-C experiences an increase in conformational dynamics. Reprinted with permission 
from [68]. Copyright 2015 National Academy of Sciences, U.S.A. 
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It has been postulated that the switch between active and inactive states depends 
on the structural architecture of the conserved hydrophobic spines. The assembly of both 
the C- and R-spine are highly regulated, with the assembly of the R-spine requiring 
phosphorylation of the activation loop (T197) and the C-spine requiring ATP binding. Once 
assembled, the kinase can bind substrate cooperatively. How the C- and R- spine 
orchestrate the transition between active and inactive states was investigated by Kim and 
coworkers[66]. To assess the contribution of slow timescale conformational dynamics to 
catalysis, authors probed the structural fluctuations of the methyl sidechains of PKA-C 
using CPMG experiments. From CPMG relaxation dispersion curves, one is able to 
determine the transverse relaxation rate (Rex), the kinetics of exchange (kex), and the 
populations of the conformational equilibrium. In the absence of nucleotide or 
(pseudo)substrate, the kinase shows significant Rex values for several residues located in 
the hydrophobic core, the C-spine (V57 and L172), the R-spine (L95), the R-spine shell 
(V104), along with residues bridging the two spines (L167, I180 and I150). Dispersion 
curves are unable to be globally fit, suggesting the motions of the apo enzyme core are 
asynchronous. Nucleotide binding attenuates Rex values throughout the enzyme and can 
be fit globally to extract an exchange rate constant (kex) of 2500 ± 300 s-1 suggesting the 
motions of the nucleotide-bound kinase become synchronous. In agreement with previous 
studies[67, 80], upon binding substrate slow timescale dynamics persist, while 
pseudosubstrate binding abrogates most of the conformational exchange. To verify the 
importance of the residues in conformational exchange in the allosteric network, authors 
mutated two highly conserved residues (V104 and I150) that experience large Rex values. 
Upon mutation, that kinase no longer is auto-phosphorylated at T197 and retains no 
activity confirming their importance in intramolecular allosteric signaling. These studies 
underscore the importance of assembled R- and C- spines with PKA-C displaying 
uncorrelated motions when either is disassembled, as is the case for apo PKA-C. 
2.6 Fast Timescale Motions 
As allostery is thermodynamic by nature, a manner in which protein motions can 
modulate allostery is through conformational entropy. Recent advances in NMR have 
allowed the fast timescale motions of various systems to be characterized to reveal how 
changes in these motions can alter allosteric signal via changes in binding affinity. 
Although multiple NMR methods including HX NOE, T1, and T2 experiments probe fast 
timescale dynamics, this section will place a particular emphasis on the role of protein 
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motions in modulating allostery via conformational entropy using relaxation violated 
coherence transfer cross-correlation experiments. 
Recently, Veglia and coworkers have used NMR to extensively characterize the 
role of fast timescale motions in catalytic turnover. The method used in the proceeding 
paragraphs to characterize ps-ns motions have been successfully applied to various 
systems including the proteasome[152], metalloproteins[153], and calmodulin[143, 154]. 
It is well established that both experimentally and computationally allosteric cooperativity 
can be modulated by changes in conformational motion. Wang and coworkers sought to 
understand the role of conformational entropy in the kinases enzymatic cycle, particularly 
in relation to the allosteric cooperativity of PKA-C that is well established[83]. The 
conformational entropy was determined by measuring the ps-ns dynamics of methyl 
groups using relaxation violated coherence transfer cross-correlation experiments.  
Using rotational correlation times obtained by dynamic light scattering, methyl 
group order parameters methyl-bearing side chains were measured. Similar to slow 
timescale dynamics measurements, authors observed an overall rigidification upon 
nucleotide binding. Upon binding the substrate PKS5-24 (shares the sequence of PKI5-24 
with a serine at the p-site), the conformational dynamics throughout the entire kinase 
increase (Figure 2.7). For the portion of the catalytic cycle following phosphorylation, a 
reverse, correlated trend is observed. Taken together, the conformational dynamics data 
indicate the nucleotide binding to PKA-C synchronizes the motions, while asynchronous 
motions in the second portion of the enzymatic cycle are critical in destabilizing the 
intramolecular dynamic network to enable product release. This study and others suggest 
that if the motions of groups of two allosteric sites are coupled, the binding of one site 
would change the distribution of competent or non-competent states on the other site, 
thereby modulating positive and negative cooperativity, respectively. Moreover, these and 
other studies suggest that by altering the conformational dynamics of a protein or 
disrupting the allosteric coupling of the motions, a kinases function can be manipulated to 
affect signaling.  
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Figure 2.7. Changes in the conformational entropy of PKA-C during the enzymatic cycle. 
Methyl group O2 values obtained for the different ligated forms of PKA-C. Values are plotted with a 
color gradient from the most rigid (blue) to the most mobile (red). Additionally, total free energy 
(green), enthalpy (red), entropy (blue) values as obtained from ITC measurements are indicated 
for each transition. Reprinted with permission from [83]. Copyright 2019 Springer Nature. 
 
2.7 Concluding Remarks  
Allostery has been intensely studied since it was originally described decades ago, 
though few systems have been studied as extensively as protein kinase A. The detailed 
mechanistic studies provided here showcase powerful experimental techniques used to 
elucidate intramolecular allostery, while at the same time offering monumental insights 
into the role allostery plays in enzymatic function. Indeed, insight gained from NMR can 
be especially helpful when combined with other experimental techniques. Additional 
methods including modern computational methods, although not described here in detail, 
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can provide another perspective on enzyme allostery. Despite decades of research, 
experimental and computational tools continue to challenge the notions we have of 
enzyme allostery and to provide novel perspectives.  
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Protein-protein interactions (PPIs) regulate a plethora of cellular processes and NMR 
spectroscopy has been a leading technique to characterize them at the atomic resolution. 
Technically, however, PPIs characterization has been challenging due to multiple samples 
required to characterize the hot spots at the protein interface. Here, we review our recently 
developed methods that greatly simplify PPI studies, minimizing the number of samples 
required to fully characterize residues involved in the protein-protein binding interface. 
This original strategy combines asymmetric labeling of two binding partners and the 
carbonyl-carbon label selective (CCLS) pulse sequence element implemented into 
heteronuclear single quantum correlation (1H-15N HSQC) spectra. The CCLS scheme 
removes signals of the J-coupled 15N-13C resonances, recording simultaneously two 
individual amide fingerprints for each binding partner. We show the application to the 
measurements of chemical shift correlations, residual dipolar couplings (RDCs) as well as 
paramagnetic relaxation enhancements (PRE). These experiments open an avenue for 




Biological processes rely primarily on protein-protein interactions (PPIs) to mediate 
cellular function [155]. Historically biochemical techniques (co-immunoprecipitation, yeast-
two hybrid, pull-down assays, etc.) measuring parameters intrinsic to the whole complex 
have been used to characterize these PPIs [156, 157]. Recently, advances in nuclear 
magnetic resonance (NMR) spectroscopy have provided the means to characterize PPIs 
at atomic resolution, offering fine details of individual macromolecules participating within 
the complex [158-160]. In addition to allowing the characterization of these complexes at 
atomic resolution, NMR is well suited for studying dynamic, transient (~100 µM KD), and 
lowly populated states of complexes [161-163]. 
The mapping of PPIs using several observables such as chemical shift 
perturbation (CSP), residual dipolar couplings (RDC), intra- and inter-molecular as well as 
solvent paramagnetic relaxation enhancement (PRE) [164-166], cross-saturation (CS), 
and nuclear Overhauser effects (NOEs) has been well established [159]. These methods 
nevertheless fall short when studying large complexes due to the inherent attenuation of 
transverse relaxation times (T2) resulting in a reduction of both signal intensity and 
resolution. Despite methods such as TROSY [167], deuteration [168, 169], and selective 
labeling [170, 171] addressing these concerns, multiple samples are still required to 
distinguish one species from another. Recently, several new NMR experiments based on 
simultaneous, interleaved detection of up to three NMR active species with distinct isotopic 
labeling have provided the opportunity to map the effect of PPIs on individual components 
within a macromolecular complex. While there are outstanding reviews on protein-protein 
interactions [172-178], here we focus on our recently developed method that exploits spin-
echo filtering-based experiments with strategic protein labeling schemes to characterize 
protein-protein complexes. 
3.3 Results 
 Mapping two binding partners fingerprints simultaneously.  
Traditional approaches to map PPIs at an atomic level involve repeat experiments 
with reverse labeling patterns such that the interaction is probed from both binding 
partners. Prior to the introduction of the spin-echo filtering experiment by Bax et al. [179], 
three-bond homonuclear 1H-1H J couplings had been used to derive backbone and side-
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chain conformational restraints [180-185]. This new experiment relied on measuring the 
magnetization loss due to unresolved J coupling and utilized an interleaved detection 
method, where two spectra are recorded simultaneously, but differ by 180° pulse positions 
on the 15N channel. The spin-echo filtered experiment introduced by Bax is the building 
block for the Carbonyl Carbon Label Selective (CCLS) 1H-15N HSQC pulse sequence 
[186], which requires specific isotopic labeling to simultaneously map the chemical shift 
perturbations from two binding partners. The CCLS 1H-15N HSQC pulse sequence utilizes 
spin-echo filtering with a short magnetization transfer period between 15N and 13C’ in order 
to detect 1H-15N correlations adjacent to the NMR inactive (12C’) carbonyl groups (Figure 
3.1 panel A). Building on the constant time (CT) HSQC, the CCLS 1H-15N HSQC 
necessitates the acquisition of two spectra, a reference spectrum and a suppression 
spectrum, in an interleaved manner. The reference spectrum is acquired using the pulse 
sequence reported in Figure 3.1 panel A, with the 180° pulse on 13C’ during the 15N CT 
evolution period applied at position a as proposed by Vuister et.al. [179], allowing for the 
removal of 13C’-15N coupling. The suppression spectrum is acquired with the 180° 13C’ 
pulse at position b, leaving 13C-15N J coupling active and converting the transverse in-
phase magnetization of 15N spins linked to 13C’ to antiphase magnetization. This antiphase 
magnetization contains components in both the x- and y-direction. The π 1H and 13C 
pulses appliedat the end of the 15N evolution convert the y-component, 4HzNyC’z, to an 
unobservable multiple quantum coherence, 4HyNzC’y, while the x-component, 4HyNzC’y, is 
dephased by the G2 gradient (Figure 3.1 panel A). As a result, signals from 1H-15N groups 
coupled to 13C’ are suppressed, while signals from 1H-15N groups coupled to 12C’ are 
unaffected. The suppression spectrum can then be subtracted from the reference 
spectrum leaving the U-15N, 13C species observable (Figure 3.1 panel B).  
We tested the sensitivity of the CCLS method by comparing a reference CCLS-
HSQC spectrum and a conventional HNCO spectrum of the 20-kDa protein U-13C, 15N-
Ubiquitin at 10, 20, 30, and 40°C corresponding to average T2 values of 27, 33, 40, and 
47 ms, respectively [186]. The slower tumbling rates at lower temperatures lead to longer 
rotational correlation times (τC) and faster relaxation resulting in broader linewidths. We 
found the reference CCLS-HSQC experiment was more sensitive compared to the HNCO 
experiment for lower temperatures, demonstrating that the shorter time delay (TNC) allows 
for increased sensitivity for large proteins or protein-protein complexes. The sensitivity 
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enhancement gained from optimal TNC values compensates for the decrease in S/N 
observed upon subtraction of the suppression spectrum from the reference spectrum. 
 
Figure 3.1. CCLS pulse sequence. 
(A) Schematic of the CCLS-HSQC pulse sequence. It can be assumed unless otherwise indicated 
that all rectangular pulses are applied along the x-axis. 90° and 180° flip angles are represented 
by narrow bars and wide bars, respectively. The carrier frequency for 1H is set on resonance with 
water at 4.77 ppm; the carrier frequency for 15N is set in the center of the amide region at 121.8 
ppm; the 13C offset is set to 174.8 for the C’ region. The reference spectrum is recorded with the 
shaped pulse for 13C’ (open rectangle) at position a while the suppression spectrum is recorded 
with this pulse in position b. A 3-9-19 watergate pulse scheme is used in the reverse INEPT transfer. 
GARP1 decoupling with a field strength of 1kHz is used during acquisition of 15N. Delay durations: 
Δ = 2.4 ms; δ = 0.11 ms; TNC’ = 16.5 ms. Phase cycling: φ1 = x,-x, φ2 = x,x,-x,-x, φrec = x,-x. A second 
FID is acquired for each increment by changing the φ1 phase to y,-y in order to accomplish States 
quadrature detection for the 15N indirect dimension. The φ1 and φrec phases are also incremented 
by 180° every other 15N increment for States-TPPI acquisition. The gradients use the Wurst shaped 
z-axis gradients of 1 ms. Gradient strengths (G/cm): G1: 5, G2: 7, G3: 17. The CCLS-HSQC pulse 
sequence is based on the fast HSQC experiment [187] to preserve water magnetization. (B) 
Example spectra representing the reference spectrum, the suppression spectrum, and the resulting 
subtraction spectrum followed by insets from the PKA-C/PKIα complex displaying the separation 
of resonances from each species. The blue and red species are present in the reference CCLS-
HSQC, while the suppression spectrum contains only red species. Subtraction of the suppression 
from the reference spectrum results in a third spectrum containing only the blue species. (C) CCLS-
HSQC experiment on the 50 kDa PKA-C/PKIα complex. The reference spectrum (left, purple) 
displays resonances from both U-15N labeled PKA-C as well as U-15N, 13C labeled PKIα (S/N = 40). 
The suppression spectrum (middle, blue) suppresses signal from the 13C’ labeled PKIα showing 
only peaks from 12C’ labeled PKA-C (S/N = 50). Upon subtraction of the suppression spectrum from 
the reference spectrum, a sub-spectrum is obtained containing only peaks from PKIα (right, red) 
(S/N = 15). 
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Furthermore, we applied this technique to resolve assignment ambiguities on the 
41 kDa catalytic subunit of cAMP-dependent protein kinase A (PKA-C) [53, 188]. PKA-C 
is the prototypical Ser/Thr kinase and, until relatively recently, had remained unexplored 
by NMR due to its size and presence of conformational exchange effects on the μs-ms 
timescale [75, 76, 189, 190]. Advances in pulse sequence design and sample preparation 
have since made it possible to investigate this system using NMR [62, 66, 70, 80]. We 
successfully implemented the CCLS-HSQC pulse sequence to assist in the assignment 
of multiple catalytically relevant residues of PKA-C. Furthermore, recent work from our 
group demonstrates the ability of this pulse sequence to simultaneously detect PKA-C in 
complex with an endogenous inhibitor, the heat-stable protein kinase A inhibitor (PKIα) 
[53, 191], giving the possibility to detect the mutual effect of PKA-C and PKIα interaction 
(Figure 3.1 panel C - unpublished data). Together these applications underscore the 
ability of CCLS to simultaneously detect PPIs and emphasizes the performance of this 
pulse sequence with high molecular weight systems. 
  Fingerprinting three binding partners using one sample.  
Masterson et. al. applied the CCLS pulse sequence element to deconvolute PPIs 
in a ternary mixture simultaneously [192].The dual carbon label selective (DCLS) 1H-15N 
HSQC experiment requires three labeled binding partners, with the first species U-15N 
labeled, the second 15N, 13C’ labeled, and the third U-13C, 15N labeled. The deconvolution 
of these spectra follows the same spin-echo filtering theory as CCLS, with additional 
filtering of Cα coupled spins (Figure 3.2 panel A). Cα suppression requires a longer TNCα 
delay due to both inter- and intra-residue 1H-13Cα J coupling [193]. Increasing the TNCα 
delay nullifies protein backbone conformation dependency of 1JNCα and 2JNCα as it 
completely suppresses signal from 1JNCα while inverting the residual signal intensities of 
2JNCα. 
This and the previously introduced pulse sequence rely on selective labeling of 
individual binding partners. Asymmetric selective labeling schemes to study PPIs in a 
multiple component sample are increasing in popularity [194-197] both for solution and 
solid-state NMR spectroscopy. For instance, Anglister and coworkers have demonstrated 
the application of asymmetric deuteration in combination with transferred nuclear 
Overhauser spectroscopy to study intermolecular nuclear Overhauser effects (NOEs) of 
large, fast exchanging protein complexes [198-200]. With respect to CCLS and DCLS, 
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selective labeling of 13C’ can be accomplished in recombinant proteins using either 15N- 
and 13C’-labeled amino acids or 1-13C pyruvate and 13C-labeled NaHCO3 as the sole 
carbon sources [201-205]. Selective 13Cα labeling is achieved by using 2-13C glucose as 
the sole carbon source [202].  
 
Figure 3.2. DCLS pulse sequence. 
(A) Schematic of the DCLS-HSQC pulse sequence. It can be assumed unless otherwise indicated 
that all pulses are applied along the x-axis. 90° and 180° flip angles are represented by narrow 
bars and wide bars, respectively. The reference spectrum is recorded with the shaped pulse for 13C 
(open rectangle) at position a while the 13C’ suppression spectrum is recorded with this pulse in 
position b and the 13Cα suppression spectrum is recorded with the 13Cα shaped pulse in position c. 
A 3-9-19 watergate pulse scheme is used in the reverse INEPT transfer. GARP1 decoupling with 
a field strength of 1kHz is used during acquisition of 15N. The carrier frequency for 1H is set on 
resonance with water at 4.7 ppm; the carrier frequency for 15N is set in the center of the amide 
region at 120 ppm; the 13C offset is set to 56 ppm. Selective 13C’ (13Cα) sine shaped pulses are 
centered at 174 (56 ppm) and a null 113 ppm away. Delay durations: Δ = 2.4 ms; δ = 0.11 ms; TNC’ 
= 16.4 ms; TNCα = 24.5 ms. Phase cycling: φ1 = x,-x, φ2 = x,x,-x,-x, φrec = x,-x. A second FID is 
acquired for each increment by changing the φ1 phase to y,-y in order to accomplish States 
quadrature detection for the 15N indirect dimension. The φ1 and φrec phases are also incremented 
by 180° every other 15N increment for States-TPPI acquisition. The gradients use the Wurst shaped 
z-axis gradients of 1 ms. Gradient strengths (G/cm): G1: 5, G2: 7, G3: 17. (B) Example spectra 
representing the reference spectrum, the two suppression spectra, and the resulting subtraction 
spectra. The red, green and blue species are present in the reference DCLS-HSQC (a), while the 
first suppression spectrum (b) contains resonances from the red species and the second 
suppression spectrum (c) contains resonances from the red and green species. Subtracting 
spectrum c from a results in only resonances from the blue species and subtracting spectrum c 
from b yields only resonances from the green species. This linear subtraction scheme results in 
spectra with each component in the mixture isolated. 
 
The DCLS experiment requires the acquisition of three interleaved experiments in 
parallel (Figure 3.2 panel B). A reference data set is collected observing all three species 
simultaneously, followed by the first suppression data set where amide resonances 
adjacent to 13C’ are undetected, identical to the CCLS suppression spectrum. Lastly, a 
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second suppression data set is collected where amide resonances coupled to 13Cα are 
not detected. Deconvolution of the spectra is obtained by a linear combination of the data 
set. Subtraction of the second suppression spectrum from the reference spectrum 
provides a subspectrum containing only resonances from the U-13C, 15N labeled species. 
The subtraction of the first suppression spectrum from the second suppression spectrum 
provides an additional subspectrum containing only resonances from the U-15N, 13C’ 
labeled species. In this manner, subspectra are obtained from a single sample for each 
individual component of the ternary mixture and all resonances can be resolved. As a 
proof of concept Masterson et. al. applied this labeling scheme and pulse sequence to 
three non-interacting proteins, maltose binding protein (MBP), Kemptide, and ubiquitin. By 
applying DCLS, the authors obtained subspectra corresponding to each individual 
component of the ternary mixture displaying the potential of this approach to study protein-
protein interactions with a single sample. 
 Measuring Residual Dipolar Coupling (RDC) of complexes using one 
sample. 
Residual dipolar coupling (RDC) allows orientation specific data to be derived via 
dipole-dipole interactions. The orientation restraints provided by RDC have proven useful 
in protein structure determination, nucleic acid structure, domain orientation, and more 
recently PPIs [206, 207]. We implemented CCLS and DCLS to sensitivity-enhanced 
TROSY or anti-TROSY spin-state selection to record the simultaneous measurement of 
RDCs [206, 208-211] for the relative orientations of multiple proteins within a single 
sample (Figure 3.3 panels A-B). RDC measurements are susceptible to experimental 
condition variations, which alter alignment tensors making difficult the direct correlations 
of orientational constraints obtained from different samples. Our approach, together with 
specific isotopic labeling, eliminates the need for multiple samples thus removing errors 
associated with sample inconsistencies [206]. 
Similar to DCLS (Figure 3.3 panel C), we applied this pulse sequence to a non-
interacting mixture of U-2H, 15N MBP, 15N-Ser5, 13C’-Ala4 Kemptide, and, U-13C, 15N 
ubiquitin [212]. Following the same linear subtraction scheme reported for DCLS, we were 
able to measure RDCs for each individual component in a ternary mixture. Importantly, 
these RDC values were in agreement with back calculated values determined from 
already solved crystal structures of MBP [213] and ubiquitin [214], confirming that the 
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backbone conformational space of these proteins, along with their relative alignment 
tensors, were sufficiently defined. 
 
Figure 3.3. CCLS/DCLS RDC. 
Schematic of the gradient-selected TROSY-based pulse sequence for binary (A) or ternary (B) 
mixtures of proteins. It can be assumed unless otherwise indicated that all pulses are applied along 
the x-axis. 90° and 180° flip angles are represented by narrow bars and wide bars respectfully. The 
reference spectrum is recorded with the shaped pulse for 13C (open rectangle) at position a while 
the 13C’ suppression spectrum is recorded with this pulse in position b and the 13Cα suppression 
spectrum is recorded with the 13Cα shaped pulse in position c. The carrier frequency for 1H is set 
on resonance with water at 4.77 ppm; the carrier frequency for 15N is set in the center of the amide 
region at 121.8 ppm; the 13C offset is set to 56 ppm. Selective 13C’ (13Cα) sine shaped pulses are 
centered at 174.8 ppm (56 ppm). Delay durations: Δ = 2.4 ms; δ1 = 1.5 s; TNC’ = 16.5 ms; TNCα = 
23.5 ms. Phase cycling: φ1 = x,-x, φ2 = -x,  φ3 = -y, φrec = x,-x. Gradient strengths must be adjusted 
following the relationship G2 = G1·(γN/γH), where γN and γH are the gyromagnetic ratios of 15N and 
1H, respectively. A second FID is collected for each increment by changing the φ2 and φ3 to x and 
y respectively and by inverting the sign of the G2 gradient in order to accomplish States quadrature 
detection for the 15N indirect dimension. The φ1 and φrec phases are also incremented by 180° every 
other 15N increment for States-TPPI acquisition. The gradients use the Wurst shaped z-axis 
gradients of 1 ms. Gradient strengths (G/cm): G3: 3, G4: 13, G5: 4, G6: 5. To measure 1JHN coupling 
and NH RDC (in aligned media), a second spectrum, featuring the anti-TROSY component, is 
acquired by changing the φ3 phase to y. (C) Example spectra representing the reference spectrum, 
the suppression spectrum, and the resulting subtraction spectrum. The blue and red species are 
present in the reference CCLS-HSQC, while the suppression spectrum contains only red species. 
Subtraction of the suppression from the reference spectrum results in a third spectrum containing 
only the blue species. (D) Example spectra representing the reference spectrum, the two 
suppression spectra, and the resulting subtraction spectra. The red, green and blue species are 
present in the reference DCLS-HSQC (a), while the first suppression spectrum (b) contains 
resonances from the red species and the second suppression spectrum (c) contains resonances 
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from the red and green species. Subtracting spectrum c from a results in only resonances from the 
blue species and subtracting spectrum c from b yields only resonances from the green species. 
This linear subtraction scheme results in spectra with each component in the mixture isolated. 
 
 Measuring long-range distances and transient complexes using CCLS 
for Paramagnetic Relaxation Enhancements (PRE). 
Paramagnetic relaxation enhancements (PRE) have been used extensively to 
obtain long-distance restraints for structure calculation and to study PPIs for both stable 
and transient complexes [215-220]. In the standard PRE experiment that involves two 
interacting proteins, the intra- or inter-molecular effects of a paramagnetic center are 
detected for only one of the binding partners in each independent NMR experiment 
(Figure 3.4 panel Ai). To accurately probe these interactions, a minimum of four samples 
with differing spin label positions as well as reversed labeling schemes are required. 
Recently, we incorporated the CCLS pulse sequence in the traditional 1HN-Γ2 (1HN-Γ2-
CCLS) [217] that, together with an asymmetric labeling scheme, enables the detection of 
both intra- and inter-molecular paramagnetic relaxation enhancements (PREs) 
simultaneously using only one sample [164] (Figure 3.4 panel B). In this newly proposed 
strategy, one of the two binding partners must be U-15N labeled and the second U-15N, 13C 
labeled (Figure 3.4 panel Aii). We also tested the proposed pulse sequence on the non-
covalent, transient dimerization of ubiquitin. Specifically, we studied the complex formed 
between U-15N, 13C wild-type ubiquitin and the U-15N-spin labeled K48C mutant. We were 
able to discriminate intra- and inter-molecular interactions detecting the structural and 
dynamics changes intrinsic to ubiquitin upon dimerization (Figure 3.4 panel C). The Γ2 
rates obtained with the new pulse sequence were confirmed to be identical to standard 
experiments. This work demonstrates that the Γ2-CCLS PRE experiment is suitable for 
identifying structural changes occurring in both binding partners upon formation of 
transient and permanent interactions using a reduced number of samples. 
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Figure 3.4. CCLS-PRE. 
(A) Schematic of the standard experiment for the detection of intra- and inter-molecular PRE. In 
this case four different samples are needed. The first sample for the intra-molecular PRE is 
prepared with an asymmetric labeling scheme using the first binding partner uniformly 15N labeled 
with a conjugated spin label (SL) and the second is NMR silent (unlabeled). A sample with a 
reversed labeling scheme is necessary to detect the intra-molecular PRE for the second binding 
partner (top panel A). For the inter-molecular PRE, two additional samples are required: one NMR 
silent with the conjugated SL and a second NMR active (e.g., 15N or 13C labeled) (lower panel A). 
Simultaneous detection of inter- and intra-molecular PRE using 1HN-Γ2-CCLS experiment. One 
species is uniformly 15N labeled while the other is 13C and 15N labeled (b) and this allows the 
simultaneous detection of intra- and inter-molecular PREs. As reported before, reverse positioning 
of the SL is required for obtaining a complete characterization of the complex. (B) The 1H-Γ2-CCLS 
pulse sequence for PRE Γ2 measurements. The narrow and wide bars represent 90° and 180° hard 
pulses, respectively. The three 13C 180° shaped pulses are 256 µs long Q3 pulse, the first two and 
the last one shaped pulses are applied to 13C′ and 13CA, respectively. The 13C′ 180° shaped pulse 
may be at either position a or b. When it is at position a, the 1JNC′ is decoupled and reference spectra 
are acquired. When it is at position b, the 1JNC′ is present and 13C′-suppressed spectra are acquired. 
The flipping angles and phases of the pulses in 3919 are 20.8°x, 62.2°x, 131.6°x, 131.6°-x, 62.2°-x, 
and 20.8°-x, respectively, and the interval between pulses is 188 µs (= 1/d, d is the distance in Hz 
between center and next null). T = 16.5 ms, ∆ = 2.6 ms. G1=(1 ms, 25.0 G/cm), G2=(0.3 ms, 5.0 
G/cm), G3=(0.3 ms, 8.0 G/cm), G4=(1 ms, 15.0 G/cm), G5=(1 ms, 10.0 G/cm). Phase cycling 
scheme is ϕ1= (x, -x), ϕ2=(x, x, -x, -x), ϕ3=4(x), 4(-x), ϕrec=(x, -x, x, -x, -x, x, -x, x). The quadrature 
detections in t1 dimension are acquired via States-TPPI of ϕ1. Constant time mode is used to 
measure Γ2, that is 𝛤𝛤2 = 𝑙𝑙𝑙𝑙 (𝑆𝑆1/𝑆𝑆2)/(𝜏𝜏2 − 𝜏𝜏1), where 𝑆𝑆1 and 𝑆𝑆2 are signal intensities of a peak 
measured with 𝜏𝜏 = 𝜏𝜏1 and 𝜏𝜏 = 𝜏𝜏2, respectively. 2×2 spectra are acquired in an interleave mode via 
changing relaxation delay τ (minimum 2 ms) and changing the 13C′ 180° shaped pulse from position 
a to b, respectively. (C) Intra- and inter-molecular PRE measurements of 15N-UbiK48C obtained with 
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the 1HN-Γ2-CCLS experiment. 1HN-Γ2 rate plot calculated for K48C mutant conjugate with MTSL in 
presence of UbiWT (upper panel C). 1HN-Γ2 rate plot calculated for WT ubiquitin in presence of 
UbiK48C-MTSL (lower panel C). 
 
 Improving sensitivity with the G5 pulse. 
Advances in NMR methodology (TROSY, deuteration, selective labeling) have 
allowed for studies of protein-protein complexes approaching 1 MDa [221, 222]; however, 
these studies lack the ability to distinguish one species from another without the 
preparation of multiple samples. A recent technological advance that can improve nearly 
any pulse sequence is the universal triply compensated π pulses for high field 
spectrometers [223, 224], which we have incorporated into the CCLS pulse sequence 
(Figure 3.5). All inversion and refocusing pulses in the 1H and 15N channel were replaced 
with G5 pulses except the 15N refocusing pulse in middle of 3-9-19 water suppression. We 
were able to improve the signal intensity from 6% to 23% compared to the regular CCLS 
version. These experiments were performed on the Bruker 900 MHz AVIII spectrometer 
at 298K, and this enhancement will only be more significant in GHz spectrometers.  
 
Figure 3.5. CCLS G5-pulse implementation. 
(A) CCLS 1H-15N HSQC reference spectrum of 15N, 13C UbiWT and U-15N UbiK48C mutant. (B) 
Overlay spectra of the UbiWT alanine 46 peak demonstrating a 23% signal intensity improvement 
with the G5 pulse. (C) Overlay spectra of the UbiK48C alanine 46 peak demonstrating an 18% signal 
intensity improvement with the G5 pulse. (D) Overlay spectra of the glycine 75 peak demonstrating 
a 6% improvement with the G5 pulse. 
 
3.4 Conclusion and Perspectives 
Here, we demonstrate the CCLS/DCLS pulse sequences enable the study of PPIs 
through simultaneous inter-leaved detection of all components in a single sample. As we 
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have illustrated, the CCLS and DCLS pulse sequence blocks can be applied to a multitude 
of well-established experiments (RDC and PRE). Extrapolating from this integration into 
existing NMR experiments, could NOESY be the next step? The possibility of observing 
multiple species in a single sample for NOESY experimentation is viable as Anglister et. 
al.[198] has reviewed difference spectroscopy and its application to 2D NOESY 
experiments. However, the pulse sequences are long thereby limiting sensitivity which the 
CCLS/DCLS pulse blocks show promise toward combating. Thus, reflecting upon the 
versatility of the CCLS/DCLS pulse block and the associated advantages afforded, we 
envisage the insertion into other existing NMR experiments to study a wide range of 
multicomponent systems. 
3.5 Acknowledgements 
This work is supported by the NIH (GM100310 to GV and P41 GM103399 to JLM). NMR 
experiments were carried out at the National Magnetic Resonance Facility at Madison and 
the Minnesota Nuclear Magnetic Resonance Center. 
  
51 
 Cushing’s Syndrome Driver Mutation 
Disrupts Protein Kinase A Allosteric Network, Altering 
Both Regulation and Substrate Specificity 
 
Caitlin Walker1, Yingjie Wang1,2, Cristina Olivieri1, Adak Karmafrooz1, Jordan Casby1, 
Kerstin Bathon3, Davide Calebiro4,5, Jiali Gao2,6, David A. Bernlohr1, Susan S. Taylor7, 
and Gianluigi Veglia1,2* 
1Department of Biochemistry, Molecular Biology, and Biophysics, University of 
Minnesota, Minneapolis, MN 55455, USA. 
2Department of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA. 
3Institute for Pharmacology and Toxicology, University of Würzburg, 97078 Würzburg, 
Germany. 
4Institute of Metabolism and Systems Research, University of Birmingham, Birmingham 
B15 2TT, UK. 
5Centre of Membrane Proteins and Receptors, University of Birmingham, Birmingham 
B15 2TT, UK. 
6Shenzhen Bay Laboratory and Laboratory of Computational Chemistry and Drug 
Design, Peking University Graduate School, Shenzhen 518055, China. 
7 Departments of Chemistry and Biochemistry and Pharmacology, University of 









Genetic alterations in the PRKACA gene coding for the catalytic α subunit of the cAMP-
dependent protein kinase A (PKA-C) are linked to cortisol-secreting adrenocortical 
adenomas resulting in Cushing’s syndrome. Among those, a single mutation (L205R) 
located in the P+1 loop of the kinase’s active site has been found in up to 67% of patients. 
The X-ray structures of the wild-type and mutant kinases are essentially identical and the 
aberrant mechanism of function of this mutant remains under active debate. Using NMR 
spectroscopy, thermodynamics, kinetic assays, and molecular dynamics simulations, we 
found that this single mutation causes global changes in the enzyme, disrupting the 
intramolecular allosteric network and structural coupling between the small and large 
lobes. The altered intramolecular allosteric interactions and loss of nucleotide/pseudo-
substrate binding cooperativity explain the impaired regulation of the kinase by regulatory 
subunits and the endogenous protein kinase inhibitor. Remarkably, by rewiring its internal 
allosteric network, PKA-CL205R is able to bind and phosphorylate non-canonical substrates, 
explaining the changes in substrate specificity detected by phosphoproteomic analyses. 
Both the lack of regulation and change in substrate specificity reveal the complex role of 




The cAMP-dependent protein kinase A (PKA) plays a fundamental role in the 
function and replication of endocrine cells [225] and aberrant cAMP signaling has been 
linked to several endocrine diseases [226]. The first mutations in PKA have been found in 
the regulatory (R) subunits, which have been associated with Carney complex, a multiple 
neoplasia syndrome manifesting via adrenocortical adenomas, cutaneous and neuronal 
tumors, cardiac myxomas and pigmented lesions of the skin and mucosae [226]. Only 
recently, somatic mutations have been identified in the PRKACA gene coding for the 
catalytic α subunit of PKA (PKA-C) and discovered in cortisol-secreting adrenocortical 
adenomas responsible for Cushing’s syndrome [227] (Figure 4.1 panel A). Nearly all 
identified mutations lie adjacent to the active site cleft and the regulatory/catalytic subunit 
interface (Figure 4.1 panel B,C). Among these mutations, the most frequently found 
(PKA-CL205R) is a point mutation leading to substitution of Leu at position 205 (or 206, 
depending on the convention used for numbering) with Arg and has been found in up to 
67% of Cushing’s syndrome patients [27-29, 102, 228].  
Inactive PKA exists as an inactive holoenzyme (R2C2) containing a regulatory (R) 
subunit dimer bound to two catalytic (C) subunits. The inhibitory sequence of the R-subunit 
occupies the active site of the enzyme (Figure 4.1 panel D). Upon stimulation of 
membrane receptors coupled to the stimulatory Gs protein, produced cAMP binds to the 
R-subunits unleashing active C-subunits [229]. The spatiotemporal regulation of the 
kinase is provided by ancillary proteins such as A-kinase anchoring proteins (AKAPs) that, 
via interactions with R-subunits, localize PKA-C in close proximity to its substrates [55]. In 
addition, PKA-C is regulated by an endogenous inhibitor (PKI), whose function is to block 
access to substrates and recruit PKA-C to the nuclear export complex (CRM1 and 
RanGTP) [229]. When this spatiotemporal regulation fails, PKA-C hyper-phosphorylates 
its targets, leading to disease. 
Structurally, PKA-C consists of two lobes. The N-lobe, smaller and more dynamic, 
comprises mostly β-strands as well as the αC-helix and harbors the ATP binding site [35]. 
The C-lobe, larger and made up by α-helices, is more rigid and harbors the substrate 
binding groove. PKA-C toggles between three major conformational states: open (apo), 
intermediate (nucleotide-bound), and closed (ternary complex with nucleotide/substrate-
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bound) [42]. The L205R mutation is located at the interface of the N- and C- lobes of PKA-
C in the P+1 loop, a highly conserved region of the enzyme that creates a hydrophobic 
pocket for substrate docking. Based on its positioning, the L205R mutation has been 
proposed and shown by independent laboratories to disrupt the binding of R-subunits and 
render the enzyme constitutively active [230, 231]. In vivo studies revealed that the 
catalytic activity of PKA-CL205R is comparable to that of wild-type [230]. However, recent 
phosphoproteomic mapping showed a drastic change in the phosphorylation profile, 
suggesting that the mutation preserves the ability to phosphorylate downstream 
substrates, although with a different selectivity [20, 232]. Based on these data, it has been 
proposed that disruption of the signaling network leading to the phosphorylation of novel 
substrates may contribute to tumorigenesis. Notably, the X-ray crystal structures of the 
wild-type and mutant kinase in complex with nucleotide and pseudo-substrate, PKI5-24, are 
nearly superimposable (RMSD = 0.49 Å) [106] and do not thoroughly explain the weaker 
binding for R-subunit, the lack of regulation by PKI as well as the changes in the 
phosphoproteomic profile. 
To gain mechanistic insights on the multifarious effects of this single mutation, we 
carried out solution NMR spectroscopy in concert with binding thermodynamics, kinetic 
assays, and molecular dynamics (MD) simulations. We found that this single mutation, in 
addition to changing the protein-protein interface for substrate recognition, causes a 
disruption of the internal allosteric communication, reducing its affinity for nucleotide. The 
partial ablation of the intramolecular allosteric communication prevents the kinase from 
reaching a completely closed state, reducing the binding affinity for canonical substrates 
and pseudo-substrates, thus hindering endogenous regulation. Notably, kinetic assays 
using a substrate identified by phosphoproteomic analyses as a preferred substrate of 
PKA-CL205R [20] show a higher catalytic efficiency and a rearrangement of the internal 
structural dynamics and allosteric communication. Taken together, our results indicate that 
rewiring of the internal allosteric network and global changes in dynamics contribute to the 
complex dysregulation of the signaling network of PKA-CL205R within tumor cells. 
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Figure 4.1. Architecture of PKA-C and locations of the Cushing’s syndrome mutations. 
(A) Structure of PKA-C (PDB ID: 1ATP) in complex with pseudo-substrate PKI depicting the 
location of Cushing’s syndrome mutations (yellow spheres) in relation to structural elements of the 
kinase. The E248Q mutations includes an additional deletion (del243-247) and the S212R mutation 
includes an insertion (insIILR) not depicted. (B) X-ray structure of PKA-CL205R (PDB: 4WB6) with 
the overlay of PKI5-24 (PKIWT from PDB: 1ATP) describing the architecture of the peptide binding 
site and steric clash between kinase PKA-CL205R and pseudo-substrate. (C) Structure of R/C 
complex (PDB ID: 2QCS) depicting locations of Cushing’s mutations in relation to the pseudo-
substrate inhibitory sequence of the R-subunit. (D) Primary sequence comparison of common 
regulators (RIα, RIIβ, PKI) and peptide substrates of the catalytic subunit (Kemptide and VPS36). 
 
4.3 Results 
PKA-CL205R shows a marked loss of binding cooperativity between ATP and PKI. To 
determine the thermodynamics of nucleotide binding (ATPγN) to both PKA-CWT and PKA-
CL205R, we used isothermal titration calorimetry (ITC). We found that PKA-CL205R exhibits a 
3-fold lower binding affinity compared to PKA-CWT (Kd of 215 ± 15 versus 83 ± 8 μM). 
Fitting of the titration curves shows the binding of ATPγN to PKA-CL205R is enthalpically 
favorable and entropically unfavorable; whereas both contributions are favorable for 
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ATPγN binding to PKA-CWT. To evaluate the binding cooperativity between nucleotide and 
substrate [71, 82], we analyzed the binding thermodynamics of the pseudo-substrate 
peptide inhibitor, PKI5-24, to both PKA-CWT and PKA-CL205R in the presence and absence 
of nucleotide. ∆H, -T∆S, ∆G and Kd as well as the cooperativity coefficients (σ) derived 
from ITC titrations are summarized in Table 4.1. The binding thermodynamics of PKI5-24 
to the apo forms of the two kinases is comparable, with similar enthalpy changes 
(favorable). When saturated with ATPγN, PKA-CWT binds PKI5-24 with higher affinity (Kd = 
0.16 ± 0.02 μM) [71]. In contrast, PKA-CL205R displays a 62-fold reduction in binding affinity 
(Kd = 10 ± 3 μM), with a net decrease in both ∆H and ∆S. Importantly, the binding of PKI5-
24 to the PKA-CWT/ATPγN complex is highly cooperative (σ = 106 ± 18), whereas its binding 
cooperativity to the PKA-CL205R/ATPγN complex decreases 18-fold (σ = 6 ± 2). Therefore, 
this single mutation affects both the affinity for ligands as well as the binding cooperativity 
between nucleotide and pseudo-substrate. 
L205R mutation causes a reduction in phosphorylation kinetics. To evaluate the 
catalytic efficiency of PKA-CL205R, we carried out steady-state coupled assays using the 
standard substrate, Kemptide. As expected from the binding thermodynamics and 
previous kinetic assays, the Leu to Arg substitution at the P+1 loop increases the KM 11-
fold (Table 4.2). Interestingly, the kcat for the mutant increases from 19 s-1 to 41 s-1, which 
results in an overall decrease in catalytic efficiency (kcat/KM) by over 5-fold compared to 
PKA-CWT. These results are in quantitative agreement with experiments carried out by two 
other independent groups [106, 233]. 
PKI binding to PKA-CL205R falls short in shifting the enzyme to a fully closed state. 
To analyze the structural changes of PKA-C upon binding PKI and the effects of the L205R 
mutation, we mapped the amide backbone fingerprint of the enzyme using [1H, 15N]-
TROSY-HSQC experiments [234]. The amide signatures of the kinases in different ligated 
forms are displayed in Figure 4.7. The binding of ATPγN to both PKA-CWT and PKA-CL205R 
gives rise to similar chemical shift perturbations (CSPs), with the exception of the residues 
in the Gly-rich, catalytic, and Mg2+ positioning loops that show larger chemical shift 
changes for PKA-CWT (Figure 4.8). To evaluate the global response to ligand binding for 
the kinase and its mutant, we used CONCISE (COordiNated ChemIcal Shifts bEhavior), 
which performs a statistical analysis on linear chemical shift trajectories of each amide 
resonance to identify the position of each state along the conformational equilibrium [235]. 
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Following ligand binding, the amide resonances of PKA-C display linear chemical shifts 
trajectories, with the amide resonances corresponding to the apo enzyme populating one 
extreme and those of the closed state (ternary complex with PKI) populating the opposite 
extreme of the linear correlations. This behavior exemplifies a conformational equilibrium 
along the three major conformational states of the kinase (open, intermediate, and closed), 
whose relative populations are modulated by ligand binding. A total of 55 residues exhibit 
linear chemical shift trajectories for both PKA-CWT and PKA-CL205R indicating a fast 
exchange limit in the NMR chemical shift timescale. These residues are distributed 
throughout the kinase. We found the binding of ATPγN and PKI shifts the conformational 
equilibrium of PKA-CWT towards a fully closed state. In contrast, these ligands drive the 
mutant to a partially closed state, which is located between the intermediate and the 
closed conformation (Table 4.3). This is supported by thermostability data obtained by 
circular dichroism (CD) measurements (Table 4.4). In fact, CD melting curves show that 
the PKA-CWT/ATPγN/PKI complex has a higher melting temperature (Tm) than the 
corresponding complex with PKA-CL205R, further suggesting that this complex may adopt 
a more open and unstable conformation. Since the extent of the closed state is correlated 
with binding affinity and cooperativity [71], these results are consistent with the loss in 
allosteric cooperativity revealed by thermocalorimetric data. 
L205R disrupts the allosteric network of the kinase upon PKI binding. To determine 
a possible correlation between the binding cooperativity and the intramolecular allosteric 
network, we analyzed the correlated chemical shift perturbations for both PKA-CWT and 
PKA-CL205R using CHEmical Shift Covariance Analysis (CHESCA) [129]. This method 
identifies the allosteric networks of residues that are involved in concerted responses to 
ligand binding [130, 132]. The [1H, 15N]-TROSY-HSQC spectra of the three forms of PKA-
C (apo, ATPγN-bound, and ATPγN/PKI-bound) were used for the CHESCA analyses. This 
method relies on the presumption that when subjected to ligand binding, residues 
belonging to the same allosteric network elicit a correlated linear response, i.e., the 
chemical shifts show high covariance. The identification of inter-residue covariation by 
CHESCA relies on agglomerative clustering and singular value decomposition [130, 132]. 
Pairwise correlations between chemical shift variations experienced by different residues 
are analyzed to identify networks of coupled residues and are plotted on a correlation 
matrix. A disruption of the allosteric network is diagnosed by a decrease in the density and 
extent of the inter-residue correlations. 
58 
The CHESCA matrices for PKA-CWT and PKA-CL205R reported in Figure 4.2 panel 
A,C reveal dramatic differences in their allosteric networks. In fact, there is an overall 
reduction in the number of correlations throughout PKA-CL205R (Figure 4.2 panel B,D), 
with specific domains of the enzyme more impacted by this single mutation. In particular, 
residues belonging to the Gly-rich, activation loop, and peptide-positioning loop 
experience the most dramatic reductions in both number and extent of chemical shift 
covariation. Additionally, correlations within the activation loop (W196), αF- (K217, V219, 
D220, G225, V226, A233), and αG-helices (Q245) are also ablated. The loss of 
correlations for the αF-helix is especially important as this motif spans the hydrophobic 
core of the C-lobe and is conserved throughout the AGC kinase family. The function of 
the αF-helix is to anchor all the hydrophobic motifs within the kinase core and orchestrate 
catalysis [39, 66]. As highlighted before, all Cushing’s driver mutations, with the exception 
of E31V, are located near L205R and are likely to affect the enzyme in a similar manner, 
disrupting these important allosteric nodes. 
 
Figure 4.2. Allosteric network of interactions observed upon pseudo-substrate binding.  
The CHESCA correlation matrix for (A) PKA-CWT upon binding PKI, and (B) PKA-CL205R upon 
binding PKI. (C) Correlations corresponding to the binding of PKI to PKA-CWT plotted on the 
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structure of PKA-C. Residues that are commonly correlated for both PKA-CWT and PKA-CL205R are 
highlighted. (D) Correlations corresponding to the binding of PKI to PKA-CL205R plotted on the 
structure of PKA-C. Specific residues that are correlated for only PKA-CL205R are highlighted. Only 
correlations with rij > 0.98 are shown throughout. 
 
L205R disrupts the allosteric network of the kinase upon PKI binding. To determine 
a possible correlation between the binding cooperativity and the intramolecular allosteric 
network, we analyzed the correlated chemical shift perturbations for both PKA-CWT and 
PKA-CL205R using CHEmical Shift Covariance Analysis (CHESCA) [129]. This method 
identifies the allosteric networks of residues that are involved in concerted responses to 
ligand binding [132]. The [1H, 15N]-TROSY-HSQC spectra of the three forms of wild-type 
and PKA-C mutant (apo, ATPγN-bound, and ATPγN/PKI-bound) were used for the 
analysis. The CHESCA matrices for PKA-CWT and PKA-CL205R reported in Figure 4.2 
panel A,B reveal dramatic differences in their allosteric networks. In fact, there is an 
overall reduction in the number of correlations throughout PKA-CL205R (Figure 4.2 panel 
C,D), with specific domains of the enzyme more impacted by this single mutation. In 
particular, residues belonging to the Gly-rich, activation loop, and peptide-positioning loop 
experience the most significant reductions in both number and extent of chemical shift 
covariation. Additionally, several interresidue correlations within the activation loop 
(W196), αF- (K217, V219, D220, G225, V226, A233), and αG-helices (Q245) are also 
ablated. The loss of interresidue correlations for the αF-helix is especially important as 
this motif spans the hydrophobic core of the C-lobe and is conserved throughout the AGC 
kinase family. The function of the αF-helix is to anchor all the hydrophobic motifs within 
the kinase core and to orchestrate catalysis [39, 66]. As highlighted before, all Cushing’s 
driver mutations, with the exception of E31V, are located near L205R and are likely to 
affect the enzyme in a similar manner, disrupting these important allosteric nodes. 
Binding of VPS36 substrate to PKA-CL205R rewires the intramolecular allosteric 
network and re-establishes binding cooperativity. In addition to affecting the regulation 
of PKA-C by the R-subunits, L205R changes the kinase’s downstream substrate 
specificity [20, 232]. Specifically, it was found that in E. coli PKA-CL205R favors non-
canonical substrates with negatively charged residues (Glu or Asp) at positions P+1, P+2, 
and P+3. From our own phosphoproteomic studies on endogenous substrates in human 
cells [20], we identified several substrates that are preferentially phosphorylated by the 
mutated kinase. Among those substrates, we selected the top target hyper-
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phosphorylated by PKA-CL205R: the vacuolar protein-sorting-associated protein 36 
(VPS36), a protein that plays a role in endosomal sorting of ubiquinated cargo proteins by 
the endosomal sorting complex. The recognition sequence of VPS36 (RRLSEEM) for 
PKA-C has two Glu residues in the P+1 and P+2 positions. Using steady-state coupled 
enzyme assays with Kemptide and a VPS36-derived peptide (residues 115-130 
encompassing the PKA-C recognition sequence and denoted VPS36 from hereon), we 
found that PKA-CL205R reduces the kinases catalytic efficiency for Kemptide, which 
contains a hydrophobic residue at the P+1 position. In contrast, the mutation causes an 
increase in kcat (from 5 to ~18 s-1) for VPS36, leading to a 3-fold increase in catalytic 
efficiency (Figure 4.3 panel A and Table 4.2). Additionally, the ITC analysis carried out 
with VPS36 indicates that PKA-CL205R/ATPγN has an affinity typical of other substrates (Kd 
= 3.5 ± 0.1 μM), while the binding to wild-type cannot be detected reliably, suggesting a 
significantly lower binding affinity (Table 4.1). A possible explanation is that the acidic 
residues in positions P+1 and P+2 of VPS36 hamper the intermolecular interactions 
between the peptide and the residues lining the binding pocket of PKA-CWT, while they 
might favor the interactions with PKA-CL205R. These results support the proposed altered 
substrate specificity for PKA-CL205R detected in intact cells. 
To further investigate the underlying mechanism for the change in substrate 
specificity of PKA-CL205R, we analyzed the trajectories of the amide resonances for the 
wild-type and the mutated kinase upon binding VPS36. Although VPS36 binding causes 
linear chemical shift changes similar to PKI binding, the number of residues involved in 
the binding response is significantly higher for PKA-CL205R. In addition, VPS36 binding 
causes an overall attenuation of the peak intensities throughout the entire fingerprint of 
the enzyme, with some resonances broadened beyond detection (Figure 4.9). For 
instance, resonances associated with the αF-helix and Gly-rich loop are noticeably 
broadened suggesting an increase in protein dynamics in the µs-ms timescale. The 
CONCISE analysis shows that the conformation of the PKA-CWT/ATPγN/VPS36 complex 
only reaches the intermediate state. In contrast, the PKA-CL205R/ATPγN/VPS36 complex 
reaches a state lying between the intermediate and closed state (Figure 4.3 panel B). 
This position in-between the intermediate and closed state was also observed in the 
crystal structure of PKA-CWT bound to a substrate peptide [67], suggesting that the ternary 
complex of PKA-CL205R with VPS36 adopts a catalytically committed state. 
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Figure 4.3. Rewiring of allosteric network of PKA-CL205R upon binding VPS36.  
(A) Steady-state phosphorylation kinetics of Kemptide and VPS36 peptides for PKA-CWT and PKA-
CL205R. Corresponding values can be found in Table 4.2. (B) CONCISE analysis on the apo, ATPγN, 
ATPγN/PKI, and ATPγN/VPS36 states of PKA-CWT and PKA-CL205R. (C) The CHESCA correlation 
matrix for PKA-CWT upon binding VPS36. (D) The CHESCA correlation matrix for PKA-CL205R upon 
binding VPS36. 
 
The CHESCA maps for VPS36 binding to PKA-CWT and PKA-CL205R are radically 
different (Figure 4.3 panel C,D). While the PKA-CWT/ATPγN/PKI complex shows an 
intense cross-talk between the small and large lobe, the corresponding map for PKA-
CWT/ATPγN/VPS36 reveals a complete loss of allosteric interactions. Notably, correlations 
between the nucleotide binding site and the substrate binding hub are completely missing. 
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In particular, the interresidue correlations for the activation loop, peptide-positioning loop, 
and the αF- and αG- helices are either reduced in their number or completely missing. In 
contrast, a number of correlations between the N- and C- lobes for PKA-CL205R, which are 
absent for the complex with PKI, are regained upon VPS36 binding. Note that ten of the 
resonances corresponding to residues located in and around the Gly-rich loop are 
broadened beyond detection and could not be included in the CHESCA analysis; 
therefore, the extent of coordinated changes in chemical shifts is largely underestimated. 
Nonetheless, the higher density of correlations found in the PKA-CL205R/ATPγN/VPS36 
complex underscores an extensive rewiring of the internal allosteric network, supporting 
the re-established binding cooperativity. 
 
Figure 4.4. Conformational dynamics of the activation loop of PKA-CWT and PKA-CL205R upon 
binding substrate.  
(A) Distinct opening-closing motions of the Gly-rich loop highlighting the hindered conformation that 
occludes the entering of ATP in PKA-CL205R. (B) Probability density describing the conformation of 
the activation loop in response to different substrates and pseudo-substrates. (C) [1H, 15N]-TROSY-
HSQC spectra showing the backbone amide chemical shift changes of the W196 indole amide 
(located on the activation loop) in response to binding PKI or VPS36. (D) X-ray structure of PKA-
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CWT (gray) (PDB ID: 1ATP) with the overlay PKA-CL205R in complex with PKI (light blue) (PDB ID: 
4WB6) describing the architecture of the peptide binding site and activation loop flip. (E) X-ray 
structure of PKA-CWT (gray) (PDB ID: 1ATP) with the overlay PKA-CL205R in complex with VPS36 
(light blue) (MD simulations) describing the architecture of the peptide binding site and activation 
loop flip. 
 
PKA-CWT and PKA-CL205R explore different conformational states. To determine the 
effects of the L205R mutation on the conformational energy landscape of PKA-C, we 
carried out parallel MD simulations of the ternary complexes in explicit water environments 
starting from their respective X-ray coordinates (PDB IDs: 4WB6 and 1ATP) [106]. The 
dominant motion of the kinase core was imaged using principal component analysis (PCA) 
of the Cα atoms encompassing residues 50 to 300. PC1 depicts the global opening-closing 
motion of the small and large lobes (Figure 4.10 panel A), while PC2 describes the 
shearing motion of the two lobes that can be envisioned as an ‘asymmetric bite’. To 
describe the opening-closing motion of the active site, we monitored the time dependence 
of the distance between the Cα atoms of S53 in the Gly-rich loop and G186 (Figures 4.10 
panel B,C). The binary and ternary complexes of PKA-CWT and PKA-CL205R sample similar 
conformational energy basins; however, the apo form of PKA-CL205R explores a 
considerably broader basin than the wild-type. The Gly-rich loop of PKA-CWT toggles 
between the open and closed conformations, featuring a transient hydrogen bond between 
S53 and the γ-phosphate of ATP; whereas the Gly-rich loop of PKA-CL205R exhibits larger 
motions with the S53-G186 distance ranging from 5 to 18 Å, and more frequently sampling 
a conformation that hinders nucleotide binding, which might explain its weaker binding 
affinity (Figure 4.4 panel A). The Arg 205 causes steric hindrance with the C-terminal tail 
of PKI, disrupting the hydrophobic pocket required to anchor the Ile residue in the P+1 
position, which likely contributes to the loss of PKI binding affinity. 
To visualize the alterations of the protein-protein interaction interface that may 
influence binding cooperativity, we analyzed the probability distribution of the inter-residue 
contacts between the substrate and the kinase binding pocket. Overall, PKA-CL205R shows 
a contact map with PKI similar to the wild-type enzyme (Figure 4.11 panel A,B). The high 
affinity binding region (HAR) and the consensus binding sequences remain bound 
throughout the entire MD trajectories with a probability of contact greater than 0.8. 
However, the L205R mutation reduces the probability of interactions between the Ile (at 
position P+1 in PKI) and the P+1 loop from 0.5 to 0.2. In contrast, VPS36 shows stable 
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interactions with the P+1 loop with a probability greater than 0.8 for Glu at the P+1 position 
and R205 (Figure 4.11 panel C). Moreover, the N-terminus of VPS36 forms transient 
interactions with the C-terminal tail located in the small lobe of PKA-CL205R, which are 
absent in the corresponding complex with PKI. As a result, the peptide is more dynamic, 
a feature that might explain the dramatic exchange-broadening in the NMR spectrum of 
PKA-CL205R/ATPγN/VPS36 complex. 
As observed previously [80], the backbone of the tertiary complex PKA-
CWT/ATP/PKI is mostly rigid (Figure 4.11 panel D,E,F). The activation loop adopts a stable 
conformation as in the X-ray structure (PDB ID: 1ATP) [79] throughout the entire MD 
simulations with a RMSD of ~1.5 Å. In contrast, the activation loop and the adjacent loop 
that is anchored to the αF-helix (residues 210-220) in the corresponding PKA-
CL205R/ATP/PKI complex are more flexible, adopting two distinct conformations in which 
the most populated is similar to the X-ray structure (PDB ID: 1ATP), and a second minor 
flipped conformation (Figure 4.4 panel B). In this conformation, the activation loop no 
longer interacts with the C-lobe and forms a salt bridge with E86 of the αC-helix (Figure 
4.4 panel D,E). For the PKA-CL205R/ATP/VPS36 complex, the activation loop becomes 
more ordered and the flipped configuration becomes dominant. The existence of these 
two conformations is corroborated by chemical shift trajectories observed for the indole 
resonance of W196 in the activation loop (Figure 4.4 panel C). In fact, upon ligand binding 
the indole resonance of W196 follows a linear chemical shift trajectory from apo to the 
ternary form. This conformational change is highly correlated with the other major 
allosteric nodes (CHESCA plots), indicating it follows the cooperative structural changes 
of the enzyme. In contrast, the CHESCA plots for PKA-CL205R show no correlations for 
these loops/residues, suggesting that the L205R mutation disrupts the internal allosteric 
network and may dislodge the activation loop from the large lobe. 
The disruption of the allosteric network is mirrored by the pairwise mutual 
information plots [236] obtained from the analysis of the MD trajectories. For the wild-type 
enzyme, there are strong inter-residue correlations throughout the entire core of the 
kinase, especially among key catalytic motifs such as the Gly-rich loop (S53), the 
activation loop (R194, W196), αF- (Y215), αG- (D241), αH- (N283) helices as well as the 
PIF motif at the C-terminal tail (F347) (Figure 4.12 panel A). In contrast, PKA-CL205R lacks 
of a number of allosteric interactions within the N-lobe, with only a few correlations 
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between the activation loop and the C-lobe (Figure 4.12 panel B). As for the CHESCA 
correlation maps, the mutual information plots reveal that the allosteric network between 
N-lobe and C-terminal tail of PKA-CL205R is partially recovered upon VPS36 binding 
(Figure 4.12 panel C) with the engagement of E91 in the αC-helix and S53 of the Gly-
rich loop.  
4.4 Discussion 
The L205R mutation was discovered independently in our and other laboratories 
as the dominant genetic alteration in cortisol-producing adrenocortical adenomas 
responsible for Cushing’s syndrome [26-30]. Although it has a direct link with changes in 
cAMP/PKA signaling, adrenal Cushing’s syndrome has different molecular etiologies 
[226]. Initially, rare germline mutations were found in the PRKAR1A gene encoding the 
regulatory Iα subunit of PKA in patients with Carney complex [96]. Most of these mutations 
occur at the interface between the R- and C- subunits or near the cAMP-binding site in 
CNB-A and are thought to cause aberrant regulation of the kinase [237]. Only recently, 
the focus has shifted toward somatic mutations occurring in the C-subunit of the enzyme. 
Even in this case, most mutated residues reside at the interface of the R/C complex. 
However, the molecular mechanisms for the aberrant regulation of cAMP signaling by 
these mutations have been a matter of debate. Specifically, two independent studies 
suggested that the L205R mutation interferes with the formation of the holoenzyme, 
rendering the C-subunit constitutively active [28, 29]. Sato et al., on the other hand, 
proposed that this mutation does not interfere with the R-subunit regulation and that the 
development of the pathology is linked to intrinsic higher phosphoryl transfer activity of the 
mutant kinase [27]. Recent studies both in vitro and in intact cells have put forward a 
possible new mechanism, suggesting that the mutated enzyme has altered substrate 
specificity [20, 232, 233]. Notably, this arginine preceding the APE motif is characteristic 
in the CMGC kinase family, and assumes a key role in substrate recognition and kinase 




Figure 4.5. Cushing’s mutations are located in allosteric nodes identified via CHESCA.  
(A) Correlation matrix of PKA-CWT when bound to PKI emphasizing locations of Cushing’s mutation 
in relation to allosteric nodes. (B) Missing correlations for PKA-CL205R upon binding PKI colored 
according to community map of PKA-CWT. (C) CHESCA correlation matrices for PKA-CWT + PKI, 
PKA-CL205R + PKI, and PKA-CL205R + VPS36, respectively, plotted on the structure of PKA-C with 
colors specific to the community map analyses completed previously for PKA-CWT[140]. Specific 
communities are emphasized to highlight elements that experience the most dramatic changes in 
the number and extent of chemical shift covariance for PKA-CL205R upon binding PKI and VPS36. 
 
Our studies reveal that the dysfunction of PKA-CL205R is multifaceted, whereby 
allosteric cooperativity is reduced, substrate specificity is altered, and canonical regulation 
is ablated. The L205R mutation disrupts the hydrophobic interactions between the enzyme 
and substrate, causing a dramatic decrease in PKI binding affinity. This is in line with the 
impaired binding of the R-subunits found in our previous study [230] as PKI and R-subunits 
share similar consensus sequences. Our CHESCA analyses reveal that L205R perturbs 
the allosteric network of PKA-C and disrupts specific allosteric nodes that connect the 
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small and the large lobes. The allosteric nodes are defined as the hot spots in the network 
with the highest number of CHESCA correlations [239]. In particular, the allosteric 
communication between the node including L205 and encompassing the activation loop, 
αF-, and αG-helices and the node surrounding the Gly-rich loop, β2, and β3 is ablated. 
Interestingly, closer analysis of the CHESCA map of PKA-CWT reveals that each allosteric 
node harbors Cushing’s mutations located in the activation/αF/αG node except E31V, 
where the latter resides at the N-terminal αA-helix, a unique regulatory motif in PKA-C 
(Figure 4.5 panel A) [48]. Although spatially distinct, these allosteric nodes are highly 
correlated and coupled to one another to facilitate intramolecular communication and 
control binding cooperativity. Perturbation to one node, such as the case of L205R, has 
long range effects on the other node. The latter suggests that Cushing’s mutations 
including E31V may disrupt the allosteric communication eliciting similar global responses 
in terms of binding cooperativity and regulation. 
The CHESCA analyses of the chemical shifts parallel the predictions obtained from 
MD simulations using the community analysis. McClendon et al. analyzing the different 
forms of the kinase identified allosterically linked communities within PKA-C, each 
associated with a particular function or regulatory mechanism [140]. Plotting correlated 
residues on PKA-C’s community maps reveals that the mutation reduces dramatically the 
allosteric communication between community A, D, and F with respect to the wild-type 
enzyme (Figure 4.5 panel B,C). In contrast, binding of VPS36 to PKA-CL205R re-
establishes the inter-community communication and the allosteric network. 
The lack of regulation only partially explains the aberrant function of PKA-CL205R. 
In fact, our thermodynamic and kinetic analyses reveal that this mutation shifts the 
specificity of PKA-CL205R toward substrates containing acidic residues in the P+1 and P+2 
positions, with a dramatic effect on binding cooperativity. While with the classical 
consensus sequence the cooperativity is greatly abolished, the mutated enzyme regains 
cooperativity with complementary substrates such as VPS36, among others. The reason 
for this behavior is apparent from the atomic mapping of the cooperative global response 
of the enzyme to ligand binding. While with the classical consensus sequence the 
allosteric communication between the N-lobe, harboring the ATP binding site, and the C-
lobe, with the substrate binding site, is abolished, the binding of the complementary 
substrate (VPS36) coincides with an extensive rewiring of the allosteric network of 
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communication between the two lobes altering substrate specificity. It should be noted 
that VPS36 lacks the HAR region, which might affect its binding kinetics and 
thermodynamics. As with previous studies [82], VPS36 does not drive the enzyme to a 
completely closed state, perhaps facilitating product release. It is also worth noting that 
the reduction of the binding affinity for the nucleotide we observed under our experimental 
conditions was also detected by Luzi et al. [233]. Taken with our NMR and thermodynamic 
studies, MD simulations suggest that the mutation changes the energy landscape of the 
kinase (Figure 4.6). First, the mutation causes a reduction in binding affinity for nucleotide, 
which may be due to an increase in the population of the enzyme with the Gly-loop partially 
occluded. This conformation has been detected in other crystal structures and might 
prevent the nucleotide to intercalate in the C-spine of the enzyme [240]. Moreover, a 
significant population of the enzyme spans a conformational space featuring a flipped 
conformation of the activation loop and a salt bridge formed between R194 and E86 in the 
αC-helix. Notably, an increased plasticity of the activation loop, highlighted by W196, 
contributes to disruptions in the docking surface with the R-subunit [241]. At the same 
time, the R194-E86 salt bridge suggests a different dynamic coupling between the 
activation loop and the αC-helix. It is possible that this specific conformational state might 
dictate the selectivity of the substrate binding and the aberrant profile observed in 
phosphoproteomic assays. 
 
Figure 4.6. Schematic of the energy landscape for PKA-CWT and PKA-CL205R, combining 
thermodynamics and MD simulations data. 
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Relative free energy for the binding of ATPγN, PKI, and VPS36 to PKA-CWT and PKA-CL205R derived 
from ITC data. (1) Apo PKA-CL205R samples mostly uncommitted states, with the Gly-rich loop 
partially occluded and the αC-helix turned outward. (2) Binary PKA-CL205R features a wired the 
allosteric network for substrate binding, i.e., committed state (3) Ternary PKA-CL205R complex with 
lower affinity for PKI (i.e., higher free energy relative to PKA-CWT). The conformation of the 
activation loop of PKA-CL205R is in equilibrium between an un-flipped and a sparsely populated 
flipped conformation. (4) PKA-CL205R/ATPγN/VPS36 ternary complex features a flipped 
conformation of the activation loop with the electrostatic interactions between E86 and R194. 
 
Given the ubiquitous nature of PKA and its involvement in numerous cell signaling 
events, its implication in specific diseases has been overlooked. Only recently, the 
attention of researchers has been directed to the PRKACA gene and its role in 
pathological lesions. A few years ago, Simon and co-workers discovered the presence of 
a chimeric construct of the PKA-C subunit that is the main driver of fibrolamellar 
hepatocellular carcinoma (FLHCC) [31]. Later on, our group and others discovered single 
mutations or insertions at the R/C interface that are linked to adrenal Cushing’s syndrome 
[26-30]. More recently, Tseng et al. reported the discovery of a new insertion in a similar 
region that is involved in the development of myxoma, a sporadic form of tumor in the 
atrium of the heart [111]. It is possible that other defects in the PRKACA gene might be 
found to be implicated in the development of other tumors.  
The analysis of the allosteric network carried out in this work reveals highly coupled 
allosteric nodes that harbor all Cushing’s mutations found in patients and may help to 
explain why mutations located in two spatially distinct regions of the enzyme result in the 
same phenotype. Our findings suggest that analysis of allosteric networks using CHESCA 
may prove useful in predicting mutations that perturb catalytic function for enzymes 
beyond PKA-C. Furthermore, our work reveals that rewiring of the intra- and inter-
molecular interactions leads to changes in cooperativity and selectivity. This suggests the 
opportunity to exploit small molecules or peptides able to change the internal 
communication and modulate the activity of this aberrant mutant selectively, i.e., without 
affecting the function of the wild-type. 
4.5 Materials and Methods  
Sample Preparation. Recombinant human Cα subunit of cAMP-dependent protein 
kinase A cDNA (PKA-CWT and PKA-CL205R) was cloned into a pET-28a vector. A tobacco 
etch virus (TEV) cleavage site was incorporated via mutagenesis into the vector between 
the cDNA coding for the kinase and a thrombin cleavage site. The kinase was expressed 
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in Escherichia coli BL21 (DE3) pLysS cells in M9 minimal media supplemented with 
15NH4Cl. Protein overexpression was induced with 0.4 mM isopropyl β-D-
thiogalactopyranoside (IPTG) and carried out overnight at 20°C. PKA-C purification was 
carried out using Ni2+ affinity chromatography. Cells were lysed using French press in 50 
mM Tris-HCl, 30 mM KH2PO4, 200 mM NaCl, 200 µM ATP, 5 mM 2-mercaptoethanol, and 
lysozyme (15 mg/ 100 mL lysis buffer) (pH 8.0). After removing cell debris by centrifugation 
at 18,000 rpm for 45 minutes, supernatant was incubated with Ni2+ nitrilotriacetic acid resin 
(Thermo Scientific) at 4°C overnight. The resin was washed with 50 mM Tris-HCl, 30 mM 
KH2PO4, 200 mM NaCl, 10 mM Imidazole, and 5 mM 2-mercaptoethanol (pH 8.0) and 
eluted with 50 mM Tris-HCl, 30 mM KH2PO4, 200 mM NaCl, 250 mM Imidazole, and 5 mM 
2-mercaptoethanol (pH 8.0). Fractions containing PKA-C were cleaved overnight at 4°C 
with a sufficient amount of recombinant TEV while being dialyzed into 20 mM KH2PO4, 25 
mM KCl, 0.1 mM PMSF, and 5 mM 2-mercaptoethanol (pH 6.5). The three isoforms of 
PKA-C (corresponding to the three phosphorylation states with identical catalytic 
parameters) were separated by chromatography on a HiTrap SP column (GE Healthcare 
Life Sciences) using a linear gradient from buffer A [20 mM KH2PO4 pH 6.5] to 30% buffer 
B [20 mM KH2PO4, 1 M KCl pH 6.5] at a flow rate of 2 mL/min. Isoform II with pThr197, 
pSer338, and pSer10 was used for all NMR experiments. Peptides (Kemptide/PKI5-
24/VPS36) were synthesized using standard Fmoc chemistry on a CEM Liberty Blue 
microwave synthesizer, cleaved with Reagent K (82.5% TFA, 5% phenol, 5% thioanisole, 
2.5% ethanedithiol, and 5% water) for 3 h and purified using a semipreparative Supelco 
C18 reverse-phase HPLC column at 3 mL/min. The VPS36 peptide sequence used for all 
studies is as follows: QIEFYRRLSEEMTQR. Molecular weight and the quantity of the 
peptides were verified by LC-MS and/or amino acid analysis (Texas Tech Protein 
Chemistry Laboratory).  
ITC Measurements. ITC measurements were performed with a low-volume NanoITC (TA 
Instruments). PKA-CWT and PKA-CL205R were dialyzed into 20 mM MOPS, 90 mM KCl, 10 
mM DTT, 10 mM MgCl2, and 1 mM NaN3 (pH 6.5). PKA-C concentrations for ITC 
measurements were between 100-130 µM as confirmed by A280 = 53860 M-1 cm-1. All 
measurements with ATPγN saturated PKA-CWT and PKA-CL205R were performed at 2 mM 
ATPγN, and 4 mM ATPγN, respectively. ITC measurements were performed in triplicates 
with a TA low-volume NanoITC instrument at 300K. For each experiment, 50 µL of 2-4 
mM ATPγN, 0.6-4 mM PKI, or 2 mM VPS36 were titrated into ~300 µL of PKA-C. The heat 
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of dilution was subtracted from each titration curve. Binding was assumed to be 1:1 and 
the resulting curves were analyzed with the NanoAnalyze software (TA Instruments) using 









�  (1) 
where d[MX] is the change in total complex with respect to change in total protein 
concentration, d[Xtot] is dependent on r, the ratio of Kd with respect to the total protein 
concentration, and RM, the ratio between total ligand and total protein concentration. The 
free energy of binding was determined using the following: 
Δ𝐺𝐺 = 𝑅𝑅𝑅𝑅 ln𝐾𝐾𝑑𝑑 
where R is the universal gas constant and T is the temperature at measurement (300K). 
The entropic contribution to binding was calculated using the following: 
𝑅𝑅∆𝑆𝑆 =  ∆𝑁𝑁 −  ∆𝐺𝐺. 
Calculations for the cooperativity constant (σ) were calculated as follows:  




where Kd Apo  is the Kd of PKI5-24 binding to the apoenzyme and Kd Nucleotide is the Kd of PKI5-
24 binding to the nucleotide-bound enzyme. 
Enzyme Assays. Steady-state activity assays with Kemptide and VPS36 were performed 
under saturating ATP concentrations and spectrophotometrically at 298K as described by 
Cook et al [85]. The values of Vmax and KM were obtained from a nonlinear fit of the initial 
velocities to the Michaelis-Menten equation. 
Circular Dichroism. A change in ellipticity was measured at 220 nm on a Jasco J-815 
spectrometer. A temperature scan between 20°C and 70°C at a rate of 1 °C/min with an 
equilibration time of 15 s was performed to unfold the protein. Spectra Manager Pro 
software was used to fit a two-state sigmoidal function. The inflection point was taken as 
the Tm(°C), the point at which 50% of the protein is folded. 
NMR Spectroscopy. Uniformly 15N-labeled PKA-CWT and PKA-CL205R were 
overexpressed and purified as described above. NMR experiments were performed in 90 
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mM KCl, 20 mM KH2PO4, 10 mM dithiothreitol (DTT), 10 mM MgCl2, and 1 mM NaN3 at 
pH 6.5. Standard TROSY-HSQC experiments were carried out for PKA-CL205R and PKA-
CWT on 600-MHz and 900-MHz Bruker Advance III spectrometers equipped with TCI 
cryoprobes, respectively. Concentrations for samples were 0.2-0.3 mM as determined by 
A280 measurements, 12 mM ATPγN was added for the nucleotide-bound form, and 0.2-1.2 
mM PKI or 0.4-1.8 mM VPS36 for the ternary complex. Full-length PKI was used for all 
NMR experiments and subsequent analyses. Spectra were collected at 300K, processed 
using NMRPipe [243], and visualized using Sparky [244]. 
All [1H-15N]-TROSY-HSQC experiments were acquired with 2048 (proton) and 256 
(nitrogen) complex points. Spectra acquired in complex with VPS36 were acquired with 
substantially more scans (NS = 96) compared to other spectra (NS = 32-64). Combined 
chemical shift perturbations were calculated using 1H and 15N chemical shifts according to 
the following: 
∆𝛿𝛿 =  �(Δ𝛿𝛿𝑁𝑁)2 + 0.154(Δ𝛿𝛿𝑁𝑁)2   (1) 
Change in chemical shift perturbations were calculated according to the following for both 
nucleotide binding and pseudo-substrate binding: 
∆𝐶𝐶𝑆𝑆𝐶𝐶 =  ∆𝛿𝛿𝑊𝑊𝑇𝑇 −  ∆𝛿𝛿𝐿𝐿205𝑅𝑅 
Chemical Shift Analyses.  
COordiNated ChemIcal Shift bEhavior (CONCISE). CONCISE was used to monitor 
chemical shift trajectories and measure the change in equilibrium position using each 
PKA-C construct (apo, ATPγN, ATPγN/PKI, ATPγN/VPS36). Using principal component 
analysis (PCA), this method identifies sets of residues whose chemical shifts respond 
linearly to the conformational transition. Each residue provides a measure of the 
equilibrium position for every PKA-C construct in the form of scores along the first principal 
component (PC1). The equilibrium position for a given construct is given by the average 
of all PC scores over all linear residues. To identify the residues whose chemical shift’s 
follow a linear trajectory, a threshold of 3.0 for the ratio of the standard deviations of PC1 
over PC2 was used, and residues not exhibiting a significant chemical shift were excluded 
based on linewidth. After this threshold was applied, a total of 55 residues formed the 
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subset that was used to trace the equilibrium position of each state for PKA-CWT and PKA-
CL205R.  
CHEmical Shift Covariance Analysis (CHESCA). CHESCA was used to identify and 
functionally characterize allosteric networks of residues eliciting concerted responses to 
nucleotide, pseudo-substrate, and substrate. A total of three states were used to identify 
inter-residue correlations: apo, ATPγN-bound, and either ATPγN/PKI- or ATPγN/VPS36-
bound. Identification of inter-residue correlations by CHESCA relies on agglomerative 
clustering (AC) and singular value decomposition (SVD). Pairwise correlations between 
chemical shift variations experienced by different residues are analyzed to identify 
networks of coupled residues and when plotted on a correlation matrix, allows for the 
identification of regions that are correlated to one another. A correlation coefficient cutoff 
of 0.98 was used to filter non-linear residues. Residues not exhibiting a significant 
chemical shift (small shifts in ppm) were excluded based on linewidth. Linewidth was 
calculated for each resonance in each of the three forms (apo, ATPγN, ATPγN/PKI or 
ATPγN/VPS36). For each residue the max change in chemical shift was calculated in both 
the 1H (x) and 15N (y) dimension (∆δx,y). Residues were included in CHESCA analysis only 
if they satisfied the following: ∆δx,y > ½ ∆δxA,yA+½ ∆δ xB,yB , where A and B correspond to 
two different forms analyzed (note there is no dependence on which two forms satisfied 
this statement). 
MD Simulations. 
System Setup on WT and L205R. We used the crystal structure of PKA-CWT (PDB ID: 
1ATP) [79] and PKA-CL205R (PDB ID: 4WB6) [106] as the template, and chose a monomer 
(Chain A: protein, Chain I: PKI5-24 ) from the dimer. We further aligned the current structure 
with the full length PKA-CWT and added the missing residues 1-12 at the N terminus. The 
protonation state of histidine residues followed our previous settings [47]. The protein was 
solvated in a rhombic dodecahedron solvent box with TIP3P [245] water molecule layer 
extended approximately 10 Å away from the surface of the proteins. Counter ions (K+ and 
Cl-) were added to ensure electrostatic neutrality corresponding to an ionic concentration 
of ~150 mM. All protein covalent H-bonds were constrained with the LINCS [246] 
algorithm. and long-range electrostatic interactions are treated with the particle-mesh 
Ewald [247] method with a real-space cutoff of 10 Å. Parallel simulations on the apo form, 
the binary form with one Mg2+ ion and one ATP, and the ternary form with two Mg2+ ions, 
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one ATP and one PKI5-24 were performed simultaneously using GROMACS 4.6 [248] in 
CHARMM36a1 force fields [249]. Each system was minimized using the steepest decent 
algorithm to remove the bad contacts, and then gradually heated to 300K at a constant 
volume over 1 ns, using harmonic restraints with a force constant 1000 kJ/(mol*Å2) on 
heavy atoms of both proteins and nucleotides. Over the following 12 ns of simulations at 
constant pressure (1 atm) and temperature (300K), the restraints were gradually released. 
The systems were equilibrated for an additional 20 ns without positional restraints. A 
Parrinello-Rahman barostat [250] was used to keep the pressure constant, while a V-
rescale thermostat with a time step of 2 fs was used to keep the temperature constant. 
Each system was simulated for 1.05 µs, with snapshots recorded every 20 ps. A total 3.15 
µs and 157500 conformations were utilized for the analyses. 
Energy Landscapes using Principal Component Analysis. Cartesian principal 
components of the backbone atoms were calculated using the GROMACS [248] modules 
g_covar and g_anaeig to identify the large-scale, low-frequency conformational dynamics 
of the catalytic core. All the trajectories were aligned with the starting structure 
(minimization of the crystal structure to remove bad contacts) using helices E (Residues 
140-160) and F (Residues 217-233) as a reference frame. Dominant principal components 
were computed from the each resulting ensemble from the individual simulations. 
Moreover, the distance between Cα atom of Ser53 and Gly186 was measured to 
characterize the opening and closing motions of Gly-rich loop. Different trajectories were 
mapped onto the 2D projection along PC1 and S53-G186 distances. 
Docking and simulation of the ternary complexes bound with VPS36 peptide and 
ATP. The peptide sequence of QIEFYRRLSEEMTQR adopts α-helix in the crystal 
structure (PDB ID: 2HTH) [251]. The recognition and phosphorylation of the peptide by 
PKA-C, would require an extended conformation. Therefore, we unwound the helices and 
used HADDOCK [252] server for docking into the binding cleft of PKA-C for both WT and 
L205R. Specifically, we used the easy interface and selected the active residues of PKA-
C, i.e., 133,168,202,198,204,205,207,230 and 330, as well as the active residues for 
VPS36, i.e, 3,6,7,9, and 10. The passive residues are set automatically around the active 
residues by the server. The top-scored structures were further solvated for MD simulations 
following the same protocol as the ternary complexes with PKI.  
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Mutual information analysis and mapping of allosteric network. To monitor the 
allosteric differences of the WT and L205R, MutInf [236] was used to compute mutual 
information between all residues. MutInf is a python package that translates the 
distribution of dihedral angles of residues into their conformational entropy and identifies 
the correlated motions between residues. The time series of dihedral angles in the MD 
ensemble was computed using g_chi and divided into 6 overlapped blocks, and then 
correlations of local motions are computed as the mutual information between selected 
residue pairs in each block. The results were averaged over these blocks to filter out the 
correlations that were not statistically significant. These matrices of mutual information 
and their differences were further mapped onto the crystal structure with Xpyder [253] 
plugin for PYMOL. Graph analysis was applied to detect hubs in the networks and key 
allosteric communication pathways in PKA-C. 
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4.8 Supplementary Figures 
 
Figure 4.7. [1H, 15N]-TROSY-HSQC spectra for PKA-CWT and PKA-CL205R in apo, ATPγN, 




Figure 4.8. Chemical shift perturbations (CSP) observed upon ligand binding for PKA-CWT 
and PKA-CL205R.  
Histograms show the combined 1H/15N chemical shift perturbations vs. residue. The cutoff for the 




Figure 4.9. Intensity plot for the binding of VPS36 to ATPγN-saturated PKA-CL205R. 
Asterisks indicate residues that are broadened beyond detection. Intensity was corrected to 
account for the increase in number of scans following addition of VPS36 and was normalized to 




Figure 4.10. Principal component analysis (PCA) of the catalytic lobes in PKA-CWT and PKA-
CL205R.  
(A) The first principal component of the catalytic lobes differentiates the open, intermediate and 
closed conformations. (B) The distances between Cα of S53 and G186 characterize the motion of 
Gly-rich loop. (C) 2D-scattering plot along dS53-G186 and PC1, and the corresponding distribution 
plots for PKA-CWT (cyan), PKA-CWT /ATP (gray) and PKA-CWT /ATP/PKI (dark pink). Right panel: 
2D-scattering plot along dS53-G186 and PC1, and the corresponding distribution plots for PKA-
CL205R (cyan), PKA-CL205R/ATP (gray) and PKA-CL205R/ATP/PKI (dark pink). The black shapes 




Figure 4.11. Probability of the formation of inter-residue contact and ∆RMSF of PKA-C upon 
forming ternary complexes with PKI5-24 or VPS36.  
The probability distribution of the distances for (A) PKA-CWT and PKI highlighting stable contact 
between HAR of PKI and C-lobe of PKA-CWT, (B) PKA-CL205R and PKI highlighting the weakened 
interaction around the activation loop of PKA-CL205R, and (C) PKA-CL205R and VPS36 highlighting 
the stable contact at R205 and the transient contact of the N-terminal region of VPS36 with the 
hinge region and C-terminal tail of PKA-CL205R. The probability distribution of the distances is 
defined by a cutoff of 5 Å between heavy atoms of residue pairs. The ∆RMSF of (D) PKA-CWT 
against the apo state upon forming ternary complex with PKI, (E) PKA-CL205R against apo state 
upon forming ternary complex with PKI, and (F) PKA-CL205R against apo state upon forming ternary 




Figure 4.12. Allosteric changes upon peptide binding revealed by MD simulation and mutual 
information (Mutinf) analysis.  
Mufinf matrices of (A) PKA-CWT in complex with PKI, (B) PKA-CL205R in complex with PKI, and (C) 
PKA-CL205R in complex with VPS36. Mutinf matrices are mapped to the structures of PKA-CWT and 
PKA-CL205R with a cutoff of 0.15. 
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4.9 Supplementary Tables 
Table 4.1. Changes in enthalpy, entropy, free energy, and dissociation constant of binding 
ATPγN, PKI5-24 and VPS36 for PKA-CWT and PKA-CL205R. 
Errors in ∆G, ∆H, -T∆S, and Kd were calculated using triplicate measurements. Errors in σ were 
propagated from error in Kd. ND (not detected) indicates that the heat released upon binding is 
below the detection of the instrument. N/A indicates the value is not applicable to the particular 
measurements. 
 
ATPγN to apo forms  
 Kd (µM) ∆G (kcal/mol) ∆H (kcal/mol) -T∆S (kcal/mol) σ 
PKA-CWT 83 ± 8 -5.61 ± 0.06 -3.6 ± 0.1 - 2.0 ± 0.1 N/A 
PKA-CL205R 215 ± 15 -5.04 ± 0.04 -6.2 ± 0.3 1.1 ± 0.2 N/A 
PKI5-24 to apo forms  
 Kd (µM) ∆G (kcal/mol) ∆H (kcal/mol) -T∆S (kcal/mol) σ 
PKA-CWT 17 ± 2 -6.57 ± 0.08 -10.8 ± 0.5 4.2 ± 0.5 N/A 
PKA-CL205R 61 ± 5 -5.79 ± 0.04 -9.7 ± 0.1 3.9 ± 0.1 N/A 
PKI5-24 to ATPγN saturated forms  
 Kd (µM) ∆G (kcal/mol) ∆H (kcal/mol) -T∆S (kcal/mol) σ 
PKA-CWT 0.16 ± 0.02 -9.33 ± 0.07 -13.9 ± 0.5 4.6 ± 0.4 106 ± 18 
PKA-CL205R 10 ± 3 -6.9 ± 0.2 -8.8 ± 0.8 1.9 ± 0.6 6 ± 2 
VPS36 to ATPγN saturated forms  
 Kd (µM) ∆G (kcal/mol) ∆H (kcal/mol) -T∆S (kcal/mol) σ 
PKA-CWT ND ND ND ND N/A 




Table 4.2. Kinetic parameters of Kemptide and VPS36 phosphorylation by PKA-CWT and 
PKA-CL205R.  
Values for KM and kcat were obtained from a non-linear least squares analysis of the concentration-
dependent initial phosphorylation rates using a standard coupled enzyme activity assay (related to 
Figure 4.3). Error in kcat/KM was propagated from error in KM and kcat. 
 
Kemptide 
 PKA-CWT PKA-CL205R 
Vmax (µM/sec) 0.42 ± 0.02 0.90 ± 0.02 
KM (µM) 29 ± 1 335 ± 17 
kcat (s-1) 19 ± 1 41 ± 1 
kcat/KM 0.66 ± 0.04 0.12 ± 0.01 
VPS36 
 PKA-CWT PKA-CL205R 
Vmax (µM/sec) 0.12 ± 0.02 0.39 ± 0.01 
KM (µM) 224 ± 48 326 ± 20 
kcat (s-1) 5 ± 1 18 ± 1 
kcat/KM 0.022 ± 0.006 0.055 ± 0.004 
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Table 4.3. PCA and standard deviation of the CONCISE analysis of the structural states 
analyzed. 
 PCA1 SD % Closed 
PKA-CWT 
Apo 
-1.213 0.56 0% 
PKA-CL205R 
Apo 
-1.042 0.57 7% 
PKA-CWT 
ATPγN 
-0.059 0.56 45% 
PKA-CL205R 
ATPγN 
-0.082 0.53 44% 
PKA-CWT 
ATPγN/PKI 
1.335 0.61 100% 
PKA-CL205R 
ATPγN/PKI 
0.904 0.55 83% 
PKA-CWT 
ATPγN/VPS36 
-0.072 0.54 45% 
PKA-CL205R 
ATPγN/VPS36 




Table 4.4. Melting temperatures (Tm) as determined using circular dichroism. 
All values are in °C and Tm was taken as the inflection point at which 50% of the enzyme complex 
was folded. Error was calculated using triplicate measurements.  
 
 Apo Binary (MgATP) Ternary (MgATP + PKI5-24) 
PKAWT 53.2 ± 0.5 55.0 ± 0.7 60.2 ± 0.4 
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An aberrant fusion of the DNAJB1 and PRKACA genes generates a chimeric protein 
kinase (PKA-CDNAJB1) in which the J-domain of the heat shock protein 40 is fused to the 
catalytic α subunit of cAMP-dependent protein kinase A (PKA-C). Deceivingly, this 
chimeric construct appears to be fully functional, as it phosphorylates canonical 
substrates, forms holoenzymes, responds to cAMP activation, and recognizes the 
endogenous inhibitor PKI. Nonetheless, PKA-CDNAJB1 has been recognized as the primary 
driver of fibrolamellar hepatocellular carcinoma and is implicated in other neoplasms for 
which the molecular mechanisms remain elusive. Here we determined the chimera's 
allosteric response to nucleotide and pseudo-substrate binding. We found that the fusion 
of the dynamic J-domain to PKA-C disrupts the internal allosteric network, causing 
dramatic attenuation of the nucleotide/PKI binding cooperativity. Our findings suggest that 
the reduced allosteric cooperativity exhibited by PKA-CDNAJB1 alters specific recognitions 




Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare and aggressive form of 
liver cancer that predominantly affects young patients without underlying cirrhosis or 
disease[254]. Treatment is limited, as FL-HCC does not respond to chemotherapy[255, 
256], and surgical excision remains the only therapy[257, 258]. Sequencing the tumor 
genomes of FL-HCC patients identified a recurrent chimeric gene[31, 32, 259, 260] that 
originates from a ~400kb deletion in chromosome 19. This deletion causes an in-frame 
fusion of exon 1 from the DNAJB1 gene, which encodes a member of the heat-shock 
protein 40 family, with exons 2-to-10 of the PRKACA gene, encoding for the catalytic 
subunit of cAMP-dependent protein kinase A (PKA-C)[31]. The resulting chimeric enzyme 
(PKA-CDNAJB1) is fully functional and comprises 405 residues with 69 amino acids of 
DNAJB1 (J-domain), replacing the first 14 residues of the N-terminal αA-helix of PKA-
C[31]. The N-terminal deletion of part of the αA-helix prevents essential post-translational 
modifications such as N-myristoylation, deamidation, as well as phosphorylation at Ser10, 
which are responsible for the spatiotemporal localization of the kinase[42, 261].  
The fusion of the J-domain does not alter the structure of the catalytic core of PKA-
CDNAJB1, which remains virtually identical to the wild-type kinase (PKA-CWT). Instead, the 
αA-helix of PKA-CDNAJB1 is extended with the J-domain tucked under the large lobe of the 
enzyme (Figure 5.1 panel A)[106]. Moreover, PKA-CDNAJB1 retains the ability to form 
stable holoenzymes with all regulatory (R) subunit isoforms, although with non-canonical 
arrangements, and more importantly, responds to cAMP activation[262, 263]. In vivo 
enzymatic assays, as well as conventional in vitro coupled assays, have shown that the 
kinetic parameters of PKA-CWT and PKA-CDNAJB1 are similar[31, 262, 264]. Furthermore, 
PKA-CDNAJB1 binds the endogenous inhibitor PKI (both full-length and derived peptides) 
with an affinity comparable to wild-type[264]. 
Despite little differences conferred to the structure and activity of the kinase by the 
fusion of the J-domain, in vivo studies have shed light on the signaling changes induced 
by the chimeric fusion. Recently, Scott and co-workers suggested that the J-domain is 
able to recruit Hsp70, stabilizing the chimeric fusion protein[108]. Together with the higher 
expression levels due to the DNAJB1 gene[31], the enhanced stability of the enzyme in 
complex with Hsp70 may explain the dominant expression in FL-HCC cells. Furthermore, 
these researchers showed that the phosphoproteomics of PKA-CDNAJB1 is different from 
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that of the wild-type, implying that the J-domain skews the phosphorylation profile of cells 
toward alternative pathways[108]. According to this study, the J-domain is directly 
implicated in the oncogenicity of PKA-CDNAJB1. However, other evidence shows that the 
kinase domain is also required for tumorigenesis[105]. To date, it remains unclear how 
this aberrant kinase contributes to the progression of the disease.  
A prominent feature of PKA-C is the alternation of positive and negative binding 
cooperativity that drives the enzymatic cycle[83]. Positive binding cooperativity induced by 
ATP binding enhances the affinity for the substrate, while negative binding cooperativity 
of ADP facilitates the release of the phosphorylated product. Since binding cooperativity 
is essential to signal transduction amplification[265], we surmised that the 
nucleotide/substrate binding cooperativity of the aberrant kinase is disrupted, with 
implications for phosphorylation profiles and regulation by R-subunits. With this in mind, 
we investigated local and global responses of the kinase to nucleotide and pseudo-
substrate binding using a combination of NMR spectroscopy, isothermal titration 
calorimetry (ITC), small-angle X-ray scattering (SAXS), and molecular dynamics (MD) 
simulations. We found that the J-domain fused to the N-terminus of PKA-C dramatically 
attenuates the canonical positive nucleotide/pseudo-substrate binding cooperativity 
through alterations in the intramolecular network of communication. Analogous to other 
pathologic mutants of PKA-C[65], the concomitant loss in binding cooperativity and 
intramolecular communication may render highly cooperative events, such as regulation, 
dysfunctional, contributing to disease progression.  
5.3 Results 
The dynamic J-domain of PKA-CDNAJB1 interconverts between in and out 
conformations. Previous X-ray crystallographic studies[106] have shown that the core of 
PKA-CDNAJB1 adopts a conformation similar to the wild-type. The catalytic domain in 
complex with an ATP analog and a pseudo-substrate peptide is virtually superimposable 
to the structure of the wild-type enzyme[36, 106], while the J-domain of the chimera is 
tucked tightly under the large lobe of the enzyme (Figure 5.1 panel A). In contrast, our 
computational and solution NMR studies suggest that PKA-CDNAJB1 spans a large 
ensemble of conformations, with the J-domain undergoing fast re-orientational dynamics 
relative to the core of the enzyme[64]. To provide orthogonal validation, we compared the 
SAXS profiles of PKA-CWT and PKA-CDNAJB1. For both binary (ATPγN-bound) and ternary 
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(ATPγN/PKI-bound) complexes of PKA-CDNAJB1, we fit the SAXS profiles with the compact 
(J-domain in), intermediate, and extended (J-domain out) conformations extracted from 
the trajectories of molecular dynamics (MD) simulations (Figure 5.1 panel B,C). We found 
all structures fit well with the SAXS profile with χ < 1.0 in the low q region (q < 0.2 Å-1). 
However, the radius of gyration (Rg) increases from 23.7 to 26.9 Å, indicating that the J-
domain can dislodge from the kinase core and adopt an extended conformation. In 
contrast, the flexible N-terminus of PKA-CWT is much smaller and does not influence the 
Rg of the enzyme (21.7 Å) for both binary and ternary complexes (Figure 5.7). The addition 
of PKI to nucleotide-saturated PKA-CWT and PKA-CDNAJB1 does not change the SAXS 
profiles, suggesting that PKI binding does not alter the overall size and shape of the two 
kinases. 
 
Figure 5.1. Multiple conformations adopted by the dynamic J-domain alters allosteric 
binding cooperativity of PKA-C. 
 a Overlay of selected snapshots of PKA-CDNAJB1 from the MD trajectories highlighting the ensemble 
of conformers sampled by the J-domain. b SAXS profiles of PKA-CDNAJB1. Continuous lines show 
the structural fitting of the experimental SAXS data with the closed (J-domain in, blue), intermediate 
(green), and extended (J-domain out, magenta) conformations for binary (ATPγN-bound) and 
ternary (ATPγN/PKI-bound) forms. The conformations are extracted from the MD trajectories. c 
Corresponding Kratky plot of PKA-CDNAJB1 bound to ATPγN and ATPγN/PKI. d Bar graph showing 
the dissociation constants (Kd) calculated from the ITC titration curves of PKI5-24 binding to the apo 
and ATPγN-bound forms of PKA-CWT and PKA-CDNAJB1 (see also Table 5.2). 
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The J-domain of PKA-CDNAJB1 reduces the nucleotide/substrate degree of binding 
cooperativity (σ). Previous studies from our group have shown that PKA-CWT, a K-type 
enzyme, exhibits positive binding cooperativity between nucleotide (ATPγN) and pseudo-
substrate (PKI5-24), which can be reduced by mutation while maintaining maximal rate[65, 
71, 82]. Thus, we sought to understand how this canonical positive binding cooperativity 
is altered in PKA-CDNAJB1, using isothermal titration calorimetry (ITC). For the binding of 
nucleotide alone, PKA-CDNAJB1 exhibits a 4-fold higher binding affinity for ATPγN compared 
to PKA-CWT (Kd = 19 ± 4 µM versus 83 ± 8 µM; Table 5.1 and Figure 5.8). To determine 
the degree of binding cooperativity (σ) for PKA-CDNAJB1, we monitored the binding affinity 
of PKI5-24 in the absence and presence of nucleotide. In the absence of nucleotide, PKA-
CDNAJB1 binds PKI5-24 with a 2-fold higher affinity compared to wild-type (Kd =9 ± 2 µM 
versus 17 ± 2 µM; Figure 5.1 panel D and Figure 5.8). In contrast, upon saturation with 
nucleotide, the PKA-CDNAJB1/ATPγN complex binds PKI5-24 with a 7-fold decrease in 
binding affinity (Kd =1.1 ± 0.2 µM versus 0.16 ± 0.02 µM). Together, these data show that 
addition of the J-domain causes a sizeable decrease (13-fold) in nucleotide/pseudo-
substrate binding cooperativity (Table 5.2). 
To evaluate the effect of the dramatic reduction in binding cooperativity on the 
ability of PKA-CDNAJB1 to perform phosphoryl transfer, we used steady-state coupled 
enzyme assays. Specifically, we evaluated the catalytic efficiencies of PKA-CWT and PKA-
CDNAJB1 toward the standard peptide substrate, Kemptide, physiological substrate, CREB, 
and a known hyper-phosphorylated substrate identified by Scott and coworkers, 
KSR1[108] (Figure 5.2 panel A). Though the substrates displayed different maximal 
velocities (Vmax = 0.21 – 0.35 µM/s) and Michaelis constants (KM = 29-56 µM), PKA-CDNAJB1 
consistently displayed higher Vmax values resulting in slightly higher catalytic efficiencies 
(kcat/KM) compared to wild-type for all substrates tested (Figure 5.2 panel B, Table 6.3, 
and Figure 5.9). While the binding cooperativity is affected by the presence of the J-
domain, these assays with peptides encompassing the recognition sequences of different 




Figure 5.2. Attenuation in binding cooperativity does not influence phosphoryl transfer.  
a Comparison of the substrate recognition sequences of substrates Kemptide, CREB, and KSR1, 
regulatory subunits, RIα and RIIβ, and endogenous inhibitor, PKI. b Bar graph displaying the 
catalytic efficiencies (kcat/KM) of PKA-CWT and PKA-CDNAJB1 towards Kemptide, CREB, and KSR1. 
Errors were calculated from triplicate measurements. All kinetics parameters are summarized in 
Table 5.3 and shown in Figure 5.9. 
 
The J-domain disrupts the internal allosteric network of PKA-CDNAJB1. To determine 
the origin of the decreased allosteric binding cooperativity, we analyzed the structural 
response of the kinases to ligand binding using solution NMR spectroscopy. Specifically, 
we mapped the amide fingerprints of both enzymes using [1H, 15N]-TROSY-HSQC 
experiments[266] upon addition of nucleotide and PKI5-24 (Figure 5.10). The amide 
fingerprints of PKA-CWT and the PKA-CDNAJB1 kinase core are almost superimposable, 
reflecting their identical structures. This similarity enabled us to transfer the previously 
assigned PKA-CWT amide resonances[82] to the PKA-CDNAJB1 spectrum (Figure 5.10 
panel A). To assign the remaining resonances of the J-domain, we expressed the 69-
residue construct (DNAJB11-69) uniformly labeled with 15N and 13C in E. coli bacteria and 
assigned the resonances in the [1H, 15N]-TROSY-HSQC spectrum using the classical out-
and-back triple-resonance experiments (Figure 5.11). A total of 340 amide resonances 
were assigned over the 388 expected. As previously reported[267], the DNAJB11-69 
domain folds autonomously, and its resonances overlay with those of the J-domain fused 
to PKA-CDNAJB1 (Figure 5.10 panel B). To analyze the kinases response to ATPγN and 
PKI5-24 binding, we followed the 1H and 15N chemical shift perturbations (CSPs) of the 
amide fingerprints for the two kinases. We found that the fingerprints of both PKA-CWT and 
PKA-CDNAJB1 show similar CSPs upon binding ATPγN (Figure 5.12 panel A). However, 
residues of PKA-CDNAJB1 encompassing the Gly-rich loop, activation loop, αF-helix, αG-
helix, and the C-terminal tail show greater CSPs compared to PKA-CWT. Notably, these 
domains undergo the largest structural rearrangements from the open (apo) to closed 
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(ternary) form. The J-domain is not directly involved in the binding events as it experiences 
CSPs well below one standard deviation. As for PKA-CWT, the binding of ATPγN causes 
broadening of amide resonances throughout the core of PKA-CDNAJB1, suggesting the 
presence of conformational dynamics in the µs-ms timescale[268]. Upon binding PKI5-24 
to the ATPγN-saturated kinase, the CSPs of the kinase cores are similar, with effects 
propagated from the substrate-binding sites to both small and large lobes (Figure 5.12 
panel B). The J-domain remains structurally isolated from the core as we observe only a 
few chemical shift changes upon binding PKI5-24. As found for PKA-CWT, PKI5-24 binding 
sharpens the amide fingerprint resonances, indicating that the enzyme is trapped in a well-
defined conformational minimum[82]. The linewidths of the J-domain, on the other hand, 
are unperturbed, suggesting that pseudo-substrate binding does not change its 
conformational dynamics. 
 
Figure 5.3. Defective internal allosteric network of PKA-CDNAJB1.  
Chemical shift correlation matrices for a PKA-CWT and b PKA-CDNAJB1. The cross-peaks represent 
pairs of residues with the absolute value of the Pearson's coefficient ≥ 0.98. The secondary 
structures for the two kinases are reported above and below the matrix. The bar graphs shown 




Figure 5.4. Reduced crosstalk amongst structural communities of chimeric PKA-CDNAJB1 
relative to PKA-CWT.  
a Structure of PKA-C highlighting all communities and their roles in various functions and regulatory 
mechanisms. CHESCA community matrices for b PKA-CWT and c PKA-CDNAJB1 upon binding PKI5-
24. d-e CHESCA community matrices plotted on their corresponding structures. The size of each 
node is independent of the number of residues it encompasses, meanwhile the weight of each line 
indicates the strength of coupling between the individual communities. 
 
95 
To analyze the internal network of communication of both PKA-CDNAJB1 and PKA-
CWT, we used CHEmical Shift Covariance Analysis (CHESCA)[129, 132]. This method 
identifies allosteric networks among the protein residues by tracking each residue's 
coordinated changes of chemical shifts in response to ligand binding or mutations. For a 
binding process occurring in the fast NMR timescale, the resonances associated with 
allosterically coupled residues exhibit a correlated linear response. When plotted on a 
correlation matrix, changes in allosteric networks manifest as variations in the number and 
extent of inter-residue correlations[131, 132]. We analyzed the chemical shift responses 
of four different forms of the kinase: apo, ATPγN-bound, ADP-bound, and ATPγN/PKI5-24-
bound. The CHESCA matrix of PKA-CWT shows a coordinated response for many residues 
spanning the entire enzyme, with a higher density of correlations in the N-lobe near the 
nucleotide-binding site and the substrate-binding groove at the interface between the N- 
and C-lobes (Figure 5.3 panel A). These correlations constitute central allosteric nodes 
necessary for binding cooperativity[65, 81, 83]. Additionally, allosteric crosstalk exists 
between residues in the C-terminal tail and residues in the αA-helix (K21, K28), αE-helix 
(R144, A147, L152), activation loop (R190, V191, G193), and αF-helix (G214, G225). In 
contrast, the matrix of PKA-CDNAJB1 exhibits an overall attenuation in CHESCA correlations 
throughout the entire kinase, with a rewiring of the network between nucleotide and 
substrate binding sites. Specific structural domains such as the αA-helix (K21, K27), αE-
helix (A143, R144, A147, L152), αC-helix (Q96, A97), and C-terminal tail (I335, N340, 
E349) are more noticeably attenuated (Figure 5.3 panel B). The functional relevance of 
this extensive rewiring of the intramolecular communication is apparent when we 
combined CHESCA with the definition of the structural and functional communities 
(community CHESCA)[140]. Upon dividing the kinase into nine different communities 
defined by McClendon et al (Figure 5.4 panel A)[140], each with different structural and 
functional roles, we observe a clear parallel between experimental data and theory[81, 
140]. The correlation matrix for community CHESCA for PKA-CWT (Figure 5.4 panel B) 
shows that structurally adjacent communities in the N-lobe and at the N/C lobe interface 
(ComA, ComB, ComC, and ComE) are strongly coupled with distal communities (ComH) 
as they exhibit high correlation coefficients (RX,Y). A structural representation of the extent 
of coupling is reported in Figure 5.4 panel D, where crosstalk between the nucleotide-
binding (ComA) with the positioning of the αC-helix (ComB), the R-spine assembly 
(ComC) and the activation loop (ComF) is apparent. Although attenuated, there is 
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substantial coupling between these communities and the more peripheral communities 
that have structural roles, such as ComH. The cooperative response to nucleotide and 
PKI5-24 binding involves the entire enzyme, causing coordinated CSPs interspersed 
throughout its three-dimensional structure. In contrast, the community CHESCA for PKA-
CDNAJB1 exhibits a dramatic decrease in inter-community coupling (Figure 5.4 panel C, E). 
The coupling network between the ATP-binding site (ComA) and the αC-helix (ComC) or 
the activation loop (ComF) is sparse. Notably, the correlations between the N-lobe 
communities with peripheral communities in the C-lobe (ComD and ComE) are either 
notably reduced or lost. This phenomenon is especially evident for ComH located near the 
J-domain, which includes residues that are involved in docking of the R-subunits or kinase 
binding partners. Other correlations not found in the wild-type are observed between 
ComG and ComA, ComB, ComD, and ComF; and stronger correlations are observed 
between ComE and ComF1. Overall, the community CHESCA show that the reduced 
degree of cooperativity determined thermodynamically corresponds to a decrease in 
coordinated structural changes upon ligand binding in PKA-CDNAJB1. 
 
Figure 5.5. Global coordinated response of PKA-CWT and PKA-CDNAJB1 to ligand binding.  
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Coordinated chemical shift changes analyzed with CONCISE for a PKA-CWT and b PKA-CDNAJB1. 
Changes in the free energy of binding of c PKA-CWT and d PKA-CDNAJB1 to ATPγN and PKI5-24. Black 
lines indicate the values obtained from ITC and pink lines correspond to values obtained from NMR 
measurements. 
 
Global versus community-specific responses to ligand binding. While CHESCA 
provides an estimate of the correlated response for individual residues (or communities) 
to ligand binding, the analysis of the amide chemical shifts with CONCISE (COordiNated 
ChemIcal Shifts bEhavior)[235] provides the probability density (population) of each state 
along the conformational equilibrium. According to CONCISE analysis, the probability 
density of the amide resonances for the apo form of the enzyme (open state) is clustered 
around an average principal component (PC) score (<PC>) of ~-1.2 (Figure 5.5 panel 
A)[269]. Upon binding ATPγN, ADP, and PKI5-24, the probability densities for the amide 
resonances of PKA-CWT progressively shift toward more positive <PC> values, with the 
density for the binary complex (intermediate state) showing a <PC> ~ 0, and the ternary 
complex an <PC> ~1.3 (closed state). A similar trend is observed for PKA-CDNAJB1, though 
the probability densities are broader, indicating that the amide resonances follow a less 
coordinated response[235]. Also, the maximum of the probability density for the 
intermediate state of PKA-CDNAJB1 is slightly shifted toward the closed conformation, while 
the probability density for the ternary complex is slightly more open than the corresponding 
wild-type (Figure 5.5 panel B). These probability densities or populations of each state 
can be converted into free energy, and the shift of the maxima from free to bound state 
along the <PC> axis reflects the free energy of binding[235]. Indeed, the ∆∆G values 
obtained from ITC data are very similar to those calculated from CONCISE (Figure 5.5 
panel C, D and Table 5.4). Consequently, the attenuation in the collective response of the 
amide resonances of the PKA-CDNAJB1 is correlated with the reduced extent of binding 
cooperativity. Interestingly, we found that the two enzymes respond to ligand binding in a 
community-specific manner (Figure 5.6 panel A, B). For PKA-CWT, the resonances 
associated to ComA have the most prominent response upon nucleotide binding. Also, 
large conformational transitions are observed for ComB, ComC, ComD, and ComE, while 
the remaining communities, located mostly in the C-lobe, show only marginal changes, 
with an <PC1> of approximately -0.4. Binding of PKI5-24 to the PKA-C/ATPγN complex 
shifts all the communities toward a fully closed state (<PC1> ~1) (Figure 5.6 panel C and 
Figure 5.13 panel A). In contrast, the probability densities for ComA, ComB, ComC, 
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ComD, and ComE for PKA-CDNAJB1 are shifted to a more closed intermediate state (<PC1> 
~0). Moreover, PKI5-24 binding to PKA-CDNAJB1/ATPγN complex shifts the probability 
densities of the various communities toward the closed state to different extents (<PC1> 
~ 0.75), with only ComF, ComF1, ComG, and ComH reaching a fully closed state. The 
remaining communities located in the N-lobe cluster around PC1 ~0.65, adopting a slightly 
more open conformation (Figure 5.6 panel D and Figure 5.13 panel B). Overall, the J-
domain fused to the catalytic core decreases the number of correlated chemical shift 
responses, i.e., the community of the kinase no longer transition in a correlated fashion, 
and prevents several communities (ComA, ComB, ComC, ComD, and ComE) from 
reaching a fully closed state, which explains the reduced extent of nucleotide/substrate 
binding cooperativity[71].  
 
Figure 5.6. Community-specific responses of PKA-CWT and PKA-CDNAJB1 upon ATPγN and 
PKI5-24 binding.  
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CONCISE analysis for each individual community for a PKA-CWT and b PKA-CDNAJB1. The top panel 
on the graphs shows the average PC1 (<PC1>) over all communities, while the bottom panel shows 
the PC1 scores of each individual community. CONCISE scores of each community mapped onto 
the surface of c PKA-CWT (PDB: 4WB5) and d PKA-CDNAJB1 (PDB: 4WB7) for each state (apo, 
+ATPγN, and +ATPγN/PKI5-24). 
 
5.4 Discussion 
There is mounting evidence that PKA-CDNAJB1 is the primary driver of FL-HCC[31, 
32, 259] and may be involved in other pathologies[270, 271]. Despite its link to 
tumorigenesis, initial structural and functional studies have left more questions than 
answers regarding the molecular etiology of this rare liver carcinoma. Similar to other 
oncogenic kinases involved in Cushing's syndrome, the X-ray structure of PKA-CDNAJB1 
does not reveal any structural anomalies in the catalytic core (RMSD < 0.4 Å)[106]. In 
solution, however, NMR and SAXS have shown that the J-domain is flexible, assuming 
both in and out conformations[64]. The inherent flexibility of the J-domain enables the 
kinase to form hetero-tetrameric holoenzymes with RIα subunits, although with two 
alternative conformations[263]. Interestingly, the RIα subunit is overexpressed in 
carcinoma cells, presumably to 'buffer' the PKA-CDNAJB1 overexpression[259, 262, 272]. In 
rare cases of FL-HCC, lack of PKA-C regulation by RIα may result in the progression of 
the disease[273], like the dysregulation of PKA-C in Carney Complex[95]. These data 
alone do not adequately explain the aberrant function of PKA-CDNAJB1. 
It is possible, however, that the functional repercussion of the J-domain fusion to 
PKA-C is multifaceted. First, the deletion of 14 residues in the αA-helix and N-terminus 
prevents post-translational modifications such as myristoylation, deamidation, and 
phosphorylation of Ser10. These modifications are essential for intracellular membrane 
localization[274, 275]; therefore, the J-domain may interfere with the localization of the 
enzyme in the proximity of natural substrates. Second, the phosphorylation profile of PKA-
CDNAJB1 is considerably different from the wild-type[108]. Third, the presence of the J-
domain may interfere with the formation of localization complexes with A-kinase anchoring 
proteins (AKAPs)[272]. Fourth, PKA-CDNAJB1 may form stable complexes with Hsp70, with 
the J-domain acting as a scaffold for this chaperonin[108].  
Irrespective of these putative mechanisms, our studies reveal that the fusion of the 
J-domain to the kinase reduces canonical positive binding cooperativity between 
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nucleotide and substrate[71], and alters the kinases' conformational equilibrium via 
disruptions of the intramolecular allostery. Indeed, cooperativity plays an essential role in 
macromolecular assembly, regulation, and signal transduction[276, 277]. Therefore, the 
attenuation in allosteric binding cooperativity is likely to be implicated in the altered 
interactome and phosphoproteome[108]. Since the recognition sequences of R-subunits 
are highly homologous to PKI, the reduced nucleotide/PKI binding cooperativity of PKA-
CDNAJB1 suggests an aberrant regulation of the holoenzyme as well. It is worth noting that 
a reduction in cooperativity is also a prominent feature of a single mutation in the P+1 loop 
of the catalytic subunit (PKA-CL205R) in patients affected by Cushing's syndrome[65],53,54.  
Consistent with our previous analyses of PKA-CL205R, the allosteric network of 
PKA-CDNAJB1 exhibits an overall attenuation in the density of correlations across the kinase 
with a marked reduction near the nucleotide-binding site and substrate-binding groove. 
The introduction of community-specific analyses assists in deciphering how the fusion of 
the J-domain perturbs the allosteric network and further underscores the linkage between 
the reduced binding cooperativity and the decrease in crosstalk among the structural 
communities[140]. The coupling between ComH, responsible for the docking of proteins 
such as PKI or R-subunits, to other communities is completely ablated, explaining the 
lower degree of binding cooperativity observed for PKA-CDNAJB1, and further suggesting 
that the R/C-interactions may be altered. Moreover, the dramatic decrease in the inter-
community coupling of ComC, adjacent to the αA-helix, reflects the structural and/or 
dynamic changes caused by the J-domain fusion to the αA-helix. Overall, the similarities 
observed between PKA-CL205R and PKA-CDNAJB1 suggest a common mechanism, involving 
concomitant reductions in binding cooperativity and intramolecular allostery that may elicit 
their aberrant function.  
Indeed both computational and experimental methods have successfully 
elucidated allosteric pathways in a variety of different systems outside of protein kinase 
A[77, 134, 146, 278-282]. Perhaps more importantly, many of these studies have shown 
how disruptions in these pathways act to change function. Taken with our previous 
studies, nucleotide/substrate binding cooperativity emerges as a critical function in protein 
kinase A that arises from the structural changes of multiple domains (i.e., communities) 
that must be coordinated and synchronized to ensure a cooperative binding response[65, 
83]. Like other tumorigenic transcriptomes that result in a fully active PKA-C, it is likely 
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that alterations in the allosteric network impart defective binding cooperativity and may 
play a role in their aberrant functions[270, 271, 283]. As for the chimeric PKA-CDNAJB1, 
attenuated or dysfunctional responses to allosteric effectors (such as ATP) may result in 
defective spatial and temporal control of phosphorylation-mediated signaling in other 
protein kinases, leading to disease.  
5.5 Materials and Methods 
Sample Preparation of PKA-CWT and PKA-CDNAJB1. Recombinant PKA-CWT was 
expressed and purified as described in Walker et al. [65]. PKA-CDNAJB1 was cloned into a 
pET-28a (+) vector. A tobacco etch virus (TEV) cleavage site was incorporated via 
mutagenesis into the vector between the cDNA coding for the kinase and a thrombin 
cleavage site. Transformed E.coli BL21 (DE3) pLyss (Agilent) cells were cultured in M9 
minimal media supplemented with 15NH4Cl. Protein overexpression was induced with 0.4 
mM isopropyl β-D-thiogalactopyranoside (IPTG) and carried out overnight at 20°C. 
Following harvest, the cell pellet was resuspended in 50 mM Tris-HCl, 30 mM KH2PO4, 
300 mM NaCl, 5 mM 2-mercaptoethanol, 0.15 mg/mL Lysozyme, 200 μM ATP, DNaseI, 
Roche EDTA-free protease inhibitor tablet (pH 8.0) and lysed using French press. The 
solution was cleared by centrifugation (16000 rpm, 4°C, 45 min) and the supernatant 
incubated with Ni2+ nitrilotriacetic acid resin (Thermo Scientific, 1 ml of resin per liter of 
culture) at 4°C overnight. The resin was then washed with 50 mM Tris-HCl, 30 mM 
KH2PO4, 300 mM NaCl, 5 mM 2-mercaptoethanol, 0.5 mM phenylmethylsulfonyl fluoride 
(PMSF) (pH 8.0). The resin was further washed with the same buffer supplemented with 
10 mM imidazole. PKA-CDNAJB1 was eluted using the same buffer with 250 mM imidazole. 
SDS-PAGE electrophoresis samples were taken at each purification step listed and are 
shown in Figure 5.14 panel A. Fractions containing PKA-CDNAJB1 were cleaved for 18 
hours at 4°C in a dialysis buffer composed of 20 mM KH2PO4, 25 mM KCl, 5 mM 2-
mercaptoethanol, 0.1 mM PMSF (pH 7.0). The phosphorylation states of PKA-CDNAJB1 
were separated using a cation exchange column (HiTrap Q-SP, GE Healthcare Life 
Sciences using a linear gradient of KCl in 20 mM KH2PO4.  
Sample Preparation of DNAJB1. The 69 amino acid sequence corresponding to the 
DNAJB1 heat shock protein fragment, DNAJB11-69, was cloned into the pET-28a (+) 
vector. DNAJB11-69 was expressed in E.coli BL21 (DE3) (Agilent) in M9 minimal media 
containing 15NH4Cl and 13C-glucose as the sole source of nitrogen and carbon, 
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respectively. Overexpression was induced with 0.4 mM IPTG and carried out for 5 hours 
at 30°C. The cell pellet was resuspended in 20 mM Tris-HCl, 300 mM NaCl, 5 mM 2-
mercaptoethanol, 15 mg/mL Lysozyme, DNaseI, Roche EDTA-free protease inhibitor 
tablet (pH 8.0) and lysed using sonication. The lysate was cleared by centrifugation (18000 
rpm, 4°C, 30 min,) and the supernatant was incubated with Ni2+ nitrilotriacetic acid resin 
at 4°C overnight. Resin was washed with 20 mM Tris-HCl, 300 mM NaCl, 5 mM 2-
mercaptoethanol, 0.5 mM PMSF (pH 8.0). DNAJB11-69 was eluted using the same buffer 
supplemented with 250 mM imidazole. SDS-PAGE electrophoresis samples were taken 
at each purification step listed as shown in Figure 5.14 panel B. The elution was dialyzed 
for 3 hours at 4°C into 20 mM Tris-HCl, 150 mM NaCl and 5 mM 2-mercaptoethanol (pH 
8.0). To cleave the His-tag, an appropriate amount of thrombin was added to the solution 
and allowed to occur at RT for 4 hours. The cleavage reaction was monitored by SDS-
PAGE, and upon completion, thrombin was inactivated by adding 1 mM PMSF. To purify 
the protein, the cleavage solution was passed through a Ni2+ nitrilotriacetic acid resin. The 
flowthrough was collected, concentrated using a 10 kDa, and subsequently a 3 kDa spin 
concentrator and stored at 4°C in 20 mM Tris-HCl, 150 mM NaCl and 2 mM DTT 
supplemented with 0.5 mM of PMSF (pH 8.0). 
Sample Preparation of Peptides. Kemptide (LRRASLG), CREB 
(123KRREILSRRPSYR135), and KSR1 (880LPKLNRRLSHPGHFWKS896), and PKI5-24 were 
synthesized on a CEM Liberty Blue microwave synthesizer. All peptides were purified 
using reverse-phase high-pressure liquid chromatography. The purified peptide was 
concentrated, lyophilized, and stored at -20°C. All peptides molecular weight was verified 
by MALDI-TOF. Kemptide’s molecular weight quantity was verified by amino acid analysis 
(Texas A&M University). 
ITC Measurements. ITC measurements were performed with a low-volume NanoITC (TA 
Instruments). PKA-CWT and PKA-CDNAJB1 were dialyzed into 20 mM MOPS, 90 mM KCl, 
10 mM DTT, 10 mM MgCl2, and 1 mM NaN3 (pH 6.5). PKA-CWT and PKA-CDNAJB1 
concentrations for ITC measurements were between 80-130 µM as confirmed by A280 = 
53,860 M-1 cm-1 and A280 = 62,800 M-1 cm-1, respectively. Approximately 300 µL of the 
kinase was used for each experiment, with 50 µL of 2 mM ATPγN and/or 0.6-1 mM PKI5-
24 in the titrant syringe. The heat of dilution of the ligand into the buffer was taken into 
account for all experiments and subtracted. For experiments with saturated nucleotide, 2 
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mM ATPγN was added. All measurements were performed at 300 K in triplicates. The 
binding was assumed to be 1:1, and curves were analyzed with the NanoAnalyze software 









�   (1) 
where d[MX] is the change in total complex relative to the change in total protein 
concentration, d[Xtot] is dependent on r, the ratio of Kd relative to the total protein 
concentration, and Rm, the ratio between total ligand and total protein concentration. The 
free energy of binding was determined using the following: 
∆G = RT ln Kd  
where R is the universal gas constant, and T is the temperature at measurement (300 K). 
The entropic contribution to binding was calculated using the following: 
T∆S =  ∆H −  ∆G. 
The degree of cooperativity (σ) was calculated as follows:  




where Kd Apo is the dissociation constant of PKI5-24 binding to the apoenzyme, and Kd Nucleotide 
is the corresponding dissociation constant for PKI5-24 binding to the nucleotide-bound PKA-
C. 
Enzyme Assays. Steady-state activity assays with Kemptide, CREB, and KSR1 were 
performed under saturating ATP concentrations and spectrophotometrically at 298 K as 
described by Cook et al. [85]. The values of Vmax and KM were obtained from a non-linear 
fit of the initial velocities to the Michaelis-Menten equation. 
Small-angle X-ray scattering (SAXS). Following the purification method outlined above, 
PKA-CDNAJB1 was buffer exchanged into 20 mM MOPS, 90 mM KCl, 60 mM MgCl2, 10 mM 
DTT, and 1 mM NaN3 (pH 6.5) and concentrated to 70 µM. For binary and ternary samples, 
12 mM ATPγN and/or 70 µM PKI (1:1 ratio) was added to PKA-CDNAJB1. Fitting of structures 
104 
from MD simulations against the experimental SAXS curves was performed using the 
FoXS web server[284]. One hundred random snapshots from MD simulations for PKA-
CWT and PKA-CDNAJB1 were chosen as representative structures for the conformational 
ensembles, and the fitting of the SAXS data was carried out for a range of q values 
spanning from 0.01 to 0.2. 
NMR Spectroscopy. Uniformly 15N-labeled PKA-CWT and PKA-CDNAJB1 were 
overexpressed and purified as described above. NMR experiments were performed in 90 
mM KCl, 20 mM KH2PO4, 10 mM dithiothreitol (DTT), 60 mM MgCl2, and 1 mM NaN3 at 
pH 6.5. Standard [1H-15N]-TROSY-HSQC experiments were carried out for PKA-CWT and 
PKA-CDNAJB1 on an 850-MHz Bruker Advance III spectrometer equipped with a TCI 
cryoprobe, respectively. Concentrations for samples were 0.1-0.3 mM as determined by 
A280 measurements, 12 mM ATPγN or ADP was added for the nucleotide-bound form, and 
0.2-0.4 mM PKI5-24 for the ternary complex. Spectra were collected at 300K, processed 
using NMRPipe[243], and visualized using Sparky[244]. 
All [1H-15N]-TROSY-HSQC experiments were acquired with 2048 (proton) and 256 
(nitrogen) complex points. Combined chemical shift perturbations were calculated using 
1H and 15N chemical shifts according to the following: 
∆𝛿𝛿 =  �(Δ𝛿𝛿𝑁𝑁)2 + (0.154 × Δ𝛿𝛿𝑁𝑁)2   (2) 
Backbone resonance assignment of DNAJB11-69. Uniformly 13C,15N-labeled DNAJB11-
69 was overexpressed and purified as described above. NMR experiments were performed 
in 90 mM KCl, 20 mM KH2PO4, 10 mM dithiothreitol (DTT), 60 mM MgCl2, and 1 mM NaN3 
(pH 6.5). Standard 3D triple resonance experiments were carried out for DNAJB11-69 on a 
600 MHz Bruker Avance NEO spectrometer equipped with a triple resonance cryogenic 
probe at 300 K. Concentrations for samples were 0.3 mM as determined by A280 
measurements. All NMR data were processed using NMRPipe[243] and visualized using 
Sparky[244]. 
Chemical Shift Analyses. COordiNated ChemIcal Shift bEhavior (CONCISE). 
CONCISE was used to measure the change in equilibrium position using the following 
PKA-C constructs: apo, ATPγN, ADP, and ATPγN/PKI5-24. This method identifies sets of 
residues whose chemical shifts respond linearly to the conformational transition using 
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principal component analysis (PCA). Community-based and domain-based CONCISE 
analyses use similar methods using only select residues that comprise either an individual 
community or domain as defined by McClendon et al. [40, 140]. ∆∆G values from NMR 
derived from CONCISE analysis and based on extent of closure (% closed). Values used 
for the calculations can be found in Table 5.4. PKA-CWT ITC values were used as a 
reference with apo PKA-CWT: ∆∆G=0 and 0% closed; and +ATPγN/PKI-bound PKA-CWT: 
∆∆G = -15 and 100% closed. Error was calculated by using the standard deviation of the 
gaussian fits from CONCISE analysis 
CHEmical Shift Covariance Analysis (CHESCA). CHESCA was used to identify and 
functionally characterize allosteric networks of residues eliciting concerted responses to, 
in this case, nucleotide and pseudo-substrate. A total of four states were used to identify 
inter-residue correlations: apo, ATPγN-bound, ADP-bound, and ATPγN/PKI5-24. The 
identification of inter-residue correlations by CHESCA relies on agglomerative clustering 
(AC) and singular value decomposition (SVD). Pairwise correlations between chemical 
shift variations experienced by different residues were calculated to identify networks. 
When plotted on a correlation matrix, this allows for the identification of regions that are 
correlated to one another. For each residue, the max change in chemical shift was 
calculated in both the 1H (x) and 15N (y) dimension (Δδx,y). Residues were included in 
CHESCA analysis only if they satisfied the following: Δδx,y > ½ ΔνxA,yA+½ Δν xB,yB, where A 
and B correspond to two different forms analyzed. (Note that there is no dependence on 
which two forms satisfied this statement) For every residue x, correlation scores were 
calculated by finding the total # of residues correlated (with Rij> 0.98) to residue x and 
dividing by the total # of residues in the kinase (350). Community CHESCA analysis is a 
chemical shift-based correlation map between various functional communities within the 
kinase. Each community is a group of residues (McClendon et al.[140]) associated with a 
function or regulatory mechanism. Mathematically, this community-based CHESCA 
analysis is a selective interpretation of CHESCA, where we evaluate a correlation score 
between residues in various communities, as shown below. To represent community-
based CHESCA analysis, we lowered the correlation cutoff such that Rcutoff > 0.8. Suppose 
community X and community Y has nX and nY number of assigned residues respectively, 
the correlation score between X and Y is defined as,  
RX,Y = Number of (Rij > Rcutoff) / (nX * nY). 
106 
Where Rij is the CHESCA correlation coefficient between residue i (belongs to community 
A) and residue j (belongs to community B). Rcutoff is the correlation value cutoff. RX,Y can 
assume values ranging from 0 (no correlation between residues in X and Y) to 1 (all 
residues in X are correlated with all residues in Y).  
Molecular Dynamics Simulations. Parallel MD simulations were set up to compare PKA-
CWT and PKADNAJB1. These simulations were repeated for the apo, the binary (ATP-bound), 
and the ternary complexes (ATP/PKI5-24). The systems with PKA-CWT and PKA-CDNAJB1 
were built directly from the X-ray structures starting from the closed configurations (PDB 
ID: 1ATP and 4WB7, respectively)[79, 106]. All simulations were performed using 
GROMACS 4.6[285] in the CHARMM36 force field [286]. The all-atom structures were 
solvated in a rhombic dodecahedron solvent box with a TIP3P[245] water molecule layer 
extending approximately 10Å away from the surface of the proteins. Counter ions (K+ and 
Cl-) were added to ensure electrostatic neutrality corresponding to an ionic concentration 
of ~150 mM. The LINCS[287] algorithm was applied to constrain all covalent H-bonds to 
the equilibrium length, and particle-mesh Ewald [288] was used to treat long-range 
electrostatic interactions with a real-space cutoff of 10 Å. All systems were minimized 
using steepest descent algorithm, and then were gradually heated to 300 K at a constant 
volume over 1 ns, using harmonic restraints with force constant of 1000 kJ/(mol*Å2) on 
heavy atoms of both proteins and nucleotides. Over the following 12 ns of simulations at 
constant pressure (1 atm) and temperature (300 K), the restraints were gradually released. 
The systems were equilibrated for an additional 20 ns without positional constraints. A 
Parrinello-Rahman barostat[289] was used to keep the pressure constant, while a V-
rescale thermostat with a time step of 2 fs was used to maintain constant temperature. 
Each system was simulated for 1.05 µs, with snapshots recorded every 20 ps. A total of 
6.3 µs and 315000 conformations were utilized for the analyses. 
Statistics and Reproducibility. Numerical ∆G, ∆H, -T∆S, and Kd values shown in 
Supplementary Tables 1 and 2 are averages of three independent ITC experiments with 
errors calculated as the standard deviation between these three measurements. 
Numerical values of Vmax and KM were determined with a nonlinear regression function 
assuming Michaelis-Menten kinetics for substrate concentration versus velocity using 
GraphPad Prism 8.0.1. Error in kcat/KM values was propagated from error in kcat and KM. 
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5.8 Supplementary Figures 
 
Figure 5.7. SAXS profiles for PKA-CWT. 
a SAXS profiles of PKA-CWT in the binary (ATPγN-bound, yellow) and ternary (ATPγN/PKI-bound, 
black) forms. Continuous lines show the fitting of the experimental SAXS data. b Corresponding 





Figure 5.8. Thermodynamics of PKA-CDNAJB1 binding nucleotide and pseudo-substrate.  
Representative ITC thermographs of apo PKA-CDNAJB1 binding a ATPγN, and b PKI5-24. 
Corresponding thermodynamic values are found in Table 5.1, 5.2. c Graphical representation of 





Figure 5.9. Steady state kinetics of phosphoryl transfer.  
Steady state phosphorylation kinetics of PKA-CWT (black) and PKA-CDNAJB1 (pink) towards a 
Kemptide, b CREB, and c KSR1. See Supplementary Table 3 for corresponding kinetic parameters 




Figure 5.10. NMR amide fingerprints of PKA-CDNAJB1 and PKA-CWT. 
 [1H,15N]-TROSY-HSQC spectrum overlay of apo PKA-CDNAJB1 to a apo PKA-CWT and b DNAJB1(1-
69). [1H,15N]-TROSY-HSQC spectrum of PKA-CDNAJB1 bound to c ATPγN and e ATPγN/PKI5-24, and 




Figure 5.11. NMR backbone assignment of DNAJB11-69.  
a Primary sequence of DNAJB1 (Uniprot 25685). The sequence underlined in green are the 
residues which through-bound connectivity is reported in panel D. Residues that could not be 
assigned are underlined in yellow. b The three-dimensional structure of the J-domain (DNAJB1) of 
PKA-CDNAJB1 (PDB 4WB7). c [1H,15N]-Heteronuclear single quantum correlation (HSQC) spectrum 
of DNAJB11-69 with resonance assignment. d Series of strip plots from the CBCA(CO)HN (a) and 




Figure 5.12. Chemical shift perturbations (CSP) observed upon ligand binding for PKA-CWT 
and PKA-CDNAJB1. 
Histograms show the combined 1H-15N chemical shift perturbations vs. residue for PKA-CWT and 
PKA-CDNAJB1 in response to a ATPγN-binding and b ATPγN/PKI5-24-binding. Each CSP is plotted on 
the structures of either PKA-CWT (PDB: 4WB5) or PKA-CDNAJB1 (PDB: 4WB7). The red line on the 
histograms indicate one standard deviation from the average CSP. Note that the CSP values for 




Figure 5.13. CONCISE scores of each individual community mapped onto the surface of a 




Figure 5.14. Isolation and purification of PKA-CDNAJB1 and DNAJB11-69. 
 a Coomassie-stained 12% Acrylamide/bis-acrylamide SDS-PAGE of the expression and 
purification (a-g), and protein integrity test (i-k) of U-15N PKA-CDNAJB1. (*) BLUEstain™ Protein 
ladder (GoldBio), 11-245 kDa; (a) before induction of expression with 0.4 mM of IPTG; (b) after 12 
hour expression; (c) Ni+-NTA flow through; (d) wash 1; (e) wash 2; (f) elution; (g) after 18 hours of 
cleavage; (h) 15 μM of U-15N PKA-CDNAJB1 used for the NMR titration; (i-l) serial dilutions of sample 
h. b Coomassie-stained 18% Acrylamide/bis-acrylamide SDS-PAGE of the purification of U-13C/15N 
DNAJB11-69. (*) BLUEstain™ Protein ladder (GoldBio), 11-245 kDa; (a) cell pellet; (b) Ni+-NTA flow 
through; (c) wash; (d) elution; (e) before thrombin cleavage; (f) 1 hour into cleavage reaction; (g) 2 
hours into cleavage reaction; (h) 3 hours into cleavage reaction; (i) 4 hours into cleavage reaction; 
(j) flow through from 10 kDa concentrator; (k) flow through from 3 kDa concentrator; (l) supernatant 
of 3 kDa concentrator; (m) NMR sample. 
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5.9 Supplementary Tables 
Table 5.1. Changes in enthalpy, entropy, free energy, and dissociation constant of binding 
ATPγN for PKA-CWT and PKA-CDNAJB1 derived from ITC experiments. 
All errors were calculated using triplicate measurements. Note that the values of Kd for PKA-CWT 
are taken from Walker et al. [65]. 
 
  Kd (µM) ΔG (kcal/mol) ΔH (kcal/mol) -TΔS (kcal/mol) 
PKA-CWT 83 ± 8 -5.61 ± 0.06 -3.6 ± 0.1 - 2.0 ± 0.1 




Table 5.2. Changes in enthalpy, entropy, free energy, and dissociation constant for the 
binding of PKI5-24 to the apo and nucleotide-saturated forms of PKA-CWT and PKA-CDNAJB1 
derived from ITC experiments. 
All errors were calculated using triplicate measurements. Errors in σ were propagated from errors 
in Kd. N/A indicates the value is not applicable to the particular measurements. Note that the values 
of Kd for PKA-CWT are taken from Walker et al. [65]. 
 
Binding of PKI5-24 to apo forms of kinases 
 Kd (μM) ΔG (kcal/mol) ΔH (kcal/mol) -TΔS (kcal/mol) σ 
PKA-CWT 17 ± 2 -6.6 ± 0.1 -10.8 ± 0.5 4.2 ± 0.5 N/A 
PKA-CDNAJB1 9 ± 2 -6.9 ± 0.1 -20.1 ± 0.4 13.1 ± 0.4 N/A 
Binding of PKI5-24 to the ATPγN saturated forms of kinases 
 Kd (μM) ΔG (kcal/mol) ΔH (kcal/mol) -TΔS (kcal/mol) σ 
PKA-CWT 0.16 ± 0.02 -9.33 ± 0.07 -13.9 ± 0.5 4.6 ± 0.4 106 ± 18 
PKA-CDNAJB1 1.1 ± 0.2 -8.2 ± 0.1 -22 ± 1 14 ± 1 8 ± 2 
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Table 5.3. Kinetic parameters of Kemptide, CREB, and KSR1 phosphorylation for PKA-CWT 
and PKA-CDNAJB1. 
Values for KM and kcat were obtained from a non-linear least-squares analysis of the concentration-
dependent initial phosphorylation rates using a standard coupled enzyme activity assay (related to 
Figure 5.2 panel B and Figure 5.9). Error in kcat/KM was propagated from the error in KM and kcat. 
 
Kemptide 
 PKA-CWT PKA-CDNAJB1 
Vmax (µM/s) 0.25 ± 0.01 0.33 ± 0.01 
KM (µM) 42 ± 5 44 ± 6 
kcat (s-1) 11.4 ± 0.5 15 ± 0.5 
kcat/KM  0.27 ± 0.03 0.34 ± 0.05 
 
CREB 
 PKA-CWT PKA-CDNAJB1 
Vmax (µM/s) 0.21 ± 0.01 0.27 ± 0.02 
KM (µM) 45 ± 8 56 ± 10 
kcat (s-1) 9.5 ± 0.5 12.3 ± 0.9 
kcat/KM  0.21 ± 0.04 0.22 ± 0.04 
 
KSR1 
 PKA-CWT PKA-CDNAJB1 
Vmax (µM/s) 0.31 ± 0.01 0.35 ± 0.02 
KM (µM) 30 ± 5 29 ± 5 
kcat (s-1) 14.1 ± 0.5 15.9 ± 0.9 




Table 5.4. CONCISE analysis of PKA-CWT and PKA-CDNAJB1. 
Value of % closed was calculated as a function of average PC scores. See the Methods section for 
calculation of ∆∆G based on CONCISE analysis. 
 
 Average PC Score % Closed ∆∆G (kcal/mol) 
PKA-CWT 
Apo 
-1.02 0% 0 
PKA-CDNAJB1 
Apo 
-1.02 0% 0 
PKA-CWT 
ATPγN 
-0.03 46% -6.9 
PKA-CDNAJB1 
ATPγN 
0.03 49% -7.4 
PKA-CWT 
ADP 
-0.06 45% N/A 
PKA-CDNAJB1 
ADP 
-0.02 47% N/A 
PKA-CWT 
ATPγN/PKI5-24 
1.11 100% -15.0 
PKA-CDNAJB1 
ATPγN/PKI5-24 
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Somatic mutations in the PRKACA gene encoding the catalytic α subunit of protein kinase 
A (PKA-C) are responsible for cortisol-producing adrenocortical adenomas. These benign 
neoplasms contribute to the development of Cushing's syndrome. The majority of these 
mutations occur at the interface between the two lobes of PKA-C and interfere with the 
enzyme's ability to recognize substrates and regulatory subunits, leading to aberrant 
phosphorylation patterns and activation. Rarely, patients with similar phenotypes carry an 
allosteric mutation, E31V, located at the αA-helix's C-terminal end and adjacent to the αC-
helix, a critical element in assembling the active conformation of kinases, but structurally 
distinct from the PKA-C interface mutations. Using a combination of solution NMR, 
thermodynamics, and kinetic assays, and molecular dynamics simulations, we show that 
the E31V allosteric mutation disrupts central communication nodes between the N- and 
C- lobes of the enzyme as well as the nucleotide-substrate binding cooperativity, a 
hallmark for kinases' substrate fidelity and regulation. For both orthosteric (L205R and 
W196R) and allosteric (E31V) Cushing’s syndrome mutants the loss of binding 
cooperativity is proportional to the density of the intramolecular allosteric network. This 
structure-activity relationship suggests a possible common mechanism for Cushing's 
syndrome driving mutations in which decreased nucleotide/substrate binding cooperativity 




Cushing's syndrome is defined by a collection of symptoms that result from 
prolonged exposure to high cortisol levels, leading to cardiovascular and metabolic 
complications [98]. Playing a fundamental role in regulating metabolism and cell 
proliferation in endocrine tissues, the cAMP signaling pathway and its aberrant activation 
are linked to several endocrine diseases [99, 226, 227]. The role of one component of this 
signaling cascade, cAMP-dependent protein kinase A (PKA), in Cushing's syndrome was 
not appreciated until recently when somatic mutations were identified in the PRKACA 
gene encoding the catalytic α subunit of PKA (PKA-C) [26-30, 102, 290, 291]. To date, a 
total of eight mutations have been discovered. Except for one mutation, E31V, all 
mutations are located near the substrate-binding cleft adjacent to the catalytic/regulatory 
(R) subunit interface (Figure 6.1 panel A).  
PKA is the principal intracellular effector of the second messenger, cAMP. Inactive 
PKA exists as a holoenzyme (R2:C2) containing an R-subunit dimer bound to two catalytic 
(C) subunits [229]. Each R-subunit contains an inhibitory sequence that occupies the 
active site of the enzyme. Following stimulation of adenylate cyclase, two cAMP molecules 
bind to each R-subunit, initiating a conformational change and releasing active PKA-C. 
While R-subunits are the primary intracellular regulator of PKA-C, an endogenous inhibitor 
(PKI) inhibits PKA-C activity within the nucleus and controls nuclear exportation [229]. 
Spatiotemporal regulation is controlled by various ancillary proteins such as A-kinase 
anchoring proteins (AKAPs) that, via interactions with R-subunits, localize PKA-C near 
substrates [55].  
PKA-C toggles between three major conformational states: open (apo), 
intermediate (nucleotide-bound), and closed (nucleotide/substrate-bound) [42]. This bean-
shaped enzyme consists of a conserved catalytic core comprised of two lobes. The N-
lobe of the kinase is smaller and contains mostly β-sheets and the αC-helix and harboring 
the ATP binding site, while the C-lobe comprises mostly α-helices and contains the 
substrate-binding cleft [35]. In contrast to other Ser/Thr kinases, PKA-C contains an αA-
helix at its N-terminus, which anchors the N-lobe to the C-lobe and contributes to the 
tethering/positioning of the αC-helix. This important structural motif is recognized for its 
role in the activation and inactivation of protein kinases [42]. E31V is located at the C-
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terminus of the αA-helix and adjacent to the C-terminus of the αC-helix. While other 
Cushing's syndrome mutations have been shown to disrupt R-subunit/PKA-C interactions, 
alter the enzyme's catalytic efficiency, and/or change its substrate specificity, the 
mechanism of dysfunction for PKA-CE31V has remained elusive [20, 65, 230]. 
 
Figure 6.1. Structural and kinetic characterization of PKA-CE31V. 
(A) Structure of PKA-C bound to endogenous inhibitor, PKI (PDB: 1ATP) highlighting important 
structural elements and locations of Cushing's syndrome mutations in relation to E31V. (B) Steady 
state phosphorylation kinetics of PKA-CE31V with Kemptide. (C) CONCISE analysis on the apo, 
ATPγN-, ADP- and ATPγN/PKI-bound forms of PKA-CWT (opaque gaussian) and PKA-CE31V 
(outlined gaussian). 
 
Recently, we discovered that the most common Cushing's syndrome mutation, 
PKA-CL205R, abrogates the nucleotide/pseudosubstrate binding cooperativity by reducing 
the intramolecular allostery between the small and large lobe [65]. Based on these 
findings, we suggested that this dysfunctional binding cooperativity and altered allostery 
disrupts substrate recognition and interactions with R-subunits, thereby altering canonical 
cAMP signaling. Despite E31V and L205R being spatially distant, our previous NMR 
analysis suggested they are allosterically coupled [65]. Therefore, we surmised that E31V 
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may affect the kinase's function in a manner similar to L205R, i.e., the non-conservative 
mutation may disrupt the allosteric network and the binding cooperativity. 
To dissect this allosteric mutation's effects, we carried out solution NMR 
spectroscopy along with isothermal titration calorimetry (ITC), kinetic assays, and 
molecular dynamics (MD) simulations. We found that the E31V mutation ablates the 
canonical positive cooperativity, typically seen for PKA-C while maintaining the kinase's 
catalytic efficiency. Specifically, the E31V mutation directly affects the allosteric node that 
connects the αA-, αC-helix, and activation loop, thereby disrupting nucleotide-substrate 
binding cooperativity. Finally, by comparing PKA-CWT with three drivers for Cushing’s 
syndrome, PKA-CE31V, PKA-CL205R, and PKA-CW196R, we found a direct relationship 
between the loss of binding cooperativity and the reduction of allosteric communication 
within the enzyme. Altogether, our results suggest the existence of a common 
dysfunctional mechanism for PKA-C Cushing's mutations discovered thus far. 
6.3 Results 
E31V mutation ablates nucleotide-substrate binding cooperativity in PKA-C. To 
evaluate the effects of E31V on the thermodynamics of nucleotide (ATPγN) and 
pseudosubstrate (PKI) binding, we used isothermal titration calorimetry (ITC) [242]. 
Values of ∆G, ∆H, -T∆S, Kd, and cooperativity coefficients (σ) obtained for PKA-CE31V are 
summarized in Table 6.1, 6.2 [65]. We found PKA-CWT and PKA-CE31V have similar binding 
affinities for ATPγN (Kd = 83 ± 8 and 91 ± 9 µM, respectively). A 7-fold higher binding 
affinity is observed for PKA-CE31V compared to PKA-CWT when binding PKI5-24 to their apo 
forms (Kd = 2.5 ± 0.5 and 17 ± 2 µM, respectively). In contrast to PKA-CWT, upon saturation 
with ATPγN, PKA-CE31V displays a 12-fold reduction in binding affinity (Kd = 0.16 ± 0.02 
and 2 ± 1 µM, respectively). As previously determined, the binding of PKI5-24 to PKA-CWT 
is highly cooperative (σ = 106 ± 18); in contrast, PKA-CE31V displays no cooperativity with 
σ = 1.3 ± 0.7. To evaluate the effects of E31V on the kinase's catalytic efficiency, we 
carried out steady-state coupled enzyme assays using the standard substrate, Kemptide. 
Despite the dramatic effects on binding cooperativity, PKA-CE31V displayed only a slight 
increase in Vmax and a slight decrease in KM, resulting in similar catalytic efficiencies 
(kcat/KM = 0.41 ± 0.05 and 0.46 ± 0.04 for PKA-CWT and PKA-CE31V, respectively; Figure 
6.1 panel B and Table 6.3). Interestingly, mutagenesis of residues adjacent to the E31 
site has shown similar kinetic behavior [48]. 
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NMR mapping of nucleotide/PKI binding response. To analyze the binding response 
of PKA-CE31V to nucleotide and pseudosubstrate, we mapped the amide backbone 
fingerprint of the enzyme using [1H, 15N]-TROSY-HSQC experiments [125]. The amide 
fingerprints of the kinase in different ligated forms are displayed in Figure 6.7. The global 
response of the two kinases to ligand binding was determined using CONCISE 
(COordiNated ChemIcal Shifts bEhavior) [235], which performs a statistical analysis on 
linear chemical shift trajectories of amide resonances to identify the position of each state 
along the conformational equilibrium, shows that nucleotide and pseudosubstrate shift the 
overall populations from an open state to an intermediate and fully closed state. Upon 
binding the nucleotide, the probability density of the amide resonances from the apo shifts 
toward an intermediate state, and the subsequent saturation with PKI peptide further shifts 
toward the fully closed state (Figure 6.1 panel C). Globally wild-type and mutant behave 
similarly; however, upon binding ATPγN, PKA-CE31V adopts a more open conformation 
compared to PKA-CWT and subsequent binding of PKI shifts the probability distribution 
toward a more closed state. 
 
Figure 6.2. Chemical shift perturbation of PKA-CE31V. 
Chemical shift perturbation (CSP) of amide fingerprint of PKA-CE31V upon binding (A) ATPγN and 
subsequent binding of (B) PKI. The average CSP is shown as a dashed line. CSPs of PKA-CE31V 
amide resonances mapped onto the structure (PDB: 1ATP). 
 
 To further confirm the changes in the global response of PKA-C induced by E31V, 
we mapped the chemical shift perturbations (CSP, ∆δ) of PKA-CE31V. Upon binding ATPγN, 
PKA-CE31V exhibits similar CSP patterns as wild-type (Figure 6.2 panel A,C) with larger 
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CSPs occurring throughout the N-lobe and in the c-terminal tail, though to a lesser extent 
than PKA-CWT. Further analysis of the ∆CSP (∆δWT-∆δE31V) shows regions of positive ∆CSP 
confirming that upon binding ATPγN, PKA-CE31V does not adopt as closed of a 
conformation as the wild-type kinase (Figure 6.8 panel A). Subsequent binding of PKI to 
ATPγN-saturated PKA-CE31V also exhibits similar CSPs compared to wild-type (Figure 6.2 
panel B,D), though to a larger extent as reflected in the negative ∆CSP values (Figure 
6.7 panel B). 
 
Figure 6.3. The reduction in binding cooperativity corresponds to a decrease in 
intramolecular allosteric connectivities. 
(A) CHESCA correlation matrix of PKA-CWT (top diagonal) and PKA-CE31V (bottom diagonal) upon 
binding PKI highlighting the notable reductions in correlations within the n-terminal tail (red), 
activation loop (orange), and c-terminal tail (green). Only correlations with Rij> 0.98 are shown. Plot 
of correlation score vs. residue for (B) PKA-CWT and (C) PKA-CE31V emphasizing the residues that 
show the largest reductions in correlation score that make contacts with the C-helix. See material 
and methods for the calculation of correlation scores. 
 
127 
Rearrangement of the allosteric network of PKA-CE31V is linked to a decrease in 
nucleotide-substrate binding cooperativity. Since cooperativity is often manifested as 
structural rearrangements upon ligand binding, we further analyzed the chemical shift 
perturbations of PKA-CWT and PKA-CE31V using CHEmical Shift Covariance Analysis 
(CHESCA). This statistical method identifies covariant residues networks involved in a 
concerted response upon ligand binding and help tracing allosteric pathways [129, 130, 
132]. The [1H, 15N]-TROSY-HSQC spectra of four forms of wild-type and PKA-CE31V (apo, 
ATPγN-bound, ADP-bound, and ATPγN/PKI-bound) were used for CHESCA. When we 
analyzed the chemical shifts changes of PKA-CWT, we identified a well-organized 
communication network in which spatially distinct clusters of residues responding to ATP 
and PKI binding in a coordinated manner [65]. In contrast, we observed a dramatic 
reduction in the intramolecular allosteric network of PKA-CE31V similar to PKA-CL205R, a 
Cushing's syndrome mutation with significantly higher occurrence [65, 228, 230]. In 
particular, highly correlated groups of residues in the N-lobe of PKA-CE31V, including the 
αA-helix (K28, W30) and αC-helix (A97), display a dramatic reduction in the number of 
correlations for distal regions of the kinase, including the activation loop (R190, G193, 
L198), αF-helix (K217, V219, G225), and C-terminal tail (E334, N340, E349) (Figure 6.3). 
Notably, the loss of correlations occurs in structural elements surrounding the αC-helix. 
 The typical CHESCA analysis gives pairwise correlations along the primary protein 
sequences. Therefore, we adopted the definition of structural 'communities' introduced by 
McClendon et al. [140] to obtain a three-dimensional view of the correlated structural 
changes. Using this analysis, we found strong correlations among the major communities 
in response to nucleotide and pseudosubstrate binding (Figure 6.4) [140]. In particular, 
ComA, ComB, and ComC show average correlation coefficients higher than 0.95, 
indicating that these communities respond to ligand binding in a concerted manner. 
Notably, there are long-range correlations between ComA, ComB, and ComC with ComE, 
ComF and ComF1. ComC, which encompasses the αA- and αC-helix including E31, acts 
as a central hub, connecting six other communities as it is centered around a critical 
allosteric mediator the αC-helix, which bridges both lobes of the kinase. The density of 
these correlations underscores the concerted response of the N- and C-lobe to ligand 
binding. While the E31V mutation exhibits some of the local and long-range correlations, 
the values of the correlation coefficients are lower. ComC and parts of the activation loop 
of the mutant exhibit the most noticeable reduction in correlation to both local (ComA and 
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ComB) and distal (ComE and ComF) communities. Indeed ComC acts as a hub in the 
wild-type community map, having connections to six other communities and centered 
around a critical allosteric mediator of the kinase regulation, the αC-helix. 
 
Figure 6.4. Community analysis of PKA-CE31V. 
(A) Community map of PKA-C highlighting functional/regulatory role of each community as defined 
by [140]. (B) Community CHESCA analysis of PKA-CWT (top diagonal, black) and PKA-CE31V 
(bottom diagonal, red). Only correlations with RA,B > 0.8 are shown. 
 
MD simulations corroborate attenuation of allosteric network of PKA-CE31V. To 
determine the effects of the E31V mutation on the conformational energy landscape of 
nucleotide-bound PKA-C, we carried out parallel MD simulations in explicit water. We set 
up the simulations starting from the X-ray coordinates of PKA-CWT (PDB: 4WB5 [106]) 
mutating E31 into a valine and removing PKI [35]. After initial equilibration, we produced 
an MD trajectory and analyzed the conformational dynamics of PKA-CE31V. Relative to 
PKA-CWT, we observed large changes of root mean squared fluctuations (RMSF) of the 
backbone coordinates with effects that propagate to distal domains [80], including the αA-
helix, αC-helix, as well as the C-terminal tail (Figure 6.5 panel A). The most noticeable 
effect of the E31V mutation is the increase in the αA-helix and αC-helix motions, 
presumably due to V31 moving towards the kinase's hydrophobic interior and disrupting 
the cation- π interactions between W30, R93 and R190. These ‘sandwiched’ cation-π 
interactions have been shown to be partially responsible for positioning the indole ring of 
W30 in a conserved pocket that can be exploited to regulate kinases activity [48, 292]. As 
the αA-helix is displaced, the indole ring of W30 undergoes a 180° flip, maintaining only 
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one cation-π interaction with R190 (Figure 6.5 panel B). The alteration of local structure 
is accompanied by the reduction of the global allostery in PKA-CE31V with respect to PKA-
CWT, as is characterized by the dihedral mutual information of all residue pairs. The most 
prominent changes are the loss of correlation between N-terminal αA-helix and other 
regions (Figure 6.9 panel A). The mutual information matrices are further mapped onto 
the kinase structure via graph analysis, highlighting the attenuated network and vanish of 
key hubs throughout the kinase, particularly for S10 at the tip of αA-helix, N216 at αF-
helix, D241 at αG-helix, and N340, F347 at the C-terminal tail(Figure 6.9 panel B), in 
good accordance with the CHESCA analysis. How does the attenuated allosteric network 
between N-lobe and C-lobe affect the binding of pseudosubstrate PKI5-24 and 
cooperativity? We first compared the dynamics of PKI in the ternary complexes. Whereas 
PKI5-24 is rather rigid with an average RMSF of about 1 Å for PKA-CWT, the short peptide 
is much more dynamic for PKA-CE31V, especially in its C-terminal end (Figure 6.5 panel 
C). We next analyzed interaction profile of PKI5-24 by computing the contact probability of 
all residue pairs between the short peptide and kinase. The stable interaction at the high 
affinity region (HAR) and the recognition sequence (P-3, P-2 and P+1 sites) is largely 
preserved, yet the contact probability between the C-terminal end of PKI and the peptide-
positioning loop (residues 198-208) decreases (Figure 6.10), indicative of dynamic C-
terminal flipping out of the hydrophobic pocket. Loss of anchoring of C-terminal end 
echoes the over 100-fold reduction of binding affinity measured by ITC.  
 
Figure 6.5. Altered dynamics of PKA-CE31V reveled by MD simulations.  
(A) ∆RMSF of PKA-CE31V in the binary form over 1.0 µs of simulation. (B) Overlay of PKA-CWT 
(PDB: 1ATP; gray) and PKA-CE31V (from MD simulations; red) highlighting the structural 
rearrangements of the αA- and αC-helices caused by the E31V mutation. The inset shows the 
cation-π stacking interactions altered in response to the mutation. (C) Distinct dynamics of the 
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pseudosubstrate, PKI5-24, in the ternary complex. Putty representation of RMSF for PKI5-24 for a 
typical MD snapshot of PKA-CWT (gray) and PKA-CE31V (red). 
 
To link the MD simulations to the binding thermodynamics derived  from the ITC 
experiments, we computed the difference in free energy of binding (∆∆Gbinding) for PKA-
CWT and PKA-CE31V using the free energy perturbation (FEP) method [293], as detailed in 
the thermodynamic cycle shown in Figure 6.11. The ratio of the cooperativity coefficients 
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𝐸𝐸31𝑉𝑉 represents the ratio of the cooperativity coefficients for wild-type and E31V, 
and the free energy change of a mutation in different states ∆𝐺𝐺1  to ∆𝐺𝐺4  is illustrated in 
Figure 6.11 panel A. Using this expression for the binding of PKI to apo PKA-CE31V, the 
FEP method calculates a free energy difference between the free and bound state of -1.1 
± 0.3 kcal/mol, corresponding to a ~7-fold reduction in the binding affinity of PKA-CE31V for 
PKI. This value is in excellent agreement with the experimental results (Table 6.4). On the 
other hand, the binding of PKI to the nucleotide-bound E31V mutant resulted in a free 
energy perturbation of 0.3 ± 0.2 kcal/mol, indicating a reduction in binding affinity. From 
the differences of these two values, it is possible to estimate approximately a 11-fold 
reduction in the nucleotide/PKI binding cooperativity (Figure 6.3 panel B), which is in 
qualitative agreement with ITC experiments. We also calculated the change in 
cooperativity for binding PKI first and then the nucleotide (Figure 6.3 panel C). These 
calculations confirmed the reduction in cooperativity with a value that is approximately 24-
fold lower for the ATP binding by PKA-CE31V, further supporting the experimentally 
observed loss in cooperativity for PKA-CE31V (Table 6.4).   
Nucleotide-substrate binding cooperativity and extent of allosteric communication 
are directly correlated. Both thermodynamic and NMR data show that Cushing's 
syndrome mutants, PKA-CL205R and PKA-CE31V, exhibit reduced binding cooperativity and 
decreased intramolecular allosteric communication. Therefore, we hypothesized that the 
coordinated structural changes might be correlated to the nucleotide-substrate 
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cooperative binding response. Hence, a disruption of the allosteric network would directly 
affect the nucleotide-substrate binding cooperativity. To test this, we analyzed the 
thermodynamics and structural response of PKA-CW196R, another mutant that was found 
in 3% of Cushing’s patients [20]. This mutation is located in the activation loop and is 
adjacent to the T197 phosphorylation site. We repeated both ITC and NMR analysis for 
PKA-CW196R, and similarly to PKA-CE31V we found a significant attenuation in both binding 
cooperativity and extent of intramolecular allosteric communication (Table 6.5, Figure 
6.12). From the CHESCA matrices of these three mutants and PKA-CWT, we extracted the 
relative correlation score (see Material and Methods), which can be used to estimate the 
density of the intramolecular allosteric networks. We then plot the relative correlation 
scores versus ln(σ). We found that these parameters are linearly correlated (R2 = 0.98, 
Figure 6.6). This relationship suggests that the extent of the nucleotide-substrate binding 
cooperativity depends on the coordinated structural changes of the two lobes of the 
enzyme upon nucleotide and substrate binding.  
 
Figure 6.6. Relationship between coordinated structural changes identified by CHESCA and 
the nucleotide-substrate binding cooperativity (σ) determined by ITC measurements. 




The cAMP/PKA pathway plays a central role in the regulation of adrenocortical growth and 
steroidogenesis [99, 227]. Although multiple components of the cAMP/PKA pathway have 
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been implicated in various endocrine disease states, it was not until recently that PKA-C 
was discovered to play a central role [294]. To date, eight mutations have been discovered 
in PRKACA in cortisol-producing ACA's responsible for Cushing's syndrome [26-30, 102, 
290, 291]. Except for E31V, all mutations are positioned in the substrate binding cleft or 
at the R/C interface, providing a justification for the loss of substrate fidelity and regulation 
of the kinase [20, 65]. However, it has been difficult to rationalize why the E31V mutant 
results in the same phenotype of the other orthosteric Cushing’s syndrome driving 
mutations. This present study shows that local conformational changes caused by the 
E31V mutation alter key allosteric interactions that link the terminal regions of the C-
terminal tail, αA- and αC-helix. MD simulations revealed that the E31V mutation increases 
the conformational dynamics within the αA-helix, causing it to dislodge from the kinase 
core and thereby disrupting canonical cation-π interactions between W30 and R93 and 
R190 [46, 47]. These structural alterations cause the N-lobe of the kinase to swing outward 
adopting a more open conformation, with the activation loop in a flipped conformation, 
forming a stable salt bridge with the αC-helix and disrupting a critical allosteric node 
responsible for inter-lobe allosteric communication and binding cooperativity [46].  
Cooperativity is fundamental factor for macromolecular assembly and signal 
amplification [3, 113, 265]. For PKA-C, binding cooperativity has been used to define the 
role of ATP as an allosteric effector, able to amplify the substrate’s binding affinity [82]. 
However, PKA-C interacts with other binding partners including the R-subunits that keep 
its function under strict control. Notably, the R-subunits recognition sequences are highly 
homologous to those of substrates and PKI. Therefore, it is likely that the loss in 
nucleotide/PKI binding cooperativity we observed for these Cushing’s syndrome mutants 
may negatively affect the assembly of the R:C complex and the entire cAMP signaling 
pathway.    
  In conclusion, we identified a common trait between orthosteric and allosteric 
mutations linked to Cushing's syndrome. These mutations display a reduced binding 
cooperativity with a concomitant loss in intramolecular allosteric communication. The 
effects derived by these events are manifested as a loss of substrate fidelity and regulation 
by the R-subunit, while the catalytic activity of these mutants remains essentially 
unaltered. These results may explain how these aberrant enzymes give rise to anomalous 
phosphoproteomic profiles [20].   
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6.5 Materials and Methods 
Sample Preparation. Recombinant human Cα subunit of cAMP-dependent protein 
kinase A cDNA (PKA-CWT and PKA-CE31V) was cloned into a pET-28a vector. A tobacco 
etch virus (TEV) cleavage site was incorporated via mutagenesis into the vector between 
the cDNA coding for the kinase and a thrombin cleavage site. The kinase was expressed 
in Escherichia coli BL21 (DE3) according to procedures previously published [65]. PKI 
(full-length) was expressed and purified according to procedures previously published 
[60]. Peptides (Kemptide/PKI5-24) were synthesized using standard Fmoc chemistry on a 
CEM Liberty Blue microwave synthesizer, cleaved with Reagent K (82.5% TFA, 5% 
phenol, 5% thioanisole, 2.5% ethanedithiol, and 5% water) for 3 h and purified using a 
semipreparative Supelco C18 reverse-phase HPLC column at 3 mL/min. Molecular weight 
and the quantity of the peptides were verified by LC-MS and/or amino acid analysis (Texas 
Tech Protein Chemistry Laboratory).  
ITC Measurements. ITC measurements were performed with a low-volume NanoITC (TA 
Instruments). PKA-CWT and PKA-CE31V were dialyzed into 20 mM MOPS, 90 mM KCl, 10 
mM DTT, 10 mM MgCl2, and 1 mM NaN3 (pH 6.5). PKA-C concentrations for ITC 
measurements were between 100-110 µM as confirmed by A280 = 53860 M-1cm-1. All 
measurements with ATPγN saturated PKA-CWT and PKA-CE31V were performed at 2 mM 
ATPγN. ITC measurements were performed at 300K in triplicates. Approximately 300 µL 
of PKA-C was used for each experiment, and 50 µL of 2 mM ATPγN and 0.6-0.8 mM PKI 
in the titrant syringe. The heat of dilution of the ligand into the buffer was taken into account 
for all experiments and subtracted. Curves were analyzed with the NanoAnalyze software 
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where d[MX] is the change in total complex with respect to change in total protein 
concentration, d[Xtot] is dependent on r, the ratio of Kd with respect to the total protein 
concentration, and RM, the ratio between total ligand and total protein concentration. The 
free energy of binding was determined using the following: 
∆𝐺𝐺 = 𝑅𝑅𝑅𝑅 ln𝐾𝐾𝑑𝑑  
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where R is the universal gas constant and T is the temperature at measurement (300K). 
The entropic contribution to binding was calculated using the following: 
𝑅𝑅∆𝑆𝑆 =  ∆𝑁𝑁 −  ∆𝐺𝐺. 
Calculations for the cooperativity constant (σ) were calculated as follows:  




where Kd Apo  is the Kd of PKI5-24 binding to the apoenzyme and Kd Nucleotide is the Kd of PKI5-
24 binding to the nucleotide-bound enzyme. 
Enzyme Assays. Steady-state activity assays with Kemptide were performed under 
saturating ATP concentrations and spectrophotometrically at 298K as described by Cook 
et al [85]. The values of Vmax and KM were obtained from a nonlinear fit of the initial 
velocities to the Michaelis-Menten equation. 
NMR Spectroscopy. Uniformly 15N-labeled PKA-CWT and PKA-CE31V were overexpressed 
and purified as described above. NMR experiments were performed in 90 mM KCl, 20 mM 
KH2PO4, 10 mM dithiothreitol (DTT), 10 mM MgCl2, and 1 mM NaN3 at pH 6.5. Standard 
[1H-15N]-TROSY-HSQC experiments were carried out for PKA-CE31V and PKA-CWT on a 
900-MHz Bruker Advance III spectrometer equipped with a TCI cryoprobe. Concentrations 
for samples were 0.2-0.3 mM as determined by A280 measurements, 12 mM ATPγN was 
added for the nucleotide-bound form, and 0.2-1.2 mM PKI for the ternary complex. Spectra 
were collected at 300K, processed using NMRPipe [243], and visualized using Sparky 
[244]. 
All [1H-15N]-TROSY-HSQC experiments were acquired with 2048 (proton) and 256 
(nitrogen) complex points. Combined chemical shift perturbations were calculated using 
1H and 15N chemical shifts according to the following: 
∆𝛿𝛿 =  �(Δ𝛿𝛿𝑁𝑁)2 + 0.154(Δ𝛿𝛿𝑁𝑁)2 
Chemical Shift Analyses. 
COordiNated ChemIcal Shift bEhavior (CONCISE). CONCISE was used to monitor 
chemical shift trajectories and measure the change in equilibrium position using each 
PKA-C construct (apo, ATPγN, ADP, ATPγN/PKI). This method uses principal component 
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analysis to identify sets of residues whose chemical shifts respond linearly to a 
conformational transition (i.e. open, intermediate, and closed). Each residue provides a 
measure of the equilibrium position for each PKA-C construct in the form of scores along 
the first principal component (PC1). To identify the residues whose chemical shifts follow 
a linear trajectory, a threshold of 3.0 for the ratio of the standard deviations of PC1 over 
PC2 was used, and residues not exhibiting a significant chemical shift were excluded 
based on the linewidth.  
CHEmical Shift Covariance Analysis (CHESCA). CHESCA was used to identify and 
functionally characterize allosteric networks of residues eliciting concerted responses to, 
in this case, nucleotide and pseudosubstrate. A total of four states were used to identify 
inter-residue correlations: apo, ADP-bound, ATPγN-bound, and ATPγN/PKI-bound. 
Identification of inter-residue correlations by CHESCA relies on agglomerative clustering 
(AC) and singular value decomposition (SVD). Pairwise correlations between chemical 
shift variations experienced by different residues are analyzed to identify networks of 
coupled residues and when plotted on a correlation matrix, allows for the identification of 
regions that are correlated to one another. A correlation coefficient (Rij) cutoff of 0.96 was 
used to filter non-linear residues. Residues not exhibiting a significant chemical shift (small 
shifts in ppm) were excluded based on linewidth. For each residue the max change in 
chemical shift was calculated in both the 1H (x) and 15N (y) dimension (Δδx,y). Residues 
were included in CHESCA analysis only if they satisfied the following: Δδx,y > ½ ΔνxA,yA+½ 
Δν xB,yB , where A and B correspond to two different forms analyzed (note there is no 
dependence on which two forms satisfied this statement). Correlation scores were used 
to quantify the CHESCA correlation of a single residue or a group of residues with another 
group. Correlation scores were evaluated for both (a) a single residue and (b) the full 
protein. The generalized mathematical expression for evaluating either case is given as 
follows:  
𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑆𝑆𝑆𝑆𝐶𝐶𝐶𝐶𝑒𝑒 =
𝑙𝑙𝑛𝑛𝑛𝑛𝑛𝑛𝑒𝑒𝐶𝐶 𝐶𝐶𝑜𝑜 (𝑅𝑅𝑁𝑁𝑖𝑖 > 𝑆𝑆𝑛𝑛𝑐𝑐𝐶𝐶𝑜𝑜𝑜𝑜)
𝑐𝑐𝐶𝐶𝑐𝑐𝑡𝑡𝑙𝑙 𝑙𝑙𝑛𝑛𝑛𝑛𝑛𝑛𝑒𝑒𝐶𝐶 𝐶𝐶𝑜𝑜 𝑅𝑅𝑁𝑁𝑖𝑖
 
where R is the CHESCA correlation matrix and i and j denote (a) a single residue and all 
other assigned residues in the protein, respectively, or (b) both represent all the assigned 
residues in the protein. Community CHESCA analysis is a chemical shift based correlation 
map between various functional communities within the kinase. Each community is a 
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group of residues (McClendon et al.[140]) associated with a function or regulatory 
mechanism. Mathematically, this community-based CHESCA analysis is a selective 
interpretation of CHESCA, where we evaluate a correlation score between residues in 
various communities as shown below. In order to represent community-based CHESCA 
analysis we lowered the correlation cutoff such that Rcutoff > 0.8. Suppose community A 
and community B has nA and nB number of assigned residues respectively, the correlation 
score between A and B is defined as,  
RA,B = Number of (Rij > Rcutoff) / (nA * nB). 
Where Rij is the CHESCA correlation coefficient between residue i (belongs to community 
A) and residue j (belongs to community B). Rcutoff is the correlation value cutoff. RA,B can 
take values from 0 (no correlation between residues in A and B) to 1 (all residues in A has 
correlation > cutoff with all residues in B).  
MD Simulations. We used the crystal structure of PKA-CWT (PDB ID: 4WB5[106]) as the 
template. We further aligned the current structure with the full length PKA-CWT and added 
the missing residues 1-12 at the N terminus. The protonation state of histidine residues 
followed our previous settings [80]. The protein was solvated in a rhombic dodecahedron 
solvent box with TIP3P water molecule layer extended approximately 10 Å away from the 
surface of the proteins. Counter ions (K+ and Cl-) were added to ensure electrostatic 
neutrality corresponding to an ionic concentration of ~150 mM. All covalent bonds 
involving a hydrogen atom of the protein were constrained with the LINCS[287]algorithm. 
and long-range electrostatic interactions were treated with the particle-mesh Ewald [288] 
method with a real-space cutoff of 10 Å. Parallel simulations on the apo form, the binary 
form with one Mg2+ ion and one ATP, and the ternary form with two Mg2+ ions, one ATP 
and one PKI5-24 were performed simultaneously using GROMACS 5.1.4 [285] with the 
CHARMM36a1 force field [286]. Each system was minimized using the steepest decent 
algorithm to remove bad contacts, and then gradually heated to 300K at a constant volume 
over 1 ns, using harmonic restraints with a force constant 1000 kJ/(mol*Å2) on heavy 
atoms of both proteins and nucleotides. Over the following 12 ns of simulations at constant 
pressure (1 atm) and temperature (300K), the restraints were gradually released. The 
systems were equilibrated for an additional 20 ns without positional restraints. The 
Parrinello-Rahman[289] barostat was used to keep the pressure constant, while a V-
rescale thermostat with a time step of 2 fs was used to keep the temperature constant. 
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Each system was simulated for 1.0 µs, with snapshots recorded every 50 ps. To 
characterize the allosteric network, the dihedral mutual information was computed using 
MDEntropy [295] for every residue pair, and the normalized mutual information matrix was 
mapped onto the structure for graph analysis using Xpyder [296] with MIcutoff = 0.3. 
Relative change of cooperativity from free energy perturbation calculations. The 
cooperativity can be defined for both nucleotide and pseudosubstrate PKI, respectively. 
For nucleotide, the change of cooperativity upon mutation can be rewritten as the 
difference in ∆∆G between the apo and the PKI-bound state, as shown in the following 
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(∆𝐺𝐺1 −∆𝐺𝐺3 )+(∆𝐺𝐺4 −∆𝐺𝐺2 )
𝑅𝑅𝑇𝑇  
The free energies ∆G due to amino acid mutations were determined following a protocol 
based on the Bennett acceptance ratio (BAR) implemented in the GROMACS and PMX 
[293]. To avoid the artifacts by introducing a charged mutation, the double-system/single-
box setup was used. The procedure employs dual protein topologies that include both 
residues of the wild-type (λ = 0) and the mutant protein (λ = 1) coupled by the progressing 
variable λ. Of course, both the complex and unbound structures were used to obtain the 
change in binding free energies using standard thermodynamic cycle approach. Single-
site mutations were performed based on the well-equilibrated structure of PKA-CWT from 
simulations. The computational details are identical to those detailed above, except that 
after 40 ns of equilibration of both initial and final states for each mutation, 200 additional 
trajectories, each lasting 100 ps, were initiated from the last 20 ns simulations both in the 
forward and in the backward transformations to accumulate statistical averages and 
fluctuations.   
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6.8 Supplementary Figures 
 
Figure 6.7. [1H, 15N]-TROSY-HSQC spectra for PKA-CWT and PKA-CE31V in the apo, ATPγN-, 




Figure 6.8. Change in chemical shift perturbation between PKA-CWT and PKA-CE31V. 




Figure 6.9. Attenuated allostery of PKA-CE31V revealed by MD simulations.  
(A) Dihedral mutual information matrices of PKA-CWT and PKA-CE31V, highlighting the prominent 
reduction of allostery in the N-terminus of PKA-CE31V. (B) Comparison of allosteric network mapping 





Figure 6.10. Distinct interaction profile of PKI5-24 in the ternary complex with PKA-CWT and 
PKA-CE31V. 
Probability of the formation of inter-residue contact between PKA-CWT (above) and PKI5-24 and 
PKA-CE31V (below) ternary complex, highlighting a prominent reduction of interaction between the 




Figure 6.11. Thermodynamic cycle linking the free energy perturbation (FEP) calculation to 
ratio of Kd and σ. 
(A). Alchemical transition steps that determine the relative change of binding free energy. 





𝑊𝑊𝑊𝑊 , or be computed from the difference between the two alchemical 
transition ∆G2-∆G1. (B). Computational scheme used to determine the ratio of the 
cooperativity coefficients (σ). ∆∆G21 is directly computed by grouping the two alchemical 
transitions in the same simulation box with forward transition of WT -> E31V, along with 
the reverse transition of E31V/PKI5-24 -> WT/PKI5-24. The same computational scheme was 
used to determine ∆∆G43. The ratio of σ was derived from the difference between ∆∆G21 
and ∆∆G43. (C). Computational scheme used to determine the ratio of the cooperativity 




Figure 6.12. Correlation score analysis of PKA-CL205R and PKA-CW196R.  
Plot of correlation score vs. residue for (A) PKA-CL205R and (B) PKA-CW196R. See materials and 
methods for the calculation of correlation scores. 
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6.9 Supplementary Tables 
Table 6.1. Changes in enthalpy, entropy, free energy, and dissociation constant for the 
binding of nucleotide to PKA-CE31V. 
All errors were calculated using triplicate measurements. Values for PKA-CWT are published in [65]. 
 Kd (µM) ∆G (kcal/mol) ∆H (kcal/mol) -T∆S (kcal/mol) 
PKA-CE31V 91 ± 9 -5.56 ± 0.06 -3.7 ± 0.2 -1.9 ± 0.2 
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Table 6.2. Changes in enthalpy, entropy, free energy, and dissociation constant for the 
binding of PKI5-24 to apo and nucleotide-saturated PKA-CE31V. 
Errors in ∆G, ∆H, -T∆S, and Kd were calculated using triplicate measurements. Errors in σ were 
propagated from error in Kd. Values for PKA-CWT are published in [65]. 
 Kd (µM) ∆G (kcal/mol) ∆H (kcal/mol) -T∆S (kcal/mol) σ 
Apo 2.5 ± 0.5 -7.7 ± 0.1 -19.8 ± 0.4 12.1 ± 0.5 N/A 




Table 6.3. Kinetic parameters of Kemptide phosphorylation by PKA-CWT and PKA-CE31V.  
Values for Km and kcat were obtained from a non-linear least squares analysis of the concentration-
dependent initial phosphorylation rates using a standard coupled enzyme activity assay. Error in 
kcat/KM was propagated from error in KM and kcat. 
 
 PKA-CWT PKA-CE31V 
Vmax (µM/sec) 0.52 ± 0.02 0.58 ± 0.02 
KM (µM) 59 ± 7 56 ± 5 
kcat (s-1) 24 ± 1 26 ± 1 




Table 6.4. Changes in relative binding free energy, ∆∆G, and cooperativity from PKA-CWT to 
PKA-CE31V for the binding of PKI5-24 and the binding of ATP in the apo and binary states. 
 ΔΔGapo (kcal/mol) ΔΔGbinary (kcal/mol) Reduction in σ 
PKI5-24 binding -1.1 ± 0.3 0.3 ± 0.2 11 ± 5 




Table 6.5. Changes in enthalpy, entropy, free energy, and dissociation constant for the 
binding of PKI5-24 to apo and nucleotide-saturated PKA-CW196R. 
Errors in ∆G, ∆H, -T∆S, and Kd were calculated using triplicate measurements. Errors in σ were 
propagated from error in Kd.  
 Kd (µM) ∆G (kcal/mol) ∆H (kcal/mol) -T∆S (kcal/mol) σ 
Apo 5 ± 2 -7.3 ± 0.2 -21.1 ± 0.8 13.8 ± 0.5 N/A 





Since it was articulated nearly half a century ago, allostery has remained essential 
in understanding processes beyond the molecular level such as signal propagation and 
disease. Despite the substantial progress in understanding the complexities, many 
aspects underlying allosteric control are still poorly understood. Nonetheless, studies of 
allostery in relation to enzymology and pharmacology continue to be intense focal points 
due its expanding role in disease and drug discovery. 
Biomolecules that exist in a range of closely related conformational states are 
defined as allosteric, as perturbation to any site in the structure leads to shifts in the 
distribution of the conformational states across the ensemble. In the cell, allosteric 
perturbations are common, typically arising from effector (ions, lipids, cAMP, drugs, 
proteins, RNA, DNA) binding; or covalent events such as phosphorylation or point 
mutations. With detailed mechanistic studies now being achievable thanks to advances in 
experimental and computational methods, recent studies have considered the impact of 
allosteric perturbations with a particular interest on how they impact cellular function and 
disease pathogenesis. Interestingly, although many characterized disease-causing 
mutations are located in binding sites, genetic analyses suggest that a majority of these 
mutations occur in locations distant from binding sites in proteins making allostery critical 
our understanding. Mutations are known to cause disease by either one of the following 
mechanisms: 1) a shift in the free-energy landscape (ensemble populations) leading to 
changing populations of the ‘on’ or ‘off’ states or leading to a change in the active site 
shape or dynamics or 2) the redistribution of the allosteric network in the protein. This 
extensive list illustrates how diverse mechanisms can be exploited to elicit dysfunction. 
This thesis presents a series of studies highlighting the intricate regulation of 
allosteric information transfer and demonstrating that small perturbations in the form of 
mutations (see Chapter 4, 5, and 6) or ligand architectures (see Chapter 4) can disrupt 
enzymatic function through alteration of allosteric pathways or conformational ensembles. 
The studies presented herein highlight the fundamental role of allostery in cellular function 
and its relevance to disease, particularly in relation to Cushing’s Syndrome and 
Fibrolamellar Hepatocellular Carcinoma. Furthermore, cumulatively these studies suggest 
that attenuated allosteric cooperativity underlies the dysfunction of protein kinase A in 
disease pathogenesis. Together these studies lay the foundation for future work 
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addressing the implications of dysfunctional allostery in the context of regulation of PKA. 
In particular: How do changes in allosteric cooperativity manifest as alterations in the 
regulation of PKA? Do changes in the intramolecular allosteric network drive non-
canonical protein-protein interactions? Moreover, what are the implications of allostery on 
the cellular level? 
From the simplest perspective, allostery takes place on a single-molecule level, 
but to understand its effects it is necessary to put allostery in the context of the cell. The 
significant crosstalk amongst signaling pathways alone suggests that dysfunction of one 
component can elicit multiple disease consequences. Despite this, the implications of 
dysfunctional allostery and cooperativity on regulation are currently not well established. 
Thus, future studies focusing on the consequences of dysfunctional allostery in the context 
of the cellular network and organism will be essential to fully grasp the significance of 
allostery. Furthermore, studies looking at the implications of allostery from a systems 
biology perspective would assist in linking aberrant allosteric events on the single-
molecule level to disease pathogenesis on the cellular level.  
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